GO Term	Description	P-value	FDR q-value	Enrichment	N	B	n	b	Genes
GO:0099537	trans-synaptic signaling	2.61E-21	3.87E-17	3.70	14984	278	1079	74	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, CEP89  -  centrosomal protein 89kda, PDE7B  -  phosphodiesterase 7b, CHRM3  -  cholinergic receptor, muscarinic 3, SYT1  -  synaptotagmin i, SYT5  -  synaptotagmin v, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, NLGN1  -  neuroligin 1, SV2B  -  synaptic vesicle glycoprotein 2b, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, EGR3  -  early growth response 3, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, UNC13B  -  unc-13 homolog b (c. elegans), SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, NLGN3  -  neuroligin 3, CPNE6  -  copine vi (neuronal), DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NRXN2  -  neurexin 2, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, SST  -  somatostatin, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, EFNB3  -  ephrin-b3, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, CNR1  -  cannabinoid receptor 1 (brain), RIMBP2  -  rims binding protein 2, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PDYN  -  prodynorphin, GRIA1  -  glutamate receptor, ionotropic, ampa 1, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, BSN  -  bassoon presynaptic cytomatrix protein, CBLN1  -  cerebellin 1 precursor, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, GLRA3  -  glycine receptor, alpha 3, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PRKCG  -  protein kinase c, gamma, CDH8  -  cadherin 8, type 2, NPTX1  -  neuronal pentraxin i, PTCHD1  -  patched domain containing 1, GRM5  -  glutamate receptor, metabotropic 5, NPTX2  -  neuronal pentraxin ii, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1]
GO:0099536	synaptic signaling	6.82E-21	5.06E-17	3.64	14984	282	1079	74	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, CEP89  -  centrosomal protein 89kda, PDE7B  -  phosphodiesterase 7b, CHRM3  -  cholinergic receptor, muscarinic 3, SYT1  -  synaptotagmin i, SYT5  -  synaptotagmin v, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, NLGN1  -  neuroligin 1, SV2B  -  synaptic vesicle glycoprotein 2b, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, EGR3  -  early growth response 3, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, EXT1  -  exostosin glycosyltransferase 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, UNC13B  -  unc-13 homolog b (c. elegans), SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, NLGN3  -  neuroligin 3, CPNE6  -  copine vi (neuronal), DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NRXN2  -  neurexin 2, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, SST  -  somatostatin, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, EFNB3  -  ephrin-b3, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, CNR1  -  cannabinoid receptor 1 (brain), RIMBP2  -  rims binding protein 2, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PDYN  -  prodynorphin, GRIA1  -  glutamate receptor, ionotropic, ampa 1, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, BSN  -  bassoon presynaptic cytomatrix protein, CBLN1  -  cerebellin 1 precursor, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, GLRA3  -  glycine receptor, alpha 3, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PRKCG  -  protein kinase c, gamma, CDH8  -  cadherin 8, type 2, NPTX1  -  neuronal pentraxin i, PTCHD1  -  patched domain containing 1, GRM5  -  glutamate receptor, metabotropic 5, NPTX2  -  neuronal pentraxin ii, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1]
GO:0098916	anterograde trans-synaptic signaling	1.63E-19	8.07E-16	3.66	14984	262	1079	69	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, CEP89  -  centrosomal protein 89kda, PDE7B  -  phosphodiesterase 7b, CHRM3  -  cholinergic receptor, muscarinic 3, SYT1  -  synaptotagmin i, SYT5  -  synaptotagmin v, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, NLGN1  -  neuroligin 1, SV2B  -  synaptic vesicle glycoprotein 2b, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, EGR3  -  early growth response 3, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, UNC13B  -  unc-13 homolog b (c. elegans), SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, NLGN3  -  neuroligin 3, CPNE6  -  copine vi (neuronal), DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NRXN2  -  neurexin 2, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, SST  -  somatostatin, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, RIMBP2  -  rims binding protein 2, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PDYN  -  prodynorphin, GRIA1  -  glutamate receptor, ionotropic, ampa 1, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, BSN  -  bassoon presynaptic cytomatrix protein, CBLN1  -  cerebellin 1 precursor, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, GLRA3  -  glycine receptor, alpha 3, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PRKCG  -  protein kinase c, gamma, PTCHD1  -  patched domain containing 1, NPTX1  -  neuronal pentraxin i, CDH8  -  cadherin 8, type 2, GRM5  -  glutamate receptor, metabotropic 5, NPTX2  -  neuronal pentraxin ii]
GO:0007268	chemical synaptic transmission	1.63E-19	6.05E-16	3.66	14984	262	1079	69	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, CEP89  -  centrosomal protein 89kda, PDE7B  -  phosphodiesterase 7b, CHRM3  -  cholinergic receptor, muscarinic 3, SYT1  -  synaptotagmin i, SYT5  -  synaptotagmin v, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, NLGN1  -  neuroligin 1, SV2B  -  synaptic vesicle glycoprotein 2b, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, EGR3  -  early growth response 3, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, EXT1  -  exostosin glycosyltransferase 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, UNC13B  -  unc-13 homolog b (c. elegans), SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, NLGN3  -  neuroligin 3, CPNE6  -  copine vi (neuronal), DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NRXN2  -  neurexin 2, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, SST  -  somatostatin, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, RIMBP2  -  rims binding protein 2, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PDYN  -  prodynorphin, GRIA1  -  glutamate receptor, ionotropic, ampa 1, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, BSN  -  bassoon presynaptic cytomatrix protein, CBLN1  -  cerebellin 1 precursor, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, GLRA3  -  glycine receptor, alpha 3, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PRKCG  -  protein kinase c, gamma, PTCHD1  -  patched domain containing 1, NPTX1  -  neuronal pentraxin i, CDH8  -  cadherin 8, type 2, GRM5  -  glutamate receptor, metabotropic 5, NPTX2  -  neuronal pentraxin ii]
GO:0007267	cell-cell signaling	1.35E-14	4.02E-11	2.68	14984	462	1030	85	[PANX1  -  pannexin 1, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, TM2D3  -  tm2 domain containing 3, ECE2  -  endothelin converting enzyme 2, PDE7B  -  phosphodiesterase 7b, CHRM3  -  cholinergic receptor, muscarinic 3, SYT1  -  synaptotagmin i, SYT5  -  synaptotagmin v, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, CARTPT  -  cart prepropeptide, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, HRH1  -  histamine receptor h1, PCDH1  -  protocadherin 1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, NLGN1  -  neuroligin 1, SV2B  -  synaptic vesicle glycoprotein 2b, GJB5  -  gap junction protein, beta 5, 31.1kda, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, EGR3  -  early growth response 3, CCL4  -  chemokine (c-c motif) ligand 4, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, IL1B  -  interleukin 1, beta, EXT1  -  exostosin glycosyltransferase 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, UNC13B  -  unc-13 homolog b (c. elegans), NLGN3  -  neuroligin 3, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, CPNE6  -  copine vi (neuronal), TEK  -  tek tyrosine kinase, endothelial, DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NRXN2  -  neurexin 2, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, SST  -  somatostatin, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, EFNB3  -  ephrin-b3, PTHLH  -  parathyroid hormone-like hormone, EFNB2  -  ephrin-b2, CNR1  -  cannabinoid receptor 1 (brain), NQO1  -  nad(p)h dehydrogenase, quinone 1, RIMBP2  -  rims binding protein 2, PDYN  -  prodynorphin, GRIA1  -  glutamate receptor, ionotropic, ampa 1, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, SFRP2  -  secreted frizzled-related protein 2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, BSN  -  bassoon presynaptic cytomatrix protein, GRIK3  -  glutamate receptor, ionotropic, kainate 3, CBLN1  -  cerebellin 1 precursor, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PRKCG  -  protein kinase c, gamma, NPTX1  -  neuronal pentraxin i, CDH8  -  cadherin 8, type 2, PTCHD1  -  patched domain containing 1, NPTX2  -  neuronal pentraxin ii, GRM5  -  glutamate receptor, metabotropic 5, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1]
GO:0023052	signaling	2.78E-14	6.88E-11	2.52	14984	537	1030	93	[PANX1  -  pannexin 1, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, TM2D3  -  tm2 domain containing 3, ECE2  -  endothelin converting enzyme 2, PDE7B  -  phosphodiesterase 7b, CHRM3  -  cholinergic receptor, muscarinic 3, SYT1  -  synaptotagmin i, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SYT5  -  synaptotagmin v, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, CARTPT  -  cart prepropeptide, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, HRH1  -  histamine receptor h1, PCDH1  -  protocadherin 1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, NLGN1  -  neuroligin 1, SV2B  -  synaptic vesicle glycoprotein 2b, GJB5  -  gap junction protein, beta 5, 31.1kda, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, EGR3  -  early growth response 3, CCL4  -  chemokine (c-c motif) ligand 4, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, IL1B  -  interleukin 1, beta, EXT1  -  exostosin glycosyltransferase 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, UNC13B  -  unc-13 homolog b (c. elegans), DSP  -  desmoplakin, NLGN3  -  neuroligin 3, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, CPNE6  -  copine vi (neuronal), TEK  -  tek tyrosine kinase, endothelial, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NRXN2  -  neurexin 2, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, SST  -  somatostatin, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, EFNB3  -  ephrin-b3, PTHLH  -  parathyroid hormone-like hormone, EFNB2  -  ephrin-b2, CNR1  -  cannabinoid receptor 1 (brain), NQO1  -  nad(p)h dehydrogenase, quinone 1, RIMBP2  -  rims binding protein 2, PDYN  -  prodynorphin, GRIA1  -  glutamate receptor, ionotropic, ampa 1, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, SFRP2  -  secreted frizzled-related protein 2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, KCNK1  -  potassium channel, subfamily k, member 1, BSN  -  bassoon presynaptic cytomatrix protein, GRIK3  -  glutamate receptor, ionotropic, kainate 3, CBLN1  -  cerebellin 1 precursor, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, GLRA3  -  glycine receptor, alpha 3, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PRKCG  -  protein kinase c, gamma, CDH8  -  cadherin 8, type 2, NPTX1  -  neuronal pentraxin i, PTCHD1  -  patched domain containing 1, NPTX2  -  neuronal pentraxin ii, GRM5  -  glutamate receptor, metabotropic 5, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1]
GO:0050804	modulation of chemical synaptic transmission	5.43E-14	1.15E-10	2.74	14984	395	1079	78	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, IQSEC2  -  iq motif and sec7 domain 2, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NLGN1  -  neuroligin 1, CALB1  -  calbindin 1, 28kda, CALB2  -  calbindin 2, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CELF4  -  cugbp, elav-like family member 4, STX1A  -  syntaxin 1a (brain), BDNF  -  brain-derived neurotrophic factor, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, NPTXR  -  neuronal pentraxin receptor, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, IL1B  -  interleukin 1, beta, ERC2  -  elks/rab6-interacting/cast family member 2, UNC13B  -  unc-13 homolog b (c. elegans), JPH4  -  junctophilin 4, BEGAIN  -  brain-enriched guanylate kinase-associated, RGS4  -  regulator of g-protein signaling 4, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, TSHZ3  -  teashirt zinc finger homeobox 3, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, NMU  -  neuromedin u, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), RIMS1  -  regulating synaptic membrane exocytosis 1, EFNB3  -  ephrin-b3, CNR1  -  cannabinoid receptor 1 (brain), ITPKA  -  inositol-trisphosphate 3-kinase a, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, TNR  -  tenascin r, GRIA1  -  glutamate receptor, ionotropic, ampa 1, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, TMEM108  -  transmembrane protein 108, DGKI  -  diacylglycerol kinase, iota, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, NTNG2  -  netrin g2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, CBLN1  -  cerebellin 1 precursor, MAPK1  -  mitogen-activated protein kinase 1, LRFN2  -  leucine rich repeat and fibronectin type iii domain containing 2, GRM1  -  glutamate receptor, metabotropic 1, DGKB  -  diacylglycerol kinase, beta 90kda, EPHA4  -  eph receptor a4, GRM8  -  glutamate receptor, metabotropic 8, GRM7  -  glutamate receptor, metabotropic 7, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PTPRA  -  protein tyrosine phosphatase, receptor type, a, CPLX3  -  complexin 3, PRKCG  -  protein kinase c, gamma, NPTX1  -  neuronal pentraxin i, USP46  -  ubiquitin specific peptidase 46, NPTX2  -  neuronal pentraxin ii, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, MPP2  -  membrane protein, palmitoylated 2 (maguk p55 subfamily member 2), NRG3  -  neuregulin 3, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, BAIAP3  -  bai1-associated protein 3]
GO:0099177	regulation of trans-synaptic signaling	6.32E-14	1.17E-10	2.74	14984	396	1079	78	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, IQSEC2  -  iq motif and sec7 domain 2, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NLGN1  -  neuroligin 1, CALB1  -  calbindin 1, 28kda, CALB2  -  calbindin 2, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CELF4  -  cugbp, elav-like family member 4, STX1A  -  syntaxin 1a (brain), BDNF  -  brain-derived neurotrophic factor, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, NPTXR  -  neuronal pentraxin receptor, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, IL1B  -  interleukin 1, beta, ERC2  -  elks/rab6-interacting/cast family member 2, UNC13B  -  unc-13 homolog b (c. elegans), JPH4  -  junctophilin 4, BEGAIN  -  brain-enriched guanylate kinase-associated, RGS4  -  regulator of g-protein signaling 4, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, TSHZ3  -  teashirt zinc finger homeobox 3, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, NMU  -  neuromedin u, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), RIMS1  -  regulating synaptic membrane exocytosis 1, EFNB3  -  ephrin-b3, CNR1  -  cannabinoid receptor 1 (brain), ITPKA  -  inositol-trisphosphate 3-kinase a, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, TNR  -  tenascin r, GRIA1  -  glutamate receptor, ionotropic, ampa 1, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, TMEM108  -  transmembrane protein 108, DGKI  -  diacylglycerol kinase, iota, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, NTNG2  -  netrin g2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, CBLN1  -  cerebellin 1 precursor, MAPK1  -  mitogen-activated protein kinase 1, LRFN2  -  leucine rich repeat and fibronectin type iii domain containing 2, GRM1  -  glutamate receptor, metabotropic 1, DGKB  -  diacylglycerol kinase, beta 90kda, EPHA4  -  eph receptor a4, GRM8  -  glutamate receptor, metabotropic 8, GRM7  -  glutamate receptor, metabotropic 7, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, PTPRA  -  protein tyrosine phosphatase, receptor type, a, CPLX3  -  complexin 3, PRKCG  -  protein kinase c, gamma, NPTX1  -  neuronal pentraxin i, USP46  -  ubiquitin specific peptidase 46, NPTX2  -  neuronal pentraxin ii, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, MPP2  -  membrane protein, palmitoylated 2 (maguk p55 subfamily member 2), NRG3  -  neuregulin 3, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, BAIAP3  -  bai1-associated protein 3]
GO:0007154	cell communication	2.87E-11	4.74E-8	2.07	14984	696	1030	99	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), CARTPT  -  cart prepropeptide, PCDH1  -  protocadherin 1, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, SV2B  -  synaptic vesicle glycoprotein 2b, GJB5  -  gap junction protein, beta 5, 31.1kda, RRAGB  -  ras-related gtp binding b, DAPL1  -  death associated protein-like 1, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, CCL4  -  chemokine (c-c motif) ligand 4, EGR3  -  early growth response 3, LPL  -  lipoprotein lipase, IL1B  -  interleukin 1, beta, WNT4  -  wingless-type mmtv integration site family, member 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, NLGN3  -  neuroligin 3, SESN3  -  sestrin 3, GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, EFNB3  -  ephrin-b3, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, PTHLH  -  parathyroid hormone-like hormone, PDYN  -  prodynorphin, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, BSN  -  bassoon presynaptic cytomatrix protein, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, NPY5R  -  neuropeptide y receptor y5, AKAP5  -  a kinase (prka) anchor protein 5, KIAA1324  -  kiaa1324, PTCHD1  -  patched domain containing 1, NPTX1  -  neuronal pentraxin i, CDH8  -  cadherin 8, type 2, NPTX2  -  neuronal pentraxin ii, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PANX1  -  pannexin 1, SYN2  -  synapsin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, TM2D3  -  tm2 domain containing 3, ECE2  -  endothelin converting enzyme 2, PDE7B  -  phosphodiesterase 7b, SYT1  -  synaptotagmin i, CHRM3  -  cholinergic receptor, muscarinic 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, SYT5  -  synaptotagmin v, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, NLGN1  -  neuroligin 1, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, FREM3  -  fras1 related extracellular matrix 3, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, IMPACT  -  impact rwd domain protein, UNC13B  -  unc-13 homolog b (c. elegans), CXADR  -  coxsackie virus and adenovirus receptor, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, CPNE6  -  copine vi (neuronal), TEK  -  tek tyrosine kinase, endothelial, DLG2  -  discs, large homolog 2 (drosophila), GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, NRXN2  -  neurexin 2, SST  -  somatostatin, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, NQO1  -  nad(p)h dehydrogenase, quinone 1, RIMBP2  -  rims binding protein 2, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, SFRP2  -  secreted frizzled-related protein 2, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, GRIK3  -  glutamate receptor, ionotropic, kainate 3, CBLN1  -  cerebellin 1 precursor, MAPK1  -  mitogen-activated protein kinase 1, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, PRKCG  -  protein kinase c, gamma, BCL2  -  b-cell cll/lymphoma 2, GRM5  -  glutamate receptor, metabotropic 5, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator]
GO:0042391	regulation of membrane potential	1.79E-10	2.66E-7	2.47	14984	381	1002	63	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, KCNH5  -  potassium voltage-gated channel, subfamily h (eag-related), member 5, PID1  -  phosphotyrosine interaction domain containing 1, CELF4  -  cugbp, elav-like family member 4, GABBR1  -  gamma-aminobutyric acid (gaba) b receptor, 1, STX1A  -  syntaxin 1a (brain), GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, UNC13B  -  unc-13 homolog b (c. elegans), DSP  -  desmoplakin, RGS4  -  regulator of g-protein signaling 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, CXADR  -  coxsackie virus and adenovirus receptor, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, NLGN3  -  neuroligin 3, FHL1  -  four and a half lim domains 1, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, GLRA2  -  glycine receptor, alpha 2, RIMS1  -  regulating synaptic membrane exocytosis 1, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, CNR1  -  cannabinoid receptor 1 (brain), GPR88  -  g protein-coupled receptor 88, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, TMEM108  -  transmembrane protein 108, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, KCNK1  -  potassium channel, subfamily k, member 1, GRIK3  -  glutamate receptor, ionotropic, kainate 3, CBLN1  -  cerebellin 1 precursor, GRM1  -  glutamate receptor, metabotropic 1, GLRA3  -  glycine receptor, alpha 3, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NPPA  -  natriuretic peptide a, BCL2  -  b-cell cll/lymphoma 2, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, MPP2  -  membrane protein, palmitoylated 2 (maguk p55 subfamily member 2), CCK  -  cholecystokinin]
GO:0050877	nervous system process	2.73E-10	3.69E-7	2.38	14984	655	653	68	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), NCAM2  -  neural cell adhesion molecule 2, OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, PCDH15  -  protocadherin-related 15, DRD2  -  dopamine receptor d2, TACR2  -  tachykinin receptor 2, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, WNT10B  -  wingless-type mmtv integration site family, member 10b, HRH1  -  histamine receptor h1, CALB1  -  calbindin 1, 28kda, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, BDNF  -  brain-derived neurotrophic factor, WFS1  -  wolfram syndrome 1 (wolframin), DCDC2  -  doublecortin domain containing 2, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, FAM65B  -  family with sequence similarity 65, member b, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, COCH  -  cochlin, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, DAW1  -  dynein assembly factor with wdr repeat domains 1, PLCB2  -  phospholipase c, beta 2, KLK8  -  kallikrein-related peptidase 8, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, RGS14  -  regulator of g-protein signaling 14, TNNI3  -  troponin i type 3 (cardiac), MYO7A  -  myosin viia, TSHZ3  -  teashirt zinc finger homeobox 3, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, NMU  -  neuromedin u, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, GLRA2  -  glycine receptor, alpha 2, C1QL1  -  complement component 1, q subcomponent-like 1, RIMS1  -  regulating synaptic membrane exocytosis 1, PRNP  -  prion protein, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, NRXN2  -  neurexin 2, PKD2L1  -  polycystic kidney disease 2-like 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, GPR88  -  g protein-coupled receptor 88, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, OTOGL  -  otogelin-like, PDYN  -  prodynorphin, TNR  -  tenascin r, PTGES  -  prostaglandin e synthase, GRIA1  -  glutamate receptor, ionotropic, ampa 1, SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, SNAI2  -  snail family zinc finger 2, GRM8  -  glutamate receptor, metabotropic 8, PRPH2  -  peripherin 2 (retinal degeneration, slow), NPY1R  -  neuropeptide y receptor y1, CPLX3  -  complexin 3, PRKCG  -  protein kinase c, gamma, PTCHD1  -  patched domain containing 1, NPTX2  -  neuronal pentraxin ii, THRB  -  thyroid hormone receptor, beta, GRPR  -  gastrin-releasing peptide receptor]
GO:0044057	regulation of system process	4.96E-10	6.14E-7	2.28	14984	471	989	71	[RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, PTPRO  -  protein tyrosine phosphatase, receptor type, o, TACR2  -  tachykinin receptor 2, CHRM3  -  cholinergic receptor, muscarinic 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, NOV  -  nephroblastoma overexpressed, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, CELF4  -  cugbp, elav-like family member 4, STX1A  -  syntaxin 1a (brain), GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, NPTXR  -  neuronal pentraxin receptor, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, IL1B  -  interleukin 1, beta, KLK8  -  kallikrein-related peptidase 8, STIM1  -  stromal interaction molecule 1, UNC13B  -  unc-13 homolog b (c. elegans), FKBP1B  -  fk506 binding protein 1b, 12.6 kda, BEGAIN  -  brain-enriched guanylate kinase-associated, DSP  -  desmoplakin, RGS4  -  regulator of g-protein signaling 4, CXADR  -  coxsackie virus and adenovirus receptor, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, CALCRL  -  calcitonin receptor-like, TNNC1  -  troponin c type 1 (slow), PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, NLGN3  -  neuroligin 3, TNNT1  -  troponin t type 1 (skeletal, slow), TNNI3  -  troponin i type 3 (cardiac), MLIP  -  muscular lmna-interacting protein, TSHZ3  -  teashirt zinc finger homeobox 3, NEUROD1  -  neuronal differentiation 1, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, FXYD6  -  fxyd domain containing ion transport regulator 6, NMU  -  neuromedin u, TPM1  -  tropomyosin 1 (alpha), RIMS1  -  regulating synaptic membrane exocytosis 1, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, SSTR2  -  somatostatin receptor 2, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, TNR  -  tenascin r, TMEM108  -  transmembrane protein 108, BDKRB2  -  bradykinin receptor b2, KCNK1  -  potassium channel, subfamily k, member 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), CBLN1  -  cerebellin 1 precursor, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, GRM1  -  glutamate receptor, metabotropic 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, NPPA  -  natriuretic peptide a, NPTX1  -  neuronal pentraxin i, NPTX2  -  neuronal pentraxin ii, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, RAB11FIP1  -  rab11 family interacting protein 1 (class i), SMAD3  -  smad family member 3, THRB  -  thyroid hormone receptor, beta, THRA  -  thyroid hormone receptor, alpha, FXYD7  -  fxyd domain containing ion transport regulator 7, CCK  -  cholecystokinin]
GO:0003008	system process	5.12E-10	5.85E-7	1.81	14984	1047	989	125	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), NCAM2  -  neural cell adhesion molecule 2, GPR155  -  g protein-coupled receptor 155, OPRM1  -  opioid receptor, mu 1, NDN  -  necdin, melanoma antigen (mage) family member, PAX2  -  paired box 2, CDH3  -  cadherin 3, type 1, p-cadherin (placental), BTC  -  betacellulin, HRH1  -  histamine receptor h1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, AQP9  -  aquaporin 9, BDNF  -  brain-derived neurotrophic factor, ABCC6  -  atp-binding cassette, sub-family c (cftr/mrp), member 6, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, COCH  -  cochlin, IL1B  -  interleukin 1, beta, LPA  -  lipoprotein, lp(a), KLK8  -  kallikrein-related peptidase 8, PLCB2  -  phospholipase c, beta 2, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RCSD1  -  rcsd domain containing 1, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, MYO7A  -  myosin viia, NMU  -  neuromedin u, TPM3  -  tropomyosin 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, TPM1  -  tropomyosin 1 (alpha), GLRA2  -  glycine receptor, alpha 2, C1QL1  -  complement component 1, q subcomponent-like 1, RIMS1  -  regulating synaptic membrane exocytosis 1, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, TCAP  -  titin-cap, GPR88  -  g protein-coupled receptor 88, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ADCY7  -  adenylate cyclase 7, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, PDYN  -  prodynorphin, TNR  -  tenascin r, PTGES  -  prostaglandin e synthase, SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, NPHP1  -  nephronophthisis 1 (juvenile), DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, NPPA  -  natriuretic peptide a, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, SNAI2  -  snail family zinc finger 2, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, NPY1R  -  neuropeptide y receptor y1, CPLX3  -  complexin 3, PTCHD1  -  patched domain containing 1, NPTX2  -  neuronal pentraxin ii, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), PCDH15  -  protocadherin-related 15, DRD2  -  dopamine receptor d2, PTPRO  -  protein tyrosine phosphatase, receptor type, o, TACR2  -  tachykinin receptor 2, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, CHRM3  -  cholinergic receptor, muscarinic 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, WNT10B  -  wingless-type mmtv integration site family, member 10b, NLGN1  -  neuroligin 1, CALB1  -  calbindin 1, 28kda, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, WFS1  -  wolfram syndrome 1 (wolframin), DCDC2  -  doublecortin domain containing 2, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, FAM65B  -  family with sequence similarity 65, member b, EXT1  -  exostosin glycosyltransferase 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, DAW1  -  dynein assembly factor with wdr repeat domains 1, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNC1  -  troponin c type 1 (slow), TNNT1  -  troponin t type 1 (skeletal, slow), TNNI3  -  troponin i type 3 (cardiac), TEK  -  tek tyrosine kinase, endothelial, TSHZ3  -  teashirt zinc finger homeobox 3, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, PRNP  -  prion protein, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, NRXN2  -  neurexin 2, PKD2L1  -  polycystic kidney disease 2-like 1, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR2  -  somatostatin receptor 2, CRYM  -  crystallin, mu, OTOGL  -  otogelin-like, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, BDKRB2  -  bradykinin receptor b2, IGF1  -  insulin-like growth factor 1 (somatomedin c), MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, GLRA3  -  glycine receptor, alpha 3, KALRN  -  kalirin, rhogef kinase, FERMT2  -  fermitin family member 2, TUSC3  -  tumor suppressor candidate 3, GRM8  -  glutamate receptor, metabotropic 8, GRM7  -  glutamate receptor, metabotropic 7, PRPH2  -  peripherin 2 (retinal degeneration, slow), BCL2  -  b-cell cll/lymphoma 2, PRKCG  -  protein kinase c, gamma, SGCD  -  sarcoglycan, delta (35kda dystrophin-associated glycoprotein), GRM5  -  glutamate receptor, metabotropic 5, PRKAR1A  -  protein kinase, camp-dependent, regulatory, type i, alpha, THRB  -  thyroid hormone receptor, beta, THRA  -  thyroid hormone receptor, alpha, GRPR  -  gastrin-releasing peptide receptor, CCK  -  cholecystokinin]
GO:0043269	regulation of ion transport	1.28E-9	1.36E-6	1.90	14984	585	1392	103	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), TRIM27  -  tripartite motif containing 27, RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, SYT17  -  synaptotagmin xvii, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CCL4  -  chemokine (c-c motif) ligand 4, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CD84  -  cd84 molecule, IL1B  -  interleukin 1, beta, HAMP  -  hepcidin antimicrobial peptide, FKBP1A  -  fk506 binding protein 1a, 12kda, NKAIN4  -  na+/k+ transporting atpase interacting 4, CRH  -  corticotropin releasing hormone, JPH4  -  junctophilin 4, RGS4  -  regulator of g-protein signaling 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, NLGN3  -  neuroligin 3, FHL1  -  four and a half lim domains 1, FXYD6  -  fxyd domain containing ion transport regulator 6, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, ARG1  -  arginase 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CNR1  -  cannabinoid receptor 1 (brain), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PTGES  -  prostaglandin e synthase, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CNTN1  -  contactin 1, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), CORO1A  -  coronin, actin binding protein, 1a, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, NPPA  -  natriuretic peptide a, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, NPY5R  -  neuropeptide y receptor y5, PDE4B  -  phosphodiesterase 4b, camp-specific, FXYD7  -  fxyd domain containing ion transport regulator 7, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, FABP3  -  fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor), TACR2  -  tachykinin receptor 2, CHRM3  -  cholinergic receptor, muscarinic 3, SYT1  -  synaptotagmin i, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, NKAIN2  -  na+/k+ transporting atpase interacting 2, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, DPP6  -  dipeptidyl-peptidase 6, KCNQ2  -  potassium voltage-gated channel, kqt-like subfamily, member 2, NLGN1  -  neuroligin 1, PPAPDC1A  -  phosphatidic acid phosphatase type 2 domain containing 1a, KCNH5  -  potassium voltage-gated channel, subfamily h (eag-related), member 5, GPM6B  -  glycoprotein m6b, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, WFS1  -  wolfram syndrome 1 (wolframin), CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1F  -  calcium channel, voltage-dependent, l type, alpha 1f subunit, CACNA1E  -  calcium channel, voltage-dependent, r type, alpha 1e subunit, STIM1  -  stromal interaction molecule 1, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, GSG1L  -  gsg1-like, KCNG3  -  potassium voltage-gated channel, subfamily g, member 3, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, HPCA  -  hippocalcin, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, DLG2  -  discs, large homolog 2 (drosophila), CRY2  -  cryptochrome 2 (photolyase-like), PRNP  -  prion protein, DPP10  -  dipeptidyl-peptidase 10 (non-functional), GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ATP8A1  -  atpase, aminophospholipid transporter (aplt), class i, type 8a, member 1, KCNV1  -  potassium channel, subfamily v, member 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, GRM7  -  glutamate receptor, metabotropic 7, BCL2  -  b-cell cll/lymphoma 2, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, PRKCD  -  protein kinase c, delta, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, CCK  -  cholecystokinin]
GO:0050808	synapse organization	2.62E-9	2.59E-6	2.86	14984	185	1189	42	[BAI3  -  brain-specific angiogenesis inhibitor 3, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, SLITRK1  -  slit and ntrk-like family, member 1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CDC42  -  cell division cycle 42, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), C1QL1  -  complement component 1, q subcomponent-like 1, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NRXN2  -  neurexin 2, WNT7B  -  wingless-type mmtv integration site family, member 7b, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, AGRN  -  agrin, CTNND2  -  catenin (cadherin-associated protein), delta 2, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, TNR  -  tenascin r, RAB39B  -  rab39b, member ras oncogene family, GPM6A  -  glycoprotein m6a, KIRREL3  -  kin of irre like 3 (drosophila), BDNF  -  brain-derived neurotrophic factor, PCLO  -  piccolo presynaptic cytomatrix protein, BSN  -  bassoon presynaptic cytomatrix protein, CBLN1  -  cerebellin 1 precursor, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, KALRN  -  kalirin, rhogef kinase, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, EPHA4  -  eph receptor a4, CBLN4  -  cerebellin 4 precursor, ERC2  -  elks/rab6-interacting/cast family member 2, LPHN3  -  latrophilin 3, KLK8  -  kallikrein-related peptidase 8, UNC13B  -  unc-13 homolog b (c. elegans), GRM5  -  glutamate receptor, metabotropic 5, CDH9  -  cadherin 9, type 2 (t1-cadherin), DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, NLGN3  -  neuroligin 3, WASF1  -  was protein family, member 1]
GO:0007611	learning or memory	4.51E-9	4.18E-6	2.46	14984	214	1481	52	[FAM19A2  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a2, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), GALR2  -  galanin receptor 2, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD5  -  dopamine receptor d5, DRD2  -  dopamine receptor d2, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, TACR2  -  tachykinin receptor 2, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, HRH1  -  histamine receptor h1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, CALB1  -  calbindin 1, 28kda, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, BDNF  -  brain-derived neurotrophic factor, VIP  -  vasoactive intestinal peptide, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, VLDLR  -  very low density lipoprotein receptor, KLK8  -  kallikrein-related peptidase 8, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, B4GALT2  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 2, CRH  -  corticotropin releasing hormone, CREB1  -  camp responsive element binding protein 1, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, BAI3  -  brain-specific angiogenesis inhibitor 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, C1QL1  -  complement component 1, q subcomponent-like 1, PRNP  -  prion protein, NRXN1  -  neurexin 1, NRXN2  -  neurexin 2, ATP8A1  -  atpase, aminophospholipid transporter (aplt), class i, type 8a, member 1, CNR1  -  cannabinoid receptor 1 (brain), GPR88  -  g protein-coupled receptor 88, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, TNR  -  tenascin r, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, KCNK2  -  potassium channel, subfamily k, member 2, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, KALRN  -  kalirin, rhogef kinase, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, PRKCG  -  protein kinase c, gamma, PTCHD1  -  patched domain containing 1, GRM5  -  glutamate receptor, metabotropic 5, NPTX2  -  neuronal pentraxin ii, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, GRPR  -  gastrin-releasing peptide receptor, THRA  -  thyroid hormone receptor, alpha, CCK  -  cholecystokinin]
GO:0048856	anatomical structure development	7.93E-9	6.93E-6	1.33	14984	2692	1544	369	[SPRR2G  -  small proline-rich protein 2g, MYLIP  -  myosin regulatory light chain interacting protein, WTAP  -  wilms tumor 1 associated protein, GALR2  -  galanin receptor 2, NDN  -  necdin, melanoma antigen (mage) family member, SCUBE2  -  signal peptide, cub domain, egf-like 2, TSHZ2  -  teashirt zinc finger homeobox 2, LIG4  -  ligase iv, dna, atp-dependent, CREG1  -  cellular repressor of e1a-stimulated genes 1, PLD6  -  phospholipase d family, member 6, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), WDR47  -  wd repeat domain 47, ABI2  -  abl-interactor 2, SPINK2  -  serine peptidase inhibitor, kazal type 2 (acrosin-trypsin inhibitor), GDA  -  guanine deaminase, DPF1  -  d4, zinc and double phd fingers family 1, MBOAT7  -  membrane bound o-acyltransferase domain containing 7, GREB1L  -  growth regulation by estrogen in breast cancer-like, BFSP1  -  beaded filament structural protein 1, filensin, KLHL41  -  kelch-like family member 41, GJB5  -  gap junction protein, beta 5, 31.1kda, CELF4  -  cugbp, elav-like family member 4, BDNF  -  brain-derived neurotrophic factor, FSTL5  -  follistatin-like 5, VWC2L  -  von willebrand factor c domain containing protein 2-like, THEG  -  theg spermatid protein, EGR3  -  early growth response 3, TWIST2  -  twist basic helix-loop-helix transcription factor 2, SOX4  -  sry (sex determining region y)-box 4, GRHL1  -  grainyhead-like 1 (drosophila), DPF3  -  d4, zinc and double phd fingers, family 3, PLXNA1  -  plexin a1, ACRV1  -  acrosomal vesicle protein 1, OLFM3  -  olfactomedin 3, HAMP  -  hepcidin antimicrobial peptide, CRH  -  corticotropin releasing hormone, CREM  -  camp responsive element modulator, PHLDA2  -  pleckstrin homology-like domain, family a, member 2, RGS4  -  regulator of g-protein signaling 4, KIF16B  -  kinesin family member 16b, CALCRL  -  calcitonin receptor-like, CREB1  -  camp responsive element binding protein 1, CRABP2  -  cellular retinoic acid binding protein 2, MYO7A  -  myosin viia, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), TPO  -  thyroid peroxidase, ADAMTS3  -  adam metallopeptidase with thrombospondin type 1 motif, 3, ACVR2A  -  activin a receptor, type iia, ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, ACVR2B  -  activin a receptor, type iib, KRT83  -  keratin 83, HPCAL4  -  hippocalcin like 4, ACTN2  -  actinin, alpha 2, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, MYBPHL  -  myosin binding protein h-like, EFNB3  -  ephrin-b3, RNF2  -  ring finger protein 2, MYO16  -  myosin xvi, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CNTN1  -  contactin 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, TMEM108  -  transmembrane protein 108, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), MEPE  -  matrix extracellular phosphoglycoprotein, PCYT1B  -  phosphate cytidylyltransferase 1, choline, beta, ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), KIRREL3  -  kin of irre like 3 (drosophila), STMN1  -  stathmin 1, TRIO  -  trio rho guanine nucleotide exchange factor, NTNG2  -  netrin g2, DDRGK1  -  ddrgk domain containing 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, SLC25A27  -  solute carrier family 25, member 27, SPEF2  -  sperm flagellar 2, SNAI2  -  snail family zinc finger 2, COL5A1  -  collagen, type v, alpha 1, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, IGSF3  -  immunoglobulin superfamily, member 3, CA10  -  carbonic anhydrase x, PTCHD1  -  patched domain containing 1, GMFB  -  glia maturation factor, beta, COL10A1  -  collagen, type x, alpha 1, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, TMEFF2  -  transmembrane protein with egf-like and two follistatin-like domains 2, LAMB1  -  laminin, beta 1, PANX1  -  pannexin 1, AP2B1  -  adaptor-related protein complex 2, beta 1 subunit, PCDH15  -  protocadherin-related 15, EXPH5  -  exophilin 5, HMGB3  -  high mobility group box 3, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, ZC3H13  -  zinc finger ccch-type containing 13, OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, FABP7  -  fatty acid binding protein 7, brain, KCNE2  -  potassium voltage-gated channel, isk-related family, member 2, HILS1  -  histone linker h1 domain, spermatid-specific 1, pseudogene, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, PDCD6  -  programmed cell death 6, ZNF541  -  zinc finger protein 541, KCNQ2  -  potassium voltage-gated channel, kqt-like subfamily, member 2, ACSL4  -  acyl-coa synthetase long-chain family member 4, CASP5  -  caspase 5, apoptosis-related cysteine peptidase, MERTK  -  c-mer proto-oncogene tyrosine kinase, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, CALB1  -  calbindin 1, 28kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, CSGALNACT1  -  chondroitin sulfate n-acetylgalactosaminyltransferase 1, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, EID2B  -  ep300 interacting inhibitor of differentiation 2b, FLRT3  -  fibronectin leucine rich transmembrane protein 3, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, ZBTB18  -  zinc finger and btb domain containing 18, AHSG  -  alpha-2-hs-glycoprotein, EXT1  -  exostosin glycosyltransferase 1, AHR  -  aryl hydrocarbon receptor, ANKLE2  -  ankyrin repeat and lem domain containing 2, VLDLR  -  very low density lipoprotein receptor, DAW1  -  dynein assembly factor with wdr repeat domains 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, CREB3L1  -  camp responsive element binding protein 3-like 1, B4GALT2  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 2, ST8SIA4  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 4, STIM1  -  stromal interaction molecule 1, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), RTN4R  -  reticulon 4 receptor, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CXADR  -  coxsackie virus and adenovirus receptor, CCDC85C  -  coiled-coil domain containing 85c, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, CPNE6  -  copine vi (neuronal), HPCA  -  hippocalcin, RNF165  -  ring finger protein 165, CRMP1  -  collapsin response mediator protein 1, KIAA2022  -  kiaa2022, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ZDHHC16  -  zinc finger, dhhc-type containing 16, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, SSTR1  -  somatostatin receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR2  -  somatostatin receptor 2, TYRO3  -  tyro3 protein tyrosine kinase, BZW2  -  basic leucine zipper and w2 domains 2, MAP2K1  -  mitogen-activated protein kinase kinase 1, ALPL  -  alkaline phosphatase, liver/bone/kidney, MYCNOS  -  mycn opposite strand/antisense rna, CSF1R  -  colony stimulating factor 1 receptor, ONECUT1  -  one cut homeobox 1, EPHA3  -  eph receptor a3, KCNK2  -  potassium channel, subfamily k, member 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, HNMT  -  histamine n-methyltransferase, CBLN1  -  cerebellin 1 precursor, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, TNN  -  tenascin n, EPHB1  -  eph receptor b1, CNNM4  -  cyclin m4, CAV2  -  caveolin 2, PRKG1  -  protein kinase, cgmp-dependent, type i, TENM3  -  teneurin transmembrane protein 3, RXRA  -  retinoid x receptor, alpha, EPHA5  -  eph receptor a5, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, RXRG  -  retinoid x receptor, gamma, EPHA8  -  eph receptor a8, ATXN10  -  ataxin 10, NANOS1  -  nanos homolog 1 (drosophila), PRKCI  -  protein kinase c, iota, AGBL4  -  atp/gtp binding protein-like 4, HMGCS1  -  3-hydroxy-3-methylglutaryl-coa synthase 1 (soluble), KLK5  -  kallikrein-related peptidase 5, GAP43  -  growth associated protein 43, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, DRAXIN  -  dorsal inhibitory axon guidance protein, TMEM107  -  transmembrane protein 107, VPS13A  -  vacuolar protein sorting 13 homolog a (s. cerevisiae), PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, SLC4A10  -  solute carrier family 4, sodium bicarbonate transporter, member 10, SECTM1  -  secreted and transmembrane 1, PAX2  -  paired box 2, RPS6KA6  -  ribosomal protein s6 kinase, 90kda, polypeptide 6, CDC42  -  cell division cycle 42, SEC24D  -  sec24 family, member d (s. cerevisiae), TAF7L  -  taf7-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 50kda, ENC1  -  ectodermal-neural cortex 1 (with btb domain), ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, KLK7  -  kallikrein-related peptidase 7, GSS  -  glutathione synthetase, INHA  -  inhibin, alpha, ING2  -  inhibitor of growth family, member 2, AGRN  -  agrin, BEX1  -  brain expressed, x-linked 1, PCDH1  -  protocadherin 1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, NLE1  -  notchless homolog 1 (drosophila), APAF1  -  apoptotic peptidase activating factor 1, OXCT1  -  3-oxoacid coa transferase 1, SIAH3  -  siah e3 ubiquitin protein ligase family member 3, PACRG  -  park2 co-regulated, DNAAF1  -  dynein, axonemal, assembly factor 1, NUMBL  -  numb homolog (drosophila)-like, OCA2  -  oculocutaneous albinism ii, CRLF1  -  cytokine receptor-like factor 1, PBX4  -  pre-b-cell leukemia homeobox 4, FAM172A  -  family with sequence similarity 172, member a, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, SNTG2  -  syntrophin, gamma 2, LCLAT1  -  lysocardiolipin acyltransferase 1, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, ATOH7  -  atonal homolog 7 (drosophila), CAMK1  -  calcium/calmodulin-dependent protein kinase i, LPHN3  -  latrophilin 3, WNT4  -  wingless-type mmtv integration site family, member 4, MMP16  -  matrix metallopeptidase 16 (membrane-inserted), LPPR4  -  lipid phosphate phosphatase-related protein type 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, MSC  -  musculin, DDX10  -  dead (asp-glu-ala-asp) box polypeptide 10, FHL1  -  four and a half lim domains 1, CNTN3  -  contactin 3 (plasmacytoma associated), TRAPPC6B  -  trafficking protein particle complex 6b, NXF5  -  nuclear rna export factor 5, CENPE  -  centromere protein e, 312kda, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, PSPH  -  phosphoserine phosphatase, CENPF  -  centromere protein f, 350/400kda, PTCH1  -  patched 1, LARGE  -  like-glycosyltransferase, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, SLC2A14  -  solute carrier family 2 (facilitated glucose transporter), member 14, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), GPR98  -  g protein-coupled receptor 98, ARG1  -  arginase 1, MKL2  -  mkl/myocardin-like 2, FGD1  -  fyve, rhogef and ph domain containing 1, GALNTL5  -  udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyltransferase-like 5, L3MBTL1  -  l(3)mbt-like 1 (drosophila), SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, TCAP  -  titin-cap, PTHLH  -  parathyroid hormone-like hormone, MEIS1  -  meis homeobox 1, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, TDRD9  -  tudor domain containing 9, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, AMIGO2  -  adhesion molecule with ig-like domain 2, NPHP1  -  nephronophthisis 1 (juvenile), MEST  -  mesoderm specific transcript, INSM1  -  insulinoma-associated 1, DPYSL4  -  dihydropyrimidinase-like 4, MET  -  met proto-oncogene, AKIRIN2  -  akirin 2, MESP1  -  mesoderm posterior 1 homolog (mouse), ASS1  -  argininosuccinate synthase 1, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, HELLS  -  helicase, lymphoid-specific, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, NPTX1  -  neuronal pentraxin i, CDH8  -  cadherin 8, type 2, ARMC4  -  armadillo repeat containing 4, CDH9  -  cadherin 9, type 2 (t1-cadherin), PTPRG  -  protein tyrosine phosphatase, receptor type, g, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1, PCDH19  -  protocadherin 19, NRCAM  -  neuronal cell adhesion molecule, PTPRF  -  protein tyrosine phosphatase, receptor type, f, ASCL2  -  achaete-scute complex homolog 2 (drosophila), EGFL6  -  egf-like-domain, multiple 6, RAD1  -  rad1 homolog (s. pombe), KREMEN2  -  kringle containing transmembrane protein 2, NNMT  -  nicotinamide n-methyltransferase, TIMP2  -  timp metallopeptidase inhibitor 2, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), DRD2  -  dopamine receptor d2, NNAT  -  neuronatin, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTPRR  -  protein tyrosine phosphatase, receptor type, r, CHRM3  -  cholinergic receptor, muscarinic 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), NOV  -  nephroblastoma overexpressed, WNT10B  -  wingless-type mmtv integration site family, member 10b, TLL1  -  tolloid-like 1, WNT7B  -  wingless-type mmtv integration site family, member 7b, TDRD1  -  tudor domain containing 1, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, CHL1  -  cell adhesion molecule l1-like, NLGN1  -  neuroligin 1, TRIM71  -  tripartite motif containing 71, e3 ubiquitin protein ligase, DPYSL3  -  dihydropyrimidinase-like 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CTC1  -  cts telomere maintenance complex component 1, GPM6B  -  glycoprotein m6b, GPM6A  -  glycoprotein m6a, TOX  -  thymocyte selection-associated high mobility group box, WFS1  -  wolfram syndrome 1 (wolframin), WHSC1  -  wolf-hirschhorn syndrome candidate 1, FAM65B  -  family with sequence similarity 65, member b, FOXP2  -  forkhead box p2, DSP  -  desmoplakin, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, HDAC9  -  histone deacetylase 9, XYLT1  -  xylosyltransferase i, TNNI3  -  troponin i type 3 (cardiac), LTBP4  -  latent transforming growth factor beta binding protein 4, TEK  -  tek tyrosine kinase, endothelial, TSHZ3  -  teashirt zinc finger homeobox 3, NEUROD1  -  neuronal differentiation 1, SH3GL3  -  sh3-domain grb2-like 3, NEK2  -  nima-related kinase 2, OSR1  -  odd-skipped related 1 (drosophila), DLG2  -  discs, large homolog 2 (drosophila), NELL1  -  nel-like 1 (chicken), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), KLHL1  -  kelch-like family member 1, SLCO4C1  -  solute carrier organic anion transporter family, member 4c1, C3orf70  -  chromosome 3 open reading frame 70, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, DLL3  -  delta-like 3 (drosophila), NFIB  -  nuclear factor i/b, LY6H  -  lymphocyte antigen 6 complex, locus h, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, MRAS  -  muscle ras oncogene homolog, RARB  -  retinoic acid receptor, beta, TRAPPC9  -  trafficking protein particle complex 9, PDGFD  -  platelet derived growth factor d, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, HSPB11  -  heat shock protein family b (small), member 11, DIAPH2  -  diaphanous-related formin 2, KDM1B  -  lysine (k)-specific demethylase 1b, RBM24  -  rna binding motif protein 24, NGFRAP1  -  nerve growth factor receptor (tnfrsf16) associated protein 1, PKNOX1  -  pbx/knotted 1 homeobox 1, LTK  -  leukocyte receptor tyrosine kinase, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, SFRP1  -  secreted frizzled-related protein 1, ATP2C1  -  atpase, ca++ transporting, type 2c, member 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, SFRP2  -  secreted frizzled-related protein 2, NEUROD6  -  neuronal differentiation 6, GRIK1  -  glutamate receptor, ionotropic, kainate 1, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, SMAD1  -  smad family member 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), RTN4RL1  -  reticulon 4 receptor-like 1, PLEKHA5  -  pleckstrin homology domain containing, family a member 5, KALRN  -  kalirin, rhogef kinase, IGFBP5  -  insulin-like growth factor binding protein 5, CRYGN  -  crystallin, gamma n, CDK20  -  cyclin-dependent kinase 20, RCN1  -  reticulocalbin 1, ef-hand calcium binding domain, DOC2A  -  double c2-like domains, alpha, RBP4  -  retinol binding protein 4, plasma, PRPH2  -  peripherin 2 (retinal degeneration, slow), BCL2  -  b-cell cll/lymphoma 2, SGCD  -  sarcoglycan, delta (35kda dystrophin-associated glycoprotein), YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, DNAH5  -  dynein, axonemal, heavy chain 5, SMAD3  -  smad family member 3, NAV3  -  neuron navigator 3, RUNDC1  -  run domain containing 1, NRG3  -  neuregulin 3, THRB  -  thyroid hormone receptor, beta, PCDH18  -  protocadherin 18, THRA  -  thyroid hormone receptor, alpha]
GO:0032501	multicellular organismal process	1.8E-8	1.49E-5	1.67	14984	2582	437	126	[NCAM2  -  neural cell adhesion molecule 2, OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, TSHZ2  -  teashirt zinc finger homeobox 2, CREG1  -  cellular repressor of e1a-stimulated genes 1, PRTN3  -  proteinase 3, TAF7L  -  taf7-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 50kda, APOC1  -  apolipoprotein c-i, ENC1  -  ectodermal-neural cortex 1 (with btb domain), BTC  -  betacellulin, PPP4R4  -  protein phosphatase 4, regulatory subunit 4, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CELF4  -  cugbp, elav-like family member 4, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, COCH  -  cochlin, SOX4  -  sry (sex determining region y)-box 4, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, IL1B  -  interleukin 1, beta, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, LPA  -  lipoprotein, lp(a), KLK8  -  kallikrein-related peptidase 8, RCSD1  -  rcsd domain containing 1, LRCOL1  -  leucine rich colipase-like 1, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, RGS14  -  regulator of g-protein signaling 14, MYO7A  -  myosin viia, ADAMTS3  -  adam metallopeptidase with thrombospondin type 1 motif, 3, BATF  -  basic leucine zipper transcription factor, atf-like, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, NXF5  -  nuclear rna export factor 5, ACVR2A  -  activin a receptor, type iia, GLRA2  -  glycine receptor, alpha 2, C1QL1  -  complement component 1, q subcomponent-like 1, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, MYBPHL  -  myosin binding protein h-like, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, TCAP  -  titin-cap, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, GPR88  -  g protein-coupled receptor 88, PTHLH  -  parathyroid hormone-like hormone, ADCY7  -  adenylate cyclase 7, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, PDYN  -  prodynorphin, PTGES  -  prostaglandin e synthase, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, MET  -  met proto-oncogene, AKIRIN2  -  akirin 2, MESP1  -  mesoderm posterior 1 homolog (mouse), NPPA  -  natriuretic peptide a, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, SNAI2  -  snail family zinc finger 2, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, NPY1R  -  neuropeptide y receptor y1, CPLX3  -  complexin 3, PTCHD1  -  patched domain containing 1, CDH8  -  cadherin 8, type 2, NPTX2  -  neuronal pentraxin ii, CDH9  -  cadherin 9, type 2 (t1-cadherin), MGP  -  matrix gla protein, ASCL2  -  achaete-scute complex homolog 2 (drosophila), PCDH15  -  protocadherin-related 15, DRD2  -  dopamine receptor d2, F12  -  coagulation factor xii (hageman factor), LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, TAC3  -  tachykinin 3, PTPRR  -  protein tyrosine phosphatase, receptor type, r, CHRM3  -  cholinergic receptor, muscarinic 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), HILS1  -  histone linker h1 domain, spermatid-specific 1, pseudogene, CALB1  -  calbindin 1, 28kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, DCDC2  -  doublecortin domain containing 2, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, FAM65B  -  family with sequence similarity 65, member b, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, EXT1  -  exostosin glycosyltransferase 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNT1  -  troponin t type 1 (skeletal, slow), TNNI3  -  troponin i type 3 (cardiac), TSHZ3  -  teashirt zinc finger homeobox 3, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, RNF165  -  ring finger protein 165, SLCO4C1  -  solute carrier organic anion transporter family, member 4c1, DLL3  -  delta-like 3 (drosophila), CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, PKD2L1  -  polycystic kidney disease 2-like 1, ISG15  -  isg15 ubiquitin-like modifier, PDGFD  -  platelet derived growth factor d, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, RFTN1  -  raftlin, lipid raft linker 1, DIAPH2  -  diaphanous-related formin 2, TYRO3  -  tyro3 protein tyrosine kinase, LTK  -  leukocyte receptor tyrosine kinase, ALPL  -  alkaline phosphatase, liver/bone/kidney, EPHA3  -  eph receptor a3, BDKRB2  -  bradykinin receptor b2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK2  -  glutamate receptor, ionotropic, kainate 2, MAPK1  -  mitogen-activated protein kinase 1, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, RSPO3  -  r-spondin 3, EPHA4  -  eph receptor a4, GRM8  -  glutamate receptor, metabotropic 8, RCN1  -  reticulocalbin 1, ef-hand calcium binding domain, PRPH2  -  peripherin 2 (retinal degeneration, slow), PRKCG  -  protein kinase c, gamma, DNAH5  -  dynein, axonemal, heavy chain 5, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator]
GO:0060078	regulation of postsynaptic membrane potential	1.94E-8	1.52E-5	4.33	14984	81	983	23	[GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, OPRM1  -  opioid receptor, mu 1, GRIK1  -  glutamate receptor, ionotropic, kainate 1, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), GABBR1  -  gamma-aminobutyric acid (gaba) b receptor, 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, DRD2  -  dopamine receptor d2, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, GLRA2  -  glycine receptor, alpha 2, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GRM5  -  glutamate receptor, metabotropic 5, MPP2  -  membrane protein, palmitoylated 2 (maguk p55 subfamily member 2), NLGN3  -  neuroligin 3, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a]
GO:0050890	cognition	2.28E-8	1.69E-5	2.27	14984	249	1483	56	[FAM19A2  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a2, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), GALR2  -  galanin receptor 2, GPR155  -  g protein-coupled receptor 155, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD5  -  dopamine receptor d5, DRD2  -  dopamine receptor d2, TACR2  -  tachykinin receptor 2, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, HRH1  -  histamine receptor h1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, CALB1  -  calbindin 1, 28kda, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, BDNF  -  brain-derived neurotrophic factor, VIP  -  vasoactive intestinal peptide, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, VLDLR  -  very low density lipoprotein receptor, SLC1A4  -  solute carrier family 1 (glutamate/neutral amino acid transporter), member 4, KLK8  -  kallikrein-related peptidase 8, B4GALT2  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 2, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, CRH  -  corticotropin releasing hormone, CREB1  -  camp responsive element binding protein 1, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, BAI3  -  brain-specific angiogenesis inhibitor 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, C1QL1  -  complement component 1, q subcomponent-like 1, PRNP  -  prion protein, JAKMIP1  -  janus kinase and microtubule interacting protein 1, NRXN1  -  neurexin 1, NRXN2  -  neurexin 2, ATP8A1  -  atpase, aminophospholipid transporter (aplt), class i, type 8a, member 1, CNR1  -  cannabinoid receptor 1 (brain), GPR88  -  g protein-coupled receptor 88, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, TNR  -  tenascin r, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, KCNK2  -  potassium channel, subfamily k, member 2, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, KALRN  -  kalirin, rhogef kinase, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, TUSC3  -  tumor suppressor candidate 3, PRKCG  -  protein kinase c, gamma, PTCHD1  -  patched domain containing 1, GRM5  -  glutamate receptor, metabotropic 5, NPTX2  -  neuronal pentraxin ii, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, THRA  -  thyroid hormone receptor, alpha, GRPR  -  gastrin-releasing peptide receptor, CCK  -  cholecystokinin]
GO:0051966	regulation of synaptic transmission, glutamatergic	3.5E-8	2.48E-5	4.46	14984	63	1120	21	[TSHZ3  -  teashirt zinc finger homeobox 3, RELN  -  reelin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, DGKI  -  diacylglycerol kinase, iota, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, DRD2  -  dopamine receptor d2, GRM1  -  glutamate receptor, metabotropic 1, SYT1  -  synaptotagmin i, GRM8  -  glutamate receptor, metabotropic 8, GRM7  -  glutamate receptor, metabotropic 7, GRM5  -  glutamate receptor, metabotropic 5, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CNR1  -  cannabinoid receptor 1 (brain), SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, NLGN3  -  neuroligin 3, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, TNR  -  tenascin r, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)]
GO:0031644	regulation of neurological system process	9.8E-8	6.61E-5	3.45	14984	123	988	28	[RELN  -  reelin, NMU  -  neuromedin u, OPRM1  -  opioid receptor, mu 1, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), RIMS1  -  regulating synaptic membrane exocytosis 1, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NOV  -  nephroblastoma overexpressed, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, CARTPT  -  cart prepropeptide, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, TNR  -  tenascin r, TMEM108  -  transmembrane protein 108, CELF4  -  cugbp, elav-like family member 4, STX1A  -  syntaxin 1a (brain), CBLN1  -  cerebellin 1 precursor, GRM1  -  glutamate receptor, metabotropic 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, NPTXR  -  neuronal pentraxin receptor, KLK8  -  kallikrein-related peptidase 8, UNC13B  -  unc-13 homolog b (c. elegans), RGS4  -  regulator of g-protein signaling 4, NPTX1  -  neuronal pentraxin i, BEGAIN  -  brain-enriched guanylate kinase-associated, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, NPTX2  -  neuronal pentraxin ii, NLGN3  -  neuroligin 3, CCK  -  cholecystokinin]
GO:0051960	regulation of nervous system development	2.08E-7	1.35E-4	1.73	14984	802	1135	105	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, LIG4  -  ligase iv, dna, atp-dependent, ENC1  -  ectodermal-neural cortex 1 (with btb domain), ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, LINGO1  -  leucine rich repeat and ig domain containing 1, ABI2  -  abl-interactor 2, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, AGRN  -  agrin, DCC  -  deleted in colorectal carcinoma, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NUMBL  -  numb homolog (drosophila)-like, BDNF  -  brain-derived neurotrophic factor, PLXNA1  -  plexin a1, IL1B  -  interleukin 1, beta, KLK8  -  kallikrein-related peptidase 8, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), FAM150B  -  family with sequence similarity 150, member b, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), RIMS1  -  regulating synaptic membrane exocytosis 1, UST  -  uronyl-2-sulfotransferase, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, EFNB3  -  ephrin-b3, GPC4  -  glypican 4, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, TNR  -  tenascin r, LINGO2  -  leucine rich repeat and ig domain containing 2, CNTN1  -  contactin 1, AMIGO2  -  adhesion molecule with ig-like domain 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), SLITRK2  -  slit and ntrk-like family, member 2, NTNG2  -  netrin g2, SLIT1  -  slit homolog 1 (drosophila), CDH4  -  cadherin 4, type 1, r-cadherin (retinal), PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PTPRF  -  protein tyrosine phosphatase, receptor type, f, ASCL2  -  achaete-scute complex homolog 2 (drosophila), DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, ARHGAP33  -  rho gtpase activating protein 33, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, FAM19A1  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a1, IMPACT  -  impact rwd domain protein, RTN4R  -  reticulon 4 receptor, CPNE6  -  copine vi (neuronal), NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), BAI3  -  brain-specific angiogenesis inhibitor 3, CRMP1  -  collapsin response mediator protein 1, IL34  -  interleukin 34, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), DLL3  -  delta-like 3 (drosophila), CSMD3  -  cub and sushi multiple domains 3, KIAA2022  -  kiaa2022, RARB  -  retinoic acid receptor, beta, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, EPHA3  -  eph receptor a3, SFRP2  -  secreted frizzled-related protein 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, CBLN1  -  cerebellin 1 precursor, TNN  -  tenascin n, RTN4RL1  -  reticulon 4 receptor-like 1, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, TTL  -  tubulin tyrosine ligase, EPHA4  -  eph receptor a4, ELL3  -  elongation factor rna polymerase ii-like 3, FBXO31  -  f-box protein 31, BCL2  -  b-cell cll/lymphoma 2, GAP43  -  growth associated protein 43, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, YWHAZ  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, NRG3  -  neuregulin 3, THRB  -  thyroid hormone receptor, beta, DRAXIN  -  dorsal inhibitory axon guidance protein, MMD  -  monocyte to macrophage differentiation-associated, CPNE5  -  copine v]
GO:0010975	regulation of neuron projection development	2.28E-7	1.41E-4	1.99	14984	457	1135	69	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, ENC1  -  ectodermal-neural cortex 1 (with btb domain), SYT1  -  synaptotagmin i, OLFM1  -  olfactomedin 1, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, LINGO1  -  leucine rich repeat and ig domain containing 1, SYT4  -  synaptotagmin iv, ABI2  -  abl-interactor 2, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, ARHGAP33  -  rho gtpase activating protein 33, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, BDNF  -  brain-derived neurotrophic factor, PLXNA1  -  plexin a1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, RTN4R  -  reticulon 4 receptor, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CPNE6  -  copine vi (neuronal), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), FAM150B  -  family with sequence similarity 150, member b, BAI3  -  brain-specific angiogenesis inhibitor 3, CRMP1  -  collapsin response mediator protein 1, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), RIMS1  -  regulating synaptic membrane exocytosis 1, CSMD3  -  cub and sushi multiple domains 3, UST  -  uronyl-2-sulfotransferase, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, EFNB3  -  ephrin-b3, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, TNR  -  tenascin r, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, SFRP2  -  secreted frizzled-related protein 2, NTNG2  -  netrin g2, RTN4RL1  -  reticulon 4 receptor-like 1, TENM3  -  teneurin transmembrane protein 3, TTL  -  tubulin tyrosine ligase, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, DRAXIN  -  dorsal inhibitory axon guidance protein, PTPRF  -  protein tyrosine phosphatase, receptor type, f, CPNE5  -  copine v]
GO:0050807	regulation of synapse organization	2.61E-7	1.55E-4	2.41	14984	193	1385	43	[ABHD17C  -  abhydrolase domain containing 17c, CAMKV  -  cam kinase-like vesicle-associated, RELN  -  reelin, BAI3  -  brain-specific angiogenesis inhibitor 3, DRD2  -  dopamine receptor d2, SLITRK1  -  slit and ntrk-like family, member 1, TUBB  -  tubulin, beta class i, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CDC42  -  cell division cycle 42, PRNP  -  prion protein, ABI2  -  abl-interactor 2, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, NRXN1  -  neurexin 1, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, ARHGAP33  -  rho gtpase activating protein 33, AGRN  -  agrin, GPC4  -  glypican 4, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), ITPKA  -  inositol-trisphosphate 3-kinase a, LINGO2  -  leucine rich repeat and ig domain containing 2, GPM6A  -  glycoprotein m6a, AMIGO2  -  adhesion molecule with ig-like domain 2, ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, SLITRK2  -  slit and ntrk-like family, member 2, BDNF  -  brain-derived neurotrophic factor, NTNG2  -  netrin g2, CBLN1  -  cerebellin 1 precursor, LRFN2  -  leucine rich repeat and fibronectin type iii domain containing 2, EPHB1  -  eph receptor b1, KALRN  -  kalirin, rhogef kinase, DGKB  -  diacylglycerol kinase, beta 90kda, SLIT1  -  slit homolog 1 (drosophila), LRRTM1  -  leucine rich repeat transmembrane neuronal 1, EPHA4  -  eph receptor a4, KLK8  -  kallikrein-related peptidase 8, CDH8  -  cadherin 8, type 2, GAP43  -  growth associated protein 43, YWHAZ  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, NLGN3  -  neuroligin 3, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35)]
GO:0007610	behavior	2.99E-7	1.71E-4	2.33	14984	451	698	49	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, TACR2  -  tachykinin receptor 2, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, ASTN1  -  astrotactin 1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CALB1  -  calbindin 1, 28kda, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, BDNF  -  brain-derived neurotrophic factor, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1, KLK8  -  kallikrein-related peptidase 8, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, RGS14  -  regulator of g-protein signaling 14, NMU  -  neuromedin u, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), C1QL1  -  complement component 1, q subcomponent-like 1, PRNP  -  prion protein, NRXN2  -  neurexin 2, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, EFNB3  -  ephrin-b3, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, GPR88  -  g protein-coupled receptor 88, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, TNR  -  tenascin r, GRIA1  -  glutamate receptor, ionotropic, ampa 1, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, KIRREL3  -  kin of irre like 3 (drosophila), GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK2  -  glutamate receptor, ionotropic, kainate 2, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, EPHA4  -  eph receptor a4, NPY5R  -  neuropeptide y receptor y5, NPY1R  -  neuropeptide y receptor y1, PRKCG  -  protein kinase c, gamma, PTCHD1  -  patched domain containing 1, USP46  -  ubiquitin specific peptidase 46, NPTX2  -  neuronal pentraxin ii, ASIC4  -  acid-sensing (proton-gated) ion channel family member 4, THRB  -  thyroid hormone receptor, beta, GRPR  -  gastrin-releasing peptide receptor, THRA  -  thyroid hormone receptor, alpha]
GO:0050806	positive regulation of synaptic transmission	6.12E-7	3.37E-4	2.67	14984	133	1392	33	[TSHZ3  -  teashirt zinc finger homeobox 3, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, RELN  -  reelin, NMU  -  neuromedin u, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, TACR2  -  tachykinin receptor 2, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NRXN1  -  neurexin 1, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CNR1  -  cannabinoid receptor 1 (brain), SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, TNR  -  tenascin r, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK2  -  glutamate receptor, ionotropic, kainate 2, STX1A  -  syntaxin 1a (brain), MAPK1  -  mitogen-activated protein kinase 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, CRH  -  corticotropin releasing hormone, UNC13B  -  unc-13 homolog b (c. elegans), AKAP5  -  a kinase (prka) anchor protein 5, RGS4  -  regulator of g-protein signaling 4, MPP2  -  membrane protein, palmitoylated 2 (maguk p55 subfamily member 2), CREB1  -  camp responsive element binding protein 1, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, BAIAP3  -  bai1-associated protein 3]
GO:0007214	gamma-aminobutyric acid signaling pathway	7.45E-7	3.95E-4	10.02	14984	22	612	9	[GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, GABBR1  -  gamma-aminobutyric acid (gaba) b receptor, 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3]
GO:0098609	cell-cell adhesion	9.74E-7	4.99E-4	2.02	14984	418	1083	61	[VEZT  -  vezatin, adherens junctions transmembrane protein, NCAM2  -  neural cell adhesion molecule 2, PCDH15  -  protocadherin-related 15, LRRC7  -  leucine rich repeat containing 7, CDH3  -  cadherin 3, type 1, p-cadherin (placental), ICAM5  -  intercellular adhesion molecule 5, telencephalin, NOV  -  nephroblastoma overexpressed, GCNT1  -  glucosaminyl (n-acetyl) transferase 1, core 2, WNT7B  -  wingless-type mmtv integration site family, member 7b, PCDH1  -  protocadherin 1, ASTN1  -  astrotactin 1, CTNND2  -  catenin (cadherin-associated protein), delta 2, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), PCDHGA9  -  protocadherin gamma subfamily a, 9, PCDH10  -  protocadherin 10, EXT1  -  exostosin glycosyltransferase 1, IL1B  -  interleukin 1, beta, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, UNC5D  -  unc-5 homolog d (c. elegans), LPHN3  -  latrophilin 3, VSTM2L  -  v-set and transmembrane domain containing 2 like, DSP  -  desmoplakin, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), CXADR  -  coxsackie virus and adenovirus receptor, CD200  -  cd200 molecule, NLGN3  -  neuroligin 3, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), PCDH20  -  protocadherin 20, SLITRK1  -  slit and ntrk-like family, member 1, DLG2  -  discs, large homolog 2 (drosophila), CLDN20  -  claudin 20, PCDHGA12  -  protocadherin gamma subfamily a, 12, NRXN2  -  neurexin 2, PCDH11Y  -  protocadherin 11 y-linked, KIRREL2  -  kin of irre like 2 (drosophila), TYRO3  -  tyro3 protein tyrosine kinase, GPC4  -  glypican 4, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, TLN2  -  talin 2, RAP2B  -  rap2b, member of ras oncogene family, TNR  -  tenascin r, AMIGO2  -  adhesion molecule with ig-like domain 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), KIRREL3  -  kin of irre like 3 (drosophila), ATP2C1  -  atpase, ca++ transporting, type 2c, member 1, SLITRK2  -  slit and ntrk-like family, member 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, NTNG2  -  netrin g2, NPHP1  -  nephronophthisis 1 (juvenile), CBLN1  -  cerebellin 1 precursor, TENM3  -  teneurin transmembrane protein 3, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), BCL2  -  b-cell cll/lymphoma 2, CDH8  -  cadherin 8, type 2, CDH9  -  cadherin 9, type 2 (t1-cadherin), IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PCDH18  -  protocadherin 18, PCDH19  -  protocadherin 19, PTPRF  -  protein tyrosine phosphatase, receptor type, f, LAMB1  -  laminin, beta 1]
GO:0022898	regulation of transmembrane transporter activity	1.09E-6	5.4E-4	2.45	14984	230	1038	39	[GSG1L  -  gsg1-like, HPCA  -  hippocalcin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, FXYD6  -  fxyd domain containing ion transport regulator 6, DRD2  -  dopamine receptor d2, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CHRM3  -  cholinergic receptor, muscarinic 3, PRNP  -  prion protein, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, TWIST1  -  twist basic helix-loop-helix transcription factor 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, NPPA  -  natriuretic peptide a, FKBP1A  -  fk506 binding protein 1a, 12kda, STIM1  -  stromal interaction molecule 1, BCL2  -  b-cell cll/lymphoma 2, JPH4  -  junctophilin 4, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, NLGN3  -  neuroligin 3, PDE4B  -  phosphodiesterase 4b, camp-specific, FXYD7  -  fxyd domain containing ion transport regulator 7, FHL1  -  four and a half lim domains 1]
GO:0032409	regulation of transporter activity	1.25E-6	6.01E-4	2.41	14984	240	1038	40	[GSG1L  -  gsg1-like, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, HPCA  -  hippocalcin, RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, FXYD6  -  fxyd domain containing ion transport regulator 6, DRD2  -  dopamine receptor d2, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CHRM3  -  cholinergic receptor, muscarinic 3, PRNP  -  prion protein, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, TWIST1  -  twist basic helix-loop-helix transcription factor 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NPPA  -  natriuretic peptide a, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, FKBP1A  -  fk506 binding protein 1a, 12kda, STIM1  -  stromal interaction molecule 1, BCL2  -  b-cell cll/lymphoma 2, JPH4  -  junctophilin 4, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, GRM5  -  glutamate receptor, metabotropic 5, PRKCD  -  protein kinase c, delta, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, NLGN3  -  neuroligin 3, PDE4B  -  phosphodiesterase 4b, camp-specific, FXYD7  -  fxyd domain containing ion transport regulator 7, FHL1  -  four and a half lim domains 1]
GO:0007613	memory	1.55E-6	7.18E-4	2.86	14984	97	1569	29	[BTBD9  -  btb (poz) domain containing 9, FAM19A2  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a2, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, DRD2  -  dopamine receptor d2, PRNP  -  prion protein, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, HRH1  -  histamine receptor h1, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, GRIA1  -  glutamate receptor, ionotropic, ampa 1, CALB1  -  calbindin 1, 28kda, KCNK2  -  potassium channel, subfamily k, member 2, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, BDNF  -  brain-derived neurotrophic factor, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), KALRN  -  kalirin, rhogef kinase, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, VLDLR  -  very low density lipoprotein receptor, KLK8  -  kallikrein-related peptidase 8, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, B4GALT2  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 2, PTCHD1  -  patched domain containing 1, CREB1  -  camp responsive element binding protein 1, RGS14  -  regulator of g-protein signaling 14, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, CCK  -  cholecystokinin]
GO:0032879	regulation of localization	1.74E-6	7.82E-4	1.32	14984	2328	1396	287	[TRIB3  -  tribbles homolog 3 (drosophila), TRIM27  -  tripartite motif containing 27, PLXNC1  -  plexin c1, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), BTC  -  betacellulin, CARTPT  -  cart prepropeptide, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PYCARD  -  pyd and card domain containing, BDNF  -  brain-derived neurotrophic factor, TWIST2  -  twist basic helix-loop-helix transcription factor 2, SOX4  -  sry (sex determining region y)-box 4, PLXNA1  -  plexin a1, LPL  -  lipoprotein lipase, CD84  -  cd84 molecule, TRIM6  -  tripartite motif containing 6, LOH12CR1  -  loss of heterozygosity, 12, chromosomal region 1, HAMP  -  hepcidin antimicrobial peptide, UBXN2B  -  ubx domain protein 2b, NKAIN4  -  na+/k+ transporting atpase interacting 4, CRH  -  corticotropin releasing hormone, JPH4  -  junctophilin 4, PHLDA2  -  pleckstrin homology-like domain, family a, member 2, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, RGS4  -  regulator of g-protein signaling 4, CREB1  -  camp responsive element binding protein 1, PGAP1  -  post-gpi attachment to proteins 1, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), GRASP  -  grp1 (general receptor for phosphoinositides 1)-associated scaffold protein, ABHD17C  -  abhydrolase domain containing 17c, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, NMU  -  neuromedin u, NUS1  -  nuclear undecaprenyl pyrophosphate synthase 1 homolog (s. cerevisiae), TPM1  -  tropomyosin 1 (alpha), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), RIMS1  -  regulating synaptic membrane exocytosis 1, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CNR1  -  cannabinoid receptor 1 (brain), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PTGES  -  prostaglandin e synthase, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, SUMO3  -  small ubiquitin-like modifier 3, CNTN1  -  contactin 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), STMN1  -  stathmin 1, NTNG2  -  netrin g2, BSN  -  bassoon presynaptic cytomatrix protein, DDRGK1  -  ddrgk domain containing 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, SLC25A27  -  solute carrier family 25, member 27, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, SNAI2  -  snail family zinc finger 2, AKAP5  -  a kinase (prka) anchor protein 5, CPLX3  -  complexin 3, TMEFF2  -  transmembrane protein with egf-like and two follistatin-like domains 2, BAIAP3  -  bai1-associated protein 3, LAMB1  -  laminin, beta 1, AP2B1  -  adaptor-related protein complex 2, beta 1 subunit, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, EXPH5  -  exophilin 5, FABP3  -  fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor), PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SYT5  -  synaptotagmin v, IQSEC2  -  iq motif and sec7 domain 2, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, TRIML2  -  tripartite motif family-like 2, PDCD6  -  programmed cell death 6, FAM110C  -  family with sequence similarity 110, member c, KCNQ2  -  potassium voltage-gated channel, kqt-like subfamily, member 2, ACSL4  -  acyl-coa synthetase long-chain family member 4, PPP3R1  -  protein phosphatase 3, regulatory subunit b, alpha, MERTK  -  c-mer proto-oncogene tyrosine kinase, PID1  -  phosphotyrosine interaction domain containing 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, CLASP2  -  cytoplasmic linker associated protein 2, PEA15  -  phosphoprotein enriched in astrocytes 15, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, TRIM17  -  tripartite motif containing 17, STX1A  -  syntaxin 1a (brain), IL33  -  interleukin 33, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1F  -  calcium channel, voltage-dependent, l type, alpha 1f subunit, CACNA1E  -  calcium channel, voltage-dependent, r type, alpha 1e subunit, AHSG  -  alpha-2-hs-glycoprotein, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, STIM1  -  stromal interaction molecule 1, UNC13B  -  unc-13 homolog b (c. elegans), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, HPCA  -  hippocalcin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, CRY2  -  cryptochrome 2 (photolyase-like), PRNP  -  prion protein, KIAA2022  -  kiaa2022, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, SPRED1  -  sprouty-related, evh1 domain containing 1, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ATP8A1  -  atpase, aminophospholipid transporter (aplt), class i, type 8a, member 1, SST  -  somatostatin, ADTRP  -  androgen-dependent tfpi-regulating protein, CD247  -  cd247 molecule, CSF1R  -  colony stimulating factor 1 receptor, ONECUT1  -  one cut homeobox 1, CEP72  -  centrosomal protein 72kda, EPHA3  -  eph receptor a3, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, YJEFN3  -  yjef n-terminal domain containing 3, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, TNN  -  tenascin n, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, PRKG1  -  protein kinase, cgmp-dependent, type i, TTL  -  tubulin tyrosine ligase, FERMT2  -  fermitin family member 2, EPHA5  -  eph receptor a5, TMSB15A  -  thymosin beta 15a, FBXO31  -  f-box protein 31, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PRKCG  -  protein kinase c, gamma, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, USP46  -  ubiquitin specific peptidase 46, PRKCD  -  protein kinase c, delta, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, CCK  -  cholecystokinin, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, IL13RA2  -  interleukin 13 receptor, alpha 2, CDC42  -  cell division cycle 42, CDH3  -  cadherin 3, type 1, p-cadherin (placental), PRTN3  -  proteinase 3, APOC1  -  apolipoprotein c-i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, SYT17  -  synaptotagmin xvii, SAPCD2  -  suppressor apc domain containing 2, INHA  -  inhibin, alpha, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, C2CD2L  -  c2cd2-like, MYRIP  -  myosin viia and rab interacting protein, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, OXCT1  -  3-oxoacid coa transferase 1, SIAH3  -  siah e3 ubiquitin protein ligase family member 3, DNAAF1  -  dynein, axonemal, assembly factor 1, RAB15  -  rab15, member ras oncogene family, NHLRC1  -  nhl repeat containing 1, P2RY2  -  purinergic receptor p2y, g-protein coupled, 2, PCLO  -  piccolo presynaptic cytomatrix protein, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CCL4  -  chemokine (c-c motif) ligand 4, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, IL1B  -  interleukin 1, beta, FKBP1A  -  fk506 binding protein 1a, 12kda, WNT4  -  wingless-type mmtv integration site family, member 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CD200  -  cd200 molecule, NLGN3  -  neuroligin 3, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, FHL1  -  four and a half lim domains 1, FXYD6  -  fxyd domain containing ion transport regulator 6, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, DCP2  -  decapping mrna 2, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, PTCH1  -  patched 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, NSFL1C  -  nsfl1 (p97) cofactor (p47), PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), ARG1  -  arginase 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, C5orf30  -  chromosome 5 open reading frame 30, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, GPC4  -  glypican 4, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, CORO1A  -  coronin, actin binding protein, 1a, PCK2  -  phosphoenolpyruvate carboxykinase 2 (mitochondrial), MEST  -  mesoderm specific transcript, TMSB10  -  thymosin beta 10, INSM1  -  insulinoma-associated 1, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, MET  -  met proto-oncogene, SLC30A4  -  solute carrier family 30 (zinc transporter), member 4, NPPA  -  natriuretic peptide a, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, CLIP3  -  cap-gly domain containing linker protein 3, NPY5R  -  neuropeptide y receptor y5, ARMC4  -  armadillo repeat containing 4, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, FXYD7  -  fxyd domain containing ion transport regulator 7, PDE4B  -  phosphodiesterase 4b, camp-specific, DRD2  -  dopamine receptor d2, DOCK4  -  dedicator of cytokinesis 4, NNAT  -  neuronatin, LRRC7  -  leucine rich repeat containing 7, BBC3  -  bcl2 binding component 3, ARPP19  -  camp-regulated phosphoprotein, 19kda, PTPRO  -  protein tyrosine phosphatase, receptor type, o, NKD2  -  naked cuticle homolog 2 (drosophila), PTPRR  -  protein tyrosine phosphatase, receptor type, r, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, CHRM3  -  cholinergic receptor, muscarinic 3, NKAIN2  -  na+/k+ transporting atpase interacting 2, UBQLN2  -  ubiquilin 2, NOV  -  nephroblastoma overexpressed, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, DPP6  -  dipeptidyl-peptidase 6, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, PPAPDC1A  -  phosphatidic acid phosphatase type 2 domain containing 1a, KCNH5  -  potassium voltage-gated channel, subfamily h (eag-related), member 5, GPM6B  -  glycoprotein m6b, LZTFL1  -  leucine zipper transcription factor-like 1, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, WFS1  -  wolfram syndrome 1 (wolframin), TMSB4Y  -  thymosin beta 4, y-linked, WHSC1  -  wolf-hirschhorn syndrome candidate 1, FAM65B  -  family with sequence similarity 65, member b, DSP  -  desmoplakin, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, HDAC9  -  histone deacetylase 9, TNNC1  -  troponin c type 1 (slow), RAB27B  -  rab27b, member ras oncogene family, KIAA1462  -  kiaa1462, GSG1L  -  gsg1-like, CCL28  -  chemokine (c-c motif) ligand 28, KCNG3  -  potassium voltage-gated channel, subfamily g, member 3, TEK  -  tek tyrosine kinase, endothelial, NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), BARD1  -  brca1 associated ring domain 1, IL34  -  interleukin 34, DLG2  -  discs, large homolog 2 (drosophila), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TERF1  -  telomeric repeat binding factor (nima-interacting) 1, DPP10  -  dipeptidyl-peptidase 10 (non-functional), NR2F2  -  nuclear receptor subfamily 2, group f, member 2, EPB41L4B  -  erythrocyte membrane protein band 4.1 like 4b, PDGFD  -  platelet derived growth factor d, RRAS2  -  related ras viral (r-ras) oncogene homolog 2, NECAB2  -  n-terminal ef-hand calcium binding protein 2, KCNV1  -  potassium channel, subfamily v, member 1, RAP2B  -  rap2b, member of ras oncogene family, GRIA1  -  glutamate receptor, ionotropic, ampa 1, AZIN1  -  antizyme inhibitor 1, SFRP1  -  secreted frizzled-related protein 1, SFRP2  -  secreted frizzled-related protein 2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, IGF1  -  insulin-like growth factor 1 (somatomedin c), KALRN  -  kalirin, rhogef kinase, IGFBP5  -  insulin-like growth factor binding protein 5, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, PIK3CD  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, BCL2  -  b-cell cll/lymphoma 2, GRM5  -  glutamate receptor, metabotropic 5, RAB11FIP1  -  rab11 family interacting protein 1 (class i), YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD3  -  smad family member 3, NAV3  -  neuron navigator 3, YWHAZ  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, NRG3  -  neuregulin 3, MMD  -  monocyte to macrophage differentiation-associated]
GO:0050767	regulation of neurogenesis	3.11E-6	1.36E-3	1.70	14984	714	1135	92	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, LIG4  -  ligase iv, dna, atp-dependent, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, ENC1  -  ectodermal-neural cortex 1 (with btb domain), OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, LINGO1  -  leucine rich repeat and ig domain containing 1, SYT4  -  synaptotagmin iv, ABI2  -  abl-interactor 2, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, ARHGAP33  -  rho gtpase activating protein 33, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, NUMBL  -  numb homolog (drosophila)-like, TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, BDNF  -  brain-derived neurotrophic factor, PLXNA1  -  plexin a1, IL1B  -  interleukin 1, beta, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, FAM19A1  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a1, IMPACT  -  impact rwd domain protein, RTN4R  -  reticulon 4 receptor, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, RGS14  -  regulator of g-protein signaling 14, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CPNE6  -  copine vi (neuronal), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), NEUROD1  -  neuronal differentiation 1, FAM150B  -  family with sequence similarity 150, member b, BAI3  -  brain-specific angiogenesis inhibitor 3, CRMP1  -  collapsin response mediator protein 1, IL34  -  interleukin 34, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), RIMS1  -  regulating synaptic membrane exocytosis 1, DLL3  -  delta-like 3 (drosophila), CSMD3  -  cub and sushi multiple domains 3, KIAA2022  -  kiaa2022, RARB  -  retinoic acid receptor, beta, UST  -  uronyl-2-sulfotransferase, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, EFNB3  -  ephrin-b3, EFNB2  -  ephrin-b2, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, TNR  -  tenascin r, LTK  -  leukocyte receptor tyrosine kinase, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, SFRP2  -  secreted frizzled-related protein 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, NTNG2  -  netrin g2, TNN  -  tenascin n, RTN4RL1  -  reticulon 4 receptor-like 1, TENM3  -  teneurin transmembrane protein 3, TTL  -  tubulin tyrosine ligase, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, ELL3  -  elongation factor rna polymerase ii-like 3, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, NRG3  -  neuregulin 3, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, THRB  -  thyroid hormone receptor, beta, DRAXIN  -  dorsal inhibitory axon guidance protein, MMD  -  monocyte to macrophage differentiation-associated, PTPRF  -  protein tyrosine phosphatase, receptor type, f, ASCL2  -  achaete-scute complex homolog 2 (drosophila), CPNE5  -  copine v]
GO:0051588	regulation of neurotransmitter transport	3.16E-6	1.34E-3	2.82	14984	115	1342	29	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), DRD2  -  dopamine receptor d2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), TACR2  -  tachykinin receptor 2, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, SYT4  -  synaptotagmin iv, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, GPM6B  -  glycoprotein m6b, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, STX1A  -  syntaxin 1a (brain), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CRH  -  corticotropin releasing hormone, UNC13B  -  unc-13 homolog b (c. elegans), PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, RGS4  -  regulator of g-protein signaling 4, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), BAIAP3  -  bai1-associated protein 3]
GO:0051049	regulation of transport	3.27E-6	1.35E-3	1.40	14984	1490	1476	205	[TRIB3  -  tribbles homolog 3 (drosophila), TRIM27  -  tripartite motif containing 27, GALR2  -  galanin receptor 2, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), CARTPT  -  cart prepropeptide, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, PYCARD  -  pyd and card domain containing, SOX4  -  sry (sex determining region y)-box 4, CD84  -  cd84 molecule, LOH12CR1  -  loss of heterozygosity, 12, chromosomal region 1, HAMP  -  hepcidin antimicrobial peptide, NKAIN4  -  na+/k+ transporting atpase interacting 4, CRH  -  corticotropin releasing hormone, JPH4  -  junctophilin 4, RGS4  -  regulator of g-protein signaling 4, CREB1  -  camp responsive element binding protein 1, PGAP1  -  post-gpi attachment to proteins 1, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), GRASP  -  grp1 (general receptor for phosphoinositides 1)-associated scaffold protein, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, NMU  -  neuromedin u, NUS1  -  nuclear undecaprenyl pyrophosphate synthase 1 homolog (s. cerevisiae), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), RIMS1  -  regulating synaptic membrane exocytosis 1, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CNR1  -  cannabinoid receptor 1 (brain), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PTGES  -  prostaglandin e synthase, CNTN1  -  contactin 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, BSN  -  bassoon presynaptic cytomatrix protein, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, SLC25A27  -  solute carrier family 25, member 27, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, AKAP5  -  a kinase (prka) anchor protein 5, CPLX3  -  complexin 3, BAIAP3  -  bai1-associated protein 3, AP2B1  -  adaptor-related protein complex 2, beta 1 subunit, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, EXPH5  -  exophilin 5, FABP3  -  fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor), TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SYT5  -  synaptotagmin v, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, KCNQ2  -  potassium voltage-gated channel, kqt-like subfamily, member 2, ACSL4  -  acyl-coa synthetase long-chain family member 4, PPP3R1  -  protein phosphatase 3, regulatory subunit b, alpha, MERTK  -  c-mer proto-oncogene tyrosine kinase, PID1  -  phosphotyrosine interaction domain containing 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, CLASP2  -  cytoplasmic linker associated protein 2, PEA15  -  phosphoprotein enriched in astrocytes 15, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, STX1A  -  syntaxin 1a (brain), CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, VIP  -  vasoactive intestinal peptide, CACNA1F  -  calcium channel, voltage-dependent, l type, alpha 1f subunit, CACNA1E  -  calcium channel, voltage-dependent, r type, alpha 1e subunit, AHSG  -  alpha-2-hs-glycoprotein, REEP5  -  receptor accessory protein 5, STIM1  -  stromal interaction molecule 1, UNC13B  -  unc-13 homolog b (c. elegans), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, HPCA  -  hippocalcin, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, CRY2  -  cryptochrome 2 (photolyase-like), PRNP  -  prion protein, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ATP8A1  -  atpase, aminophospholipid transporter (aplt), class i, type 8a, member 1, ADTRP  -  androgen-dependent tfpi-regulating protein, EPHA3  -  eph receptor a3, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, YJEFN3  -  yjef n-terminal domain containing 3, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, PHPT1  -  phosphohistidine phosphatase 1, EPHA5  -  eph receptor a5, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PRKCI  -  protein kinase c, iota, PRKCG  -  protein kinase c, gamma, USP46  -  ubiquitin specific peptidase 46, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, PRKCD  -  protein kinase c, delta, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, CCK  -  cholecystokinin, SIRPA  -  signal-regulatory protein alpha, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, IL13RA2  -  interleukin 13 receptor, alpha 2, CDC42  -  cell division cycle 42, CDH3  -  cadherin 3, type 1, p-cadherin (placental), PRTN3  -  proteinase 3, APOC1  -  apolipoprotein c-i, RAB8B  -  rab8b, member ras oncogene family, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, SYT17  -  synaptotagmin xvii, INHA  -  inhibin, alpha, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, MYRIP  -  myosin viia and rab interacting protein, C2CD2L  -  c2cd2-like, KCNMB4  -  potassium large conductance calcium-activated channel, subfamily m, beta member 4, SIAH3  -  siah e3 ubiquitin protein ligase family member 3, OXCT1  -  3-oxoacid coa transferase 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, RAB15  -  rab15, member ras oncogene family, P2RY2  -  purinergic receptor p2y, g-protein coupled, 2, PCLO  -  piccolo presynaptic cytomatrix protein, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CCL4  -  chemokine (c-c motif) ligand 4, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, IL1B  -  interleukin 1, beta, FKBP1A  -  fk506 binding protein 1a, 12kda, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CD200  -  cd200 molecule, NLGN3  -  neuroligin 3, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, FHL1  -  four and a half lim domains 1, FXYD6  -  fxyd domain containing ion transport regulator 6, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, PTCH1  -  patched 1, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARG1  -  arginase 1, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, CORO1A  -  coronin, actin binding protein, 1a, PCK2  -  phosphoenolpyruvate carboxykinase 2 (mitochondrial), SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, NPPA  -  natriuretic peptide a, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, CLIP3  -  cap-gly domain containing linker protein 3, NPY5R  -  neuropeptide y receptor y5, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PDE4B  -  phosphodiesterase 4b, camp-specific, FXYD7  -  fxyd domain containing ion transport regulator 7, DRD2  -  dopamine receptor d2, NNAT  -  neuronatin, LRRC7  -  leucine rich repeat containing 7, BBC3  -  bcl2 binding component 3, ARPP19  -  camp-regulated phosphoprotein, 19kda, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, CHRM3  -  cholinergic receptor, muscarinic 3, NKAIN2  -  na+/k+ transporting atpase interacting 2, UBQLN2  -  ubiquilin 2, NOV  -  nephroblastoma overexpressed, DPP6  -  dipeptidyl-peptidase 6, NLGN1  -  neuroligin 1, PPAPDC1A  -  phosphatidic acid phosphatase type 2 domain containing 1a, GPM6B  -  glycoprotein m6b, KCNH5  -  potassium voltage-gated channel, subfamily h (eag-related), member 5, WFS1  -  wolfram syndrome 1 (wolframin), RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNC1  -  troponin c type 1 (slow), RAB27B  -  rab27b, member ras oncogene family, KCNG3  -  potassium voltage-gated channel, subfamily g, member 3, GSG1L  -  gsg1-like, NEUROD1  -  neuronal differentiation 1, SH3GL3  -  sh3-domain grb2-like 3, BARD1  -  brca1 associated ring domain 1, OSR1  -  odd-skipped related 1 (drosophila), DLG2  -  discs, large homolog 2 (drosophila), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), DPP10  -  dipeptidyl-peptidase 10 (non-functional), NECAB2  -  n-terminal ef-hand calcium binding protein 2, KCNV1  -  potassium channel, subfamily v, member 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, AZIN1  -  antizyme inhibitor 1, SFRP1  -  secreted frizzled-related protein 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, IGF1  -  insulin-like growth factor 1 (somatomedin c), KALRN  -  kalirin, rhogef kinase, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, BCL2  -  b-cell cll/lymphoma 2, GRM5  -  glutamate receptor, metabotropic 5, RAB11FIP1  -  rab11 family interacting protein 1 (class i), YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD3  -  smad family member 3, YWHAZ  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, WASL  -  wiskott-aldrich syndrome-like]
GO:0099601	regulation of neurotransmitter receptor activity	3.46E-6	1.39E-3	3.46	14984	72	1262	21	[GSG1L  -  gsg1-like, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, RELN  -  reelin, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, OPRM1  -  opioid receptor, mu 1, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, NPTXR  -  neuronal pentraxin receptor, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, CRH  -  corticotropin releasing hormone, NPTX1  -  neuronal pentraxin i, BEGAIN  -  brain-enriched guanylate kinase-associated, NPTX2  -  neuronal pentraxin ii, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, LYPD6B  -  ly6/plaur domain containing 6b, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, NLGN3  -  neuroligin 3, GRIA1  -  glutamate receptor, ionotropic, ampa 1, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4]
GO:0051952	regulation of amine transport	3.48E-6	1.36E-3	3.02	14984	80	1552	25	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OSR1  -  odd-skipped related 1 (drosophila), DRD2  -  dopamine receptor d2, ADRA2C  -  adrenoceptor alpha 2c, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, ARG1  -  arginase 1, CARTPT  -  cart prepropeptide, CNR1  -  cannabinoid receptor 1 (brain), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), STX1A  -  syntaxin 1a (brain), P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, TOR1A  -  torsin family 1, member a (torsin a), VIP  -  vasoactive intestinal peptide, GRM7  -  glutamate receptor, metabotropic 7, CRH  -  corticotropin releasing hormone, NPY5R  -  neuropeptide y receptor y5, RGS4  -  regulator of g-protein signaling 4, CCK  -  cholecystokinin]
GO:0031344	regulation of cell projection organization	4.15E-6	1.58E-3	1.75	14984	619	1135	82	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, ENC1  -  ectodermal-neural cortex 1 (with btb domain), OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, LINGO1  -  leucine rich repeat and ig domain containing 1, SYT4  -  synaptotagmin iv, ABI2  -  abl-interactor 2, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, FAM110C  -  family with sequence similarity 110, member c, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, ARHGAP33  -  rho gtpase activating protein 33, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, AGRN  -  agrin, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, GPM6A  -  glycoprotein m6a, TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, BDNF  -  brain-derived neurotrophic factor, DCDC2  -  doublecortin domain containing 2, FAM65B  -  family with sequence similarity 65, member b, FNBP1L  -  formin binding protein 1-like, PLXNA1  -  plexin a1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, RTN4R  -  reticulon 4 receptor, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CPNE6  -  copine vi (neuronal), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), FAM150B  -  family with sequence similarity 150, member b, BAI3  -  brain-specific angiogenesis inhibitor 3, CRMP1  -  collapsin response mediator protein 1, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, RIMS1  -  regulating synaptic membrane exocytosis 1, PRNP  -  prion protein, CSMD3  -  cub and sushi multiple domains 3, UST  -  uronyl-2-sulfotransferase, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, EFNB3  -  ephrin-b3, EFNB2  -  ephrin-b2, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, TNR  -  tenascin r, LTK  -  leukocyte receptor tyrosine kinase, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, SFRP2  -  secreted frizzled-related protein 2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, NTNG2  -  netrin g2, RTN4RL1  -  reticulon 4 receptor-like 1, TENM3  -  teneurin transmembrane protein 3, TTL  -  tubulin tyrosine ligase, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, PRKCD  -  protein kinase c, delta, GAP43  -  growth associated protein 43, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, DRAXIN  -  dorsal inhibitory axon guidance protein, PTPRF  -  protein tyrosine phosphatase, receptor type, f, CPNE5  -  copine v]
GO:0048167	regulation of synaptic plasticity	4.25E-6	1.58E-3	3.42	14984	165	557	21	[CALB1  -  calbindin 1, 28kda, TSHZ3  -  teashirt zinc finger homeobox 3, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, CALB2  -  calbindin 2, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, GRIK2  -  glutamate receptor, ionotropic, kainate 2, DRD2  -  dopamine receptor d2, CBLN1  -  cerebellin 1 precursor, MAPK1  -  mitogen-activated protein kinase 1, RIMS1  -  regulating synaptic membrane exocytosis 1, EPHA4  -  eph receptor a4, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, ERC2  -  elks/rab6-interacting/cast family member 2, AKAP5  -  a kinase (prka) anchor protein 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, HRH1  -  histamine receptor h1, RGS14  -  regulator of g-protein signaling 14, ITPKA  -  inositol-trisphosphate 3-kinase a, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1]
GO:0120035	regulation of plasma membrane bounded cell projection organization	4.52E-6	1.64E-3	1.75	14984	611	1135	81	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, ENC1  -  ectodermal-neural cortex 1 (with btb domain), OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, LINGO1  -  leucine rich repeat and ig domain containing 1, SYT4  -  synaptotagmin iv, ABI2  -  abl-interactor 2, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, ARHGAP33  -  rho gtpase activating protein 33, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, AGRN  -  agrin, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, GPM6A  -  glycoprotein m6a, TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, BDNF  -  brain-derived neurotrophic factor, DCDC2  -  doublecortin domain containing 2, FAM65B  -  family with sequence similarity 65, member b, FNBP1L  -  formin binding protein 1-like, PLXNA1  -  plexin a1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, RTN4R  -  reticulon 4 receptor, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CPNE6  -  copine vi (neuronal), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), FAM150B  -  family with sequence similarity 150, member b, BAI3  -  brain-specific angiogenesis inhibitor 3, CRMP1  -  collapsin response mediator protein 1, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, RIMS1  -  regulating synaptic membrane exocytosis 1, PRNP  -  prion protein, CSMD3  -  cub and sushi multiple domains 3, UST  -  uronyl-2-sulfotransferase, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, EFNB3  -  ephrin-b3, EFNB2  -  ephrin-b2, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, TNR  -  tenascin r, LTK  -  leukocyte receptor tyrosine kinase, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, SFRP2  -  secreted frizzled-related protein 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, NTNG2  -  netrin g2, RTN4RL1  -  reticulon 4 receptor-like 1, TENM3  -  teneurin transmembrane protein 3, TTL  -  tubulin tyrosine ligase, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, GAP43  -  growth associated protein 43, PRKCD  -  protein kinase c, delta, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, DRAXIN  -  dorsal inhibitory axon guidance protein, PTPRF  -  protein tyrosine phosphatase, receptor type, f, CPNE5  -  copine v]
GO:0034762	regulation of transmembrane transport	4.91E-6	1.74E-3	1.90	14984	478	1038	63	[TRIB3  -  tribbles homolog 3 (drosophila), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, ARPP19  -  camp-regulated phosphoprotein, 19kda, CHRM3  -  cholinergic receptor, muscarinic 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, DPP6  -  dipeptidyl-peptidase 6, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, KCNH5  -  potassium voltage-gated channel, subfamily h (eag-related), member 5, PID1  -  phosphotyrosine interaction domain containing 1, PEA15  -  phosphoprotein enriched in astrocytes 15, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, IL1B  -  interleukin 1, beta, FKBP1A  -  fk506 binding protein 1a, 12kda, STIM1  -  stromal interaction molecule 1, JPH4  -  junctophilin 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RGS4  -  regulator of g-protein signaling 4, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, NLGN3  -  neuroligin 3, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, FHL1  -  four and a half lim domains 1, KCNG3  -  potassium voltage-gated channel, subfamily g, member 3, GSG1L  -  gsg1-like, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, HPCA  -  hippocalcin, FXYD6  -  fxyd domain containing ion transport regulator 6, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, DLG2  -  discs, large homolog 2 (drosophila), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PRNP  -  prion protein, DPP10  -  dipeptidyl-peptidase 10 (non-functional), HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, TWIST1  -  twist basic helix-loop-helix transcription factor 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, KCNV1  -  potassium channel, subfamily v, member 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, AZIN1  -  antizyme inhibitor 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, CORO1A  -  coronin, actin binding protein, 1a, IGF1  -  insulin-like growth factor 1 (somatomedin c), KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, NPPA  -  natriuretic peptide a, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, BCL2  -  b-cell cll/lymphoma 2, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, FXYD7  -  fxyd domain containing ion transport regulator 7, PDE4B  -  phosphodiesterase 4b, camp-specific]
GO:0051239	regulation of multicellular organismal process	5.06E-6	1.75E-3	1.32	14984	2646	1140	266	[TRIM27  -  tripartite motif containing 27, LIG4  -  ligase iv, dna, atp-dependent, PLXNC1  -  plexin c1, ABI2  -  abl-interactor 2, LINGO1  -  leucine rich repeat and ig domain containing 1, CARTPT  -  cart prepropeptide, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, HRH1  -  histamine receptor h1, ACADL  -  acyl-coa dehydrogenase, long chain, CARD17  -  caspase recruitment domain family, member 17, CELF4  -  cugbp, elav-like family member 4, BDNF  -  brain-derived neurotrophic factor, EGR3  -  early growth response 3, SOX4  -  sry (sex determining region y)-box 4, TWIST2  -  twist basic helix-loop-helix transcription factor 2, PLXNA1  -  plexin a1, LPL  -  lipoprotein lipase, TRIM6  -  tripartite motif containing 6, PYDC1  -  pyd (pyrin domain) containing 1, GHR  -  growth hormone receptor, PHLDA2  -  pleckstrin homology-like domain, family a, member 2, RGS4  -  regulator of g-protein signaling 4, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, ZC3H8  -  zinc finger ccch-type containing 8, LMO1  -  lim domain only 1 (rhombotin 1), GDPD2  -  glycerophosphodiester phosphodiesterase domain containing 2, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), NMU  -  neuromedin u, FAM150B  -  family with sequence similarity 150, member b, NUS1  -  nuclear undecaprenyl pyrophosphate synthase 1 homolog (s. cerevisiae), TPM1  -  tropomyosin 1 (alpha), ACVR2A  -  activin a receptor, type iia, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), ACVR2B  -  activin a receptor, type iib, RIMS1  -  regulating synaptic membrane exocytosis 1, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, UST  -  uronyl-2-sulfotransferase, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, EFNB3  -  ephrin-b3, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, ADCY7  -  adenylate cyclase 7, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PTGES  -  prostaglandin e synthase, TNR  -  tenascin r, CNTN1  -  contactin 1, LINGO2  -  leucine rich repeat and ig domain containing 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), TMEM108  -  transmembrane protein 108, CHID1  -  chitinase domain containing 1, SLITRK2  -  slit and ntrk-like family, member 2, POLR2L  -  polymerase (rna) ii (dna directed) polypeptide l, 7.6kda, NTNG2  -  netrin g2, SLIT1  -  slit homolog 1 (drosophila), CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, COL5A1  -  collagen, type v, alpha 1, SNAI2  -  snail family zinc finger 2, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, PANX1  -  pannexin 1, F12  -  coagulation factor xii (hageman factor), HMGB3  -  high mobility group box 3, TACR2  -  tachykinin receptor 2, ZC3H13  -  zinc finger ccch-type containing 13, OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, PDCD6  -  programmed cell death 6, ARHGAP33  -  rho gtpase activating protein 33, MERTK  -  c-mer proto-oncogene tyrosine kinase, BANK1  -  b-cell scaffold protein with ankyrin repeats 1, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, STX1A  -  syntaxin 1a (brain), IL33  -  interleukin 33, ZNF706  -  zinc finger protein 706, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, AHSG  -  alpha-2-hs-glycoprotein, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, CREB3L1  -  camp responsive element binding protein 3-like 1, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, FAM19A1  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a1, STIM1  -  stromal interaction molecule 1, UNC13B  -  unc-13 homolog b (c. elegans), RTN4R  -  reticulon 4 receptor, CXADR  -  coxsackie virus and adenovirus receptor, DARC  -  duffy blood group, atypical chemokine receptor, CPNE6  -  copine vi (neuronal), CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, KL  -  klotho, CRMP1  -  collapsin response mediator protein 1, SLITRK1  -  slit and ntrk-like family, member 1, PRNP  -  prion protein, CSMD3  -  cub and sushi multiple domains 3, KIAA2022  -  kiaa2022, SPRED1  -  sprouty-related, evh1 domain containing 1, TWIST1  -  twist basic helix-loop-helix transcription factor 1, SGPP1  -  sphingosine-1-phosphate phosphatase 1, ADTRP  -  androgen-dependent tfpi-regulating protein, SSTR2  -  somatostatin receptor 2, ITPKA  -  inositol-trisphosphate 3-kinase a, MAPK11  -  mitogen-activated protein kinase 11, EPHA3  -  eph receptor a3, KCNK2  -  potassium channel, subfamily k, member 2, KCNK1  -  potassium channel, subfamily k, member 1, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, YJEFN3  -  yjef n-terminal domain containing 3, CBLN1  -  cerebellin 1 precursor, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, TNN  -  tenascin n, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, RIPK2  -  receptor-interacting serine-threonine kinase 2, TENM3  -  teneurin transmembrane protein 3, TTL  -  tubulin tyrosine ligase, FERMT2  -  fermitin family member 2, RSPO3  -  r-spondin 3, EPHA4  -  eph receptor a4, PRKCQ  -  protein kinase c, theta, FBXO31  -  f-box protein 31, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, VASN  -  vasorin, PRKCD  -  protein kinase c, delta, GAP43  -  growth associated protein 43, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, DRAXIN  -  dorsal inhibitory axon guidance protein, CCK  -  cholecystokinin, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, CD244  -  cd244 molecule, natural killer cell receptor 2b4, BIRC3  -  baculoviral iap repeat containing 3, CD83  -  cd83 molecule, IL12RB2  -  interleukin 12 receptor, beta 2, CDH3  -  cadherin 3, type 1, p-cadherin (placental), ENC1  -  ectodermal-neural cortex 1 (with btb domain), APOC1  -  apolipoprotein c-i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, SYT17  -  synaptotagmin xvii, SAPCD2  -  suppressor apc domain containing 2, TMEM173  -  transmembrane protein 173, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, AGRN  -  agrin, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NUMBL  -  numb homolog (drosophila)-like, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, IL1B  -  interleukin 1, beta, FKBP1A  -  fk506 binding protein 1a, 12kda, KLK8  -  kallikrein-related peptidase 8, WNT4  -  wingless-type mmtv integration site family, member 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CD200  -  cd200 molecule, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, MLIP  -  muscular lmna-interacting protein, FXYD6  -  fxyd domain containing ion transport regulator 6, PTCH1  -  patched 1, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), MKL2  -  mkl/myocardin-like 2, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, C5orf30  -  chromosome 5 open reading frame 30, PTHLH  -  parathyroid hormone-like hormone, GPC4  -  glypican 4, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, AMIGO2  -  adhesion molecule with ig-like domain 2, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), MET  -  met proto-oncogene, AKIRIN2  -  akirin 2, MESP1  -  mesoderm posterior 1 homolog (mouse), PYDC2  -  pyrin domain containing 2, NPPA  -  natriuretic peptide a, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), NPY1R  -  neuropeptide y receptor y1, NPTX1  -  neuronal pentraxin i, NPTX2  -  neuronal pentraxin ii, MGP  -  matrix gla protein, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, FXYD7  -  fxyd domain containing ion transport regulator 7, PTPRF  -  protein tyrosine phosphatase, receptor type, f, ASCL2  -  achaete-scute complex homolog 2 (drosophila), PDE4B  -  phosphodiesterase 4b, camp-specific, KREMEN2  -  kringle containing transmembrane protein 2, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, DOCK4  -  dedicator of cytokinesis 4, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTPRR  -  protein tyrosine phosphatase, receptor type, r, CHRM3  -  cholinergic receptor, muscarinic 3, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NOV  -  nephroblastoma overexpressed, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, WNT10B  -  wingless-type mmtv integration site family, member 10b, ANKRD6  -  ankyrin repeat domain 6, WNT7B  -  wingless-type mmtv integration site family, member 7b, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, NPTXR  -  neuronal pentraxin receptor, IMPACT  -  impact rwd domain protein, BEGAIN  -  brain-enriched guanylate kinase-associated, DSP  -  desmoplakin, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNC1  -  troponin c type 1 (slow), KIAA1462  -  kiaa1462, TNNT1  -  troponin t type 1 (skeletal, slow), TNNI3  -  troponin i type 3 (cardiac), TSHZ3  -  teashirt zinc finger homeobox 3, TEK  -  tek tyrosine kinase, endothelial, NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), BAI3  -  brain-specific angiogenesis inhibitor 3, IL34  -  interleukin 34, NELL1  -  nel-like 1 (chicken), RASAL1  -  ras protein activator like 1 (gap1 like), DLL3  -  delta-like 3 (drosophila), CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, SH3RF1  -  sh3 domain containing ring finger 1, RARB  -  retinoic acid receptor, beta, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, EPB41L4B  -  erythrocyte membrane protein band 4.1 like 4b, ISG15  -  isg15 ubiquitin-like modifier, PDGFD  -  platelet derived growth factor d, RBM24  -  rna binding motif protein 24, LTK  -  leukocyte receptor tyrosine kinase, BDKRB2  -  bradykinin receptor b2, SFRP2  -  secreted frizzled-related protein 2, SMAD1  -  smad family member 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, RTN4RL1  -  reticulon 4 receptor-like 1, GRM1  -  glutamate receptor, metabotropic 1, KALRN  -  kalirin, rhogef kinase, ELL3  -  elongation factor rna polymerase ii-like 3, PIK3CD  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, BCL2  -  b-cell cll/lymphoma 2, RAB11FIP1  -  rab11 family interacting protein 1 (class i), YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD3  -  smad family member 3, NAV3  -  neuron navigator 3, YWHAZ  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, NRG3  -  neuregulin 3, THRB  -  thyroid hormone receptor, beta, THRA  -  thyroid hormone receptor, alpha, CPNE5  -  copine v, MMD  -  monocyte to macrophage differentiation-associated]
GO:0032502	developmental process	6.28E-6	2.12E-3	1.34	14984	3956	638	225	[SPRR2G  -  small proline-rich protein 2g, TSHZ2  -  teashirt zinc finger homeobox 2, CREG1  -  cellular repressor of e1a-stimulated genes 1, DACH2  -  dachshund homolog 2 (drosophila), PLD6  -  phospholipase d family, member 6, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), DPF1  -  d4, zinc and double phd fingers family 1, BFSP1  -  beaded filament structural protein 1, filensin, GJB5  -  gap junction protein, beta 5, 31.1kda, LOR  -  loricrin, DAPL1  -  death associated protein-like 1, CELF4  -  cugbp, elav-like family member 4, BDNF  -  brain-derived neurotrophic factor, FSTL5  -  follistatin-like 5, THEG  -  theg spermatid protein, EGR3  -  early growth response 3, SOX4  -  sry (sex determining region y)-box 4, OLFM3  -  olfactomedin 3, RGS4  -  regulator of g-protein signaling 4, HOPX  -  hop homeobox, PARVB  -  parvin, beta, MYO7A  -  myosin viia, TPO  -  thyroid peroxidase, ADAMTS3  -  adam metallopeptidase with thrombospondin type 1 motif, 3, NUS1  -  nuclear undecaprenyl pyrophosphate synthase 1 homolog (s. cerevisiae), ACVR2A  -  activin a receptor, type iia, ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, KRT83  -  keratin 83, HPCAL4  -  hippocalcin like 4, C1QL1  -  complement component 1, q subcomponent-like 1, RIMS1  -  regulating synaptic membrane exocytosis 1, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, MYBPHL  -  myosin binding protein h-like, MYO16  -  myosin xvi, RNF2  -  ring finger protein 2, CNTN1  -  contactin 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, TMEM108  -  transmembrane protein 108, KIRREL3  -  kin of irre like 3 (drosophila), DDRGK1  -  ddrgk domain containing 1, SLIT1  -  slit homolog 1 (drosophila), SNAI2  -  snail family zinc finger 2, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, CA10  -  carbonic anhydrase x, PTCHD1  -  patched domain containing 1, C17orf96  -  chromosome 17 open reading frame 96, GMFB  -  glia maturation factor, beta, COL12A1  -  collagen, type xii, alpha 1, COL10A1  -  collagen, type x, alpha 1, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, LAMB1  -  laminin, beta 1, BATF3  -  basic leucine zipper transcription factor, atf-like 3, PCDH15  -  protocadherin-related 15, PTBP3  -  polypyrimidine tract binding protein 3, FABP3  -  fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor), FABP7  -  fatty acid binding protein 7, brain, HILS1  -  histone linker h1 domain, spermatid-specific 1, pseudogene, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, PDCD6  -  programmed cell death 6, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, ACSL4  -  acyl-coa synthetase long-chain family member 4, CTNND2  -  catenin (cadherin-associated protein), delta 2, PID1  -  phosphotyrosine interaction domain containing 1, CALB1  -  calbindin 1, 28kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, MECOM  -  mds1 and evi1 complex locus, EID2B  -  ep300 interacting inhibitor of differentiation 2b, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1, DAW1  -  dynein assembly factor with wdr repeat domains 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, FAM19A1  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a1, RTN4R  -  reticulon 4 receptor, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), WDR52  -  wd repeat domain 52, VAV1  -  vav 1 guanine nucleotide exchange factor, CXADR  -  coxsackie virus and adenovirus receptor, CPNE6  -  copine vi (neuronal), RNF165  -  ring finger protein 165, KL  -  klotho, TDRKH  -  tudor and kh domain containing, TYRP1  -  tyrosinase-related protein 1, KIAA2022  -  kiaa2022, SPRED1  -  sprouty-related, evh1 domain containing 1, TWIST1  -  twist basic helix-loop-helix transcription factor 1, SSTR1  -  somatostatin receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, TYRO3  -  tyro3 protein tyrosine kinase, SP5  -  sp5 transcription factor, ALPL  -  alkaline phosphatase, liver/bone/kidney, MYCNOS  -  mycn opposite strand/antisense rna, ONECUT1  -  one cut homeobox 1, EPHA3  -  eph receptor a3, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, CBLN1  -  cerebellin 1 precursor, MAPK1  -  mitogen-activated protein kinase 1, TNN  -  tenascin n, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, RSPO3  -  r-spondin 3, RXRG  -  retinoid x receptor, gamma, NANOS1  -  nanos homolog 1 (drosophila), HMGCS1  -  3-hydroxy-3-methylglutaryl-coa synthase 1 (soluble), KLK5  -  kallikrein-related peptidase 5, PRKCD  -  protein kinase c, delta, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), PAX2  -  paired box 2, SEC24D  -  sec24 family, member d (s. cerevisiae), PRTN3  -  proteinase 3, TAF7L  -  taf7-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 50kda, ENC1  -  ectodermal-neural cortex 1 (with btb domain), ASXL3  -  additional sex combs like 3 (drosophila), KLK7  -  kallikrein-related peptidase 7, SYT17  -  synaptotagmin xvii, PCDH1  -  protocadherin 1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, ZNF521  -  zinc finger protein 521, DCC  -  deleted in colorectal carcinoma, PACRG  -  park2 co-regulated, NUMBL  -  numb homolog (drosophila)-like, OCA2  -  oculocutaneous albinism ii, PBX4  -  pre-b-cell leukemia homeobox 4, FAM172A  -  family with sequence similarity 172, member a, MTHFD1L  -  methylenetetrahydrofolate dehydrogenase (nadp+ dependent) 1-like, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, ATOH7  -  atonal homolog 7 (drosophila), FKBP1A  -  fk506 binding protein 1a, 12kda, LPHN3  -  latrophilin 3, KLK8  -  kallikrein-related peptidase 8, WNT4  -  wingless-type mmtv integration site family, member 4, FAM84A  -  family with sequence similarity 84, member a, OGG1  -  8-oxoguanine dna glycosylase, LPPR4  -  lipid phosphate phosphatase-related protein type 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CNTN3  -  contactin 3 (plasmacytoma associated), BATF  -  basic leucine zipper transcription factor, atf-like, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, NXF5  -  nuclear rna export factor 5, PTCH1  -  patched 1, LARGE  -  like-glycosyltransferase, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), MKL2  -  mkl/myocardin-like 2, GALNTL5  -  udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyltransferase-like 5, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, TCAP  -  titin-cap, PTHLH  -  parathyroid hormone-like hormone, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, MEST  -  mesoderm specific transcript, INSM1  -  insulinoma-associated 1, MET  -  met proto-oncogene, AKIRIN2  -  akirin 2, MESP1  -  mesoderm posterior 1 homolog (mouse), ASS1  -  argininosuccinate synthase 1, NPPA  -  natriuretic peptide a, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NPY5R  -  neuropeptide y receptor y5, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, NPY1R  -  neuropeptide y receptor y1, CDH8  -  cadherin 8, type 2, NPTX1  -  neuronal pentraxin i, CDH9  -  cadherin 9, type 2 (t1-cadherin), MGP  -  matrix gla protein, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PCDH19  -  protocadherin 19, ASCL2  -  achaete-scute complex homolog 2 (drosophila), KREMEN2  -  kringle containing transmembrane protein 2, NNMT  -  nicotinamide n-methyltransferase, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTPRR  -  protein tyrosine phosphatase, receptor type, r, CHRM3  -  cholinergic receptor, muscarinic 3, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, NOV  -  nephroblastoma overexpressed, TLL1  -  tolloid-like 1, WNT10B  -  wingless-type mmtv integration site family, member 10b, CHL1  -  cell adhesion molecule l1-like, TRIM71  -  tripartite motif containing 71, e3 ubiquitin protein ligase, GPM6A  -  glycoprotein m6a, SLA  -  src-like-adaptor, RILPL2  -  rab interacting lysosomal protein-like 2, WFS1  -  wolfram syndrome 1 (wolframin), DCDC2  -  doublecortin domain containing 2, FAM65B  -  family with sequence similarity 65, member b, STYK1  -  serine/threonine/tyrosine kinase 1, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNI3  -  troponin i type 3 (cardiac), LTBP4  -  latent transforming growth factor beta binding protein 4, TSHZ3  -  teashirt zinc finger homeobox 3, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), NEK2  -  nima-related kinase 2, RASAL1  -  ras protein activator like 1 (gap1 like), NELL1  -  nel-like 1 (chicken), SLCO4C1  -  solute carrier organic anion transporter family, member 4c1, DLL3  -  delta-like 3 (drosophila), CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, LY6H  -  lymphocyte antigen 6 complex, locus h, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, PDGFD  -  platelet derived growth factor d, HSPB11  -  heat shock protein family b (small), member 11, DIAPH2  -  diaphanous-related formin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, PKNOX1  -  pbx/knotted 1 homeobox 1, LTK  -  leukocyte receptor tyrosine kinase, SORBS2  -  sorbin and sh3 domain containing 2, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, SFRP2  -  secreted frizzled-related protein 2, GRIK1  -  glutamate receptor, ionotropic, kainate 1, RTN4RL1  -  reticulon 4 receptor-like 1, RCN1  -  reticulocalbin 1, ef-hand calcium binding domain, PRPH2  -  peripherin 2 (retinal degeneration, slow), DNAH5  -  dynein, axonemal, heavy chain 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, NAV3  -  neuron navigator 3, THRB  -  thyroid hormone receptor, beta, CPNE5  -  copine v]
GO:0098815	modulation of excitatory postsynaptic potential	6.7E-6	2.21E-3	4.01	14984	43	1392	16	[TMEM108  -  transmembrane protein 108, RELN  -  reelin, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), CELF4  -  cugbp, elav-like family member 4, STX1A  -  syntaxin 1a (brain), CBLN1  -  cerebellin 1 precursor, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, RIMS1  -  regulating synaptic membrane exocytosis 1, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, NRXN1  -  neurexin 1, RGS4  -  regulator of g-protein signaling 4, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN3  -  neuroligin 3]
GO:0046928	regulation of neurotransmitter secretion	7.28E-6	2.35E-3	3.12	14984	84	1317	23	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), STX1A  -  syntaxin 1a (brain), DRD2  -  dopamine receptor d2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), TACR2  -  tachykinin receptor 2, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, UNC13B  -  unc-13 homolog b (c. elegans), PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, BAIAP3  -  bai1-associated protein 3, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)]
GO:0048731	system development	7.41E-6	2.34E-3	1.61	14984	608	1544	101	[MYLIP  -  myosin regulatory light chain interacting protein, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, NDN  -  necdin, melanoma antigen (mage) family member, PAX2  -  paired box 2, RPS6KA6  -  ribosomal protein s6 kinase, 90kda, polypeptide 6, LIG4  -  ligase iv, dna, atp-dependent, ENC1  -  ectodermal-neural cortex 1 (with btb domain), ABI2  -  abl-interactor 2, GSS  -  glutathione synthetase, INHA  -  inhibin, alpha, GDA  -  guanine deaminase, DPF1  -  d4, zinc and double phd fingers family 1, PCDH1  -  protocadherin 1, BEX1  -  brain expressed, x-linked 1, MBOAT7  -  membrane bound o-acyltransferase domain containing 7, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, APAF1  -  apoptotic peptidase activating factor 1, NUMBL  -  numb homolog (drosophila)-like, BDNF  -  brain-derived neurotrophic factor, EGR3  -  early growth response 3, SOX4  -  sry (sex determining region y)-box 4, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, SNTG2  -  syntrophin, gamma 2, DPF3  -  d4, zinc and double phd fingers, family 3, CAMK1  -  calcium/calmodulin-dependent protein kinase i, MMP16  -  matrix metallopeptidase 16 (membrane-inserted), CNTN3  -  contactin 3 (plasmacytoma associated), TRAPPC6B  -  trafficking protein particle complex 6b, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, ACVR2A  -  activin a receptor, type iia, ACVR2B  -  activin a receptor, type iib, ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, CENPF  -  centromere protein f, 350/400kda, HPCAL4  -  hippocalcin like 4, PTCH1  -  patched 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, GPR98  -  g protein-coupled receptor 98, EFNB3  -  ephrin-b3, PTHLH  -  parathyroid hormone-like hormone, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, MEPE  -  matrix extracellular phosphoglycoprotein, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), TRIO  -  trio rho guanine nucleotide exchange factor, DPYSL4  -  dihydropyrimidinase-like 4, MET  -  met proto-oncogene, SPEF2  -  sperm flagellar 2, ARMC4  -  armadillo repeat containing 4, NPTX1  -  neuronal pentraxin i, GMFB  -  glia maturation factor, beta, COL10A1  -  collagen, type x, alpha 1, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, NRCAM  -  neuronal cell adhesion molecule, TIMP2  -  timp metallopeptidase inhibitor 2, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, OLFM1  -  olfactomedin 1, CHRM3  -  cholinergic receptor, muscarinic 3, FABP7  -  fatty acid binding protein 7, brain, TLL1  -  tolloid-like 1, KCNQ2  -  potassium voltage-gated channel, kqt-like subfamily, member 2, NLGN1  -  neuroligin 1, MERTK  -  c-mer proto-oncogene tyrosine kinase, GPM6B  -  glycoprotein m6b, AHSG  -  alpha-2-hs-glycoprotein, EXT1  -  exostosin glycosyltransferase 1, ANKLE2  -  ankyrin repeat and lem domain containing 2, VLDLR  -  very low density lipoprotein receptor, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, ST8SIA4  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 4, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), XYLT1  -  xylosyltransferase i, CPNE6  -  copine vi (neuronal), TEK  -  tek tyrosine kinase, endothelial, SH3GL3  -  sh3-domain grb2-like 3, OSR1  -  odd-skipped related 1 (drosophila), CRMP1  -  collapsin response mediator protein 1, NELL1  -  nel-like 1 (chicken), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), C3orf70  -  chromosome 3 open reading frame 70, DLL3  -  delta-like 3 (drosophila), KIAA2022  -  kiaa2022, LY6H  -  lymphocyte antigen 6 complex, locus h, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, TYRO3  -  tyro3 protein tyrosine kinase, ALPL  -  alkaline phosphatase, liver/bone/kidney, BZW2  -  basic leucine zipper and w2 domains 2, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIK1  -  glutamate receptor, ionotropic, kainate 1, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, IGF1  -  insulin-like growth factor 1 (somatomedin c), CBLN1  -  cerebellin 1 precursor, PLEKHA5  -  pleckstrin homology domain containing, family a member 5, KALRN  -  kalirin, rhogef kinase, ATXN10  -  ataxin 10, DOC2A  -  double c2-like domains, alpha, RBP4  -  retinol binding protein 4, plasma, NAV3  -  neuron navigator 3, SMAD3  -  smad family member 3, VPS13A  -  vacuolar protein sorting 13 homolog a (s. cerevisiae)]
GO:0006811	ion transport	7.53E-6	2.33E-3	1.80	14984	1062	572	73	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, FABP3  -  fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor), SLC7A4  -  solute carrier family 7, member 4, XK  -  x-linked kx blood group (mcleod syndrome), APOC1  -  apolipoprotein c-i, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, ADAMTS8  -  adam metallopeptidase with thrombospondin type 1 motif, 8, SLC22A10  -  solute carrier family 22, member 10, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, ACSL4  -  acyl-coa synthetase long-chain family member 4, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, GPM6A  -  glycoprotein m6a, OCA2  -  oculocutaneous albinism ii, SCARA5  -  scavenger receptor class a, member 5 (putative), CCDC109B  -  coiled-coil domain containing 109b, STX1A  -  syntaxin 1a (brain), GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, FAM26F  -  family with sequence similarity 26, member f, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, ATP6V1C1  -  atpase, h+ transporting, lysosomal 42kda, v1 subunit c1, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, FKBP1A  -  fk506 binding protein 1a, 12kda, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, PITPNM2  -  phosphatidylinositol transfer protein, membrane-associated 2, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SLCO4C1  -  solute carrier organic anion transporter family, member 4c1, RIMS1  -  regulating synaptic membrane exocytosis 1, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, CA4  -  carbonic anhydrase iv, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PKD2L1  -  polycystic kidney disease 2-like 1, SLC22A9  -  solute carrier family 22 (organic anion transporter), member 9, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, KCNV1  -  potassium channel, subfamily v, member 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, SLC10A4  -  solute carrier family 10, member 4, BDKRB2  -  bradykinin receptor b2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, ANO3  -  anoctamin 3, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, OSBPL10  -  oxysterol binding protein-like 10, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, KCNT2  -  potassium channel, subfamily t, member 2, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, SLC16A8  -  solute carrier family 16 (monocarboxylate transporter), member 8, ASIC4  -  acid-sensing (proton-gated) ion channel family member 4, SLC27A3  -  solute carrier family 27 (fatty acid transporter), member 3]
GO:0032412	regulation of ion transmembrane transporter activity	7.7E-6	2.33E-3	2.35	14984	221	1038	36	[GSG1L  -  gsg1-like, RELN  -  reelin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, HPCA  -  hippocalcin, OPRM1  -  opioid receptor, mu 1, FXYD6  -  fxyd domain containing ion transport regulator 6, DRD2  -  dopamine receptor d2, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, CHRM3  -  cholinergic receptor, muscarinic 3, PRNP  -  prion protein, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, NPPA  -  natriuretic peptide a, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, FKBP1A  -  fk506 binding protein 1a, 12kda, STIM1  -  stromal interaction molecule 1, JPH4  -  junctophilin 4, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, NLGN3  -  neuroligin 3, PDE4B  -  phosphodiesterase 4b, camp-specific, FHL1  -  four and a half lim domains 1, FXYD7  -  fxyd domain containing ion transport regulator 7]
GO:0046189	phenol-containing compound biosynthetic process	7.99E-6	2.37E-3	9.34	14984	23	558	8	[OCA2  -  oculocutaneous albinism ii, HDC  -  histidine decarboxylase, TYRP1  -  tyrosinase-related protein 1, INSM1  -  insulinoma-associated 1, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), TPH2  -  tryptophan hydroxylase 2, PNMT  -  phenylethanolamine n-methyltransferase]
GO:0007411	axon guidance	8.03E-6	2.34E-3	2.12	14984	225	1385	44	[RELN  -  reelin, RNF165  -  ring finger protein 165, CRMP1  -  collapsin response mediator protein 1, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTCH1  -  patched 1, NFIB  -  nuclear factor i/b, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, NRXN1  -  neurexin 1, CHL1  -  cell adhesion molecule l1-like, EFNB3  -  ephrin-b3, EFNB2  -  ephrin-b2, DCC  -  deleted in colorectal carcinoma, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), TNR  -  tenascin r, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), CSF1R  -  colony stimulating factor 1 receptor, ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), EPHA3  -  eph receptor a3, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, TRIO  -  trio rho guanine nucleotide exchange factor, BDNF  -  brain-derived neurotrophic factor, MAPK3  -  mitogen-activated protein kinase 3, SLIT3  -  slit homolog 3 (drosophila), MAPK1  -  mitogen-activated protein kinase 1, EPHB1  -  eph receptor b1, KALRN  -  kalirin, rhogef kinase, SLIT1  -  slit homolog 1 (drosophila), EPHA5  -  eph receptor a5, EXT1  -  exostosin glycosyltransferase 1, EPHA4  -  eph receptor a4, EPHA8  -  eph receptor a8, PRKCQ  -  protein kinase c, theta, VLDLR  -  very low density lipoprotein receptor, DOK6  -  docking protein 6, UNC5D  -  unc-5 homolog d (c. elegans), SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, PIK3CD  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), VSTM2L  -  v-set and transmembrane domain containing 2 like, PTPRA  -  protein tyrosine phosphatase, receptor type, a, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), DRAXIN  -  dorsal inhibitory axon guidance protein, NRCAM  -  neuronal cell adhesion molecule, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35)]
GO:0001505	regulation of neurotransmitter levels	8.24E-6	2.35E-3	1.92	14984	278	1575	56	[SIRPA  -  signal-regulatory protein alpha, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, CYB5B  -  cytochrome b5 type b (outer mitochondrial membrane), DRD2  -  dopamine receptor d2, TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, KCNMB4  -  potassium large conductance calcium-activated channel, subfamily m, beta member 4, NLGN1  -  neuroligin 1, GPM6B  -  glycoprotein m6b, DPYD  -  dihydropyrimidine dehydrogenase, STX1A  -  syntaxin 1a (brain), GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, TOR1A  -  torsin family 1, member a (torsin a), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, BHMT  -  betaine--homocysteine s-methyltransferase, IL1B  -  interleukin 1, beta, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, SLC1A4  -  solute carrier family 1 (glutamate/neutral amino acid transporter), member 4, UNC13B  -  unc-13 homolog b (c. elegans), RGS4  -  regulator of g-protein signaling 4, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TPH2  -  tryptophan hydroxylase 2, BTBD9  -  btb (poz) domain containing 9, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), RIMS1  -  regulating synaptic membrane exocytosis 1, NRXN1  -  neurexin 1, NRXN2  -  neurexin 2, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, CNR1  -  cannabinoid receptor 1 (brain), UNC13A  -  unc-13 homolog a (c. elegans), CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), HNMT  -  histamine n-methyltransferase, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), DMGDH  -  dimethylglycine dehydrogenase, GRM1  -  glutamate receptor, metabotropic 1, ASS1  -  argininosuccinate synthase 1, DOC2A  -  double c2-like domains, alpha, CPLX3  -  complexin 3, PRKCG  -  protein kinase c, gamma, HDC  -  histidine decarboxylase, SLC22A3  -  solute carrier family 22 (organic cation transporter), member 3, SMAD3  -  smad family member 3, BAIAP3  -  bai1-associated protein 3]
GO:0007616	long-term memory	8.43E-6	2.36E-3	26.91	14984	29	96	5	[CALB1  -  calbindin 1, 28kda, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, PTCHD1  -  patched domain containing 1, DRD2  -  dopamine receptor d2, RGS14  -  regulator of g-protein signaling 14]
GO:0097485	neuron projection guidance	8.82E-6	2.43E-3	2.11	14984	226	1385	44	[RELN  -  reelin, RNF165  -  ring finger protein 165, CRMP1  -  collapsin response mediator protein 1, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTCH1  -  patched 1, NFIB  -  nuclear factor i/b, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, NRXN1  -  neurexin 1, CHL1  -  cell adhesion molecule l1-like, EFNB3  -  ephrin-b3, EFNB2  -  ephrin-b2, DCC  -  deleted in colorectal carcinoma, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), TNR  -  tenascin r, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), CSF1R  -  colony stimulating factor 1 receptor, ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), EPHA3  -  eph receptor a3, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, TRIO  -  trio rho guanine nucleotide exchange factor, BDNF  -  brain-derived neurotrophic factor, MAPK3  -  mitogen-activated protein kinase 3, SLIT3  -  slit homolog 3 (drosophila), MAPK1  -  mitogen-activated protein kinase 1, EPHB1  -  eph receptor b1, KALRN  -  kalirin, rhogef kinase, SLIT1  -  slit homolog 1 (drosophila), EPHA5  -  eph receptor a5, EXT1  -  exostosin glycosyltransferase 1, EPHA4  -  eph receptor a4, EPHA8  -  eph receptor a8, PRKCQ  -  protein kinase c, theta, VLDLR  -  very low density lipoprotein receptor, DOK6  -  docking protein 6, UNC5D  -  unc-5 homolog d (c. elegans), SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, PIK3CD  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), VSTM2L  -  v-set and transmembrane domain containing 2 like, PTPRA  -  protein tyrosine phosphatase, receptor type, a, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), DRAXIN  -  dorsal inhibitory axon guidance protein, NRCAM  -  neuronal cell adhesion molecule, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35)]
GO:0007186	G protein-coupled receptor signaling pathway	9.5E-6	2.57E-3	1.96	14984	747	584	57	[GNG10  -  guanine nucleotide binding protein (g protein), gamma 10, OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, TAC3  -  tachykinin 3, TACR2  -  tachykinin receptor 2, CHRM3  -  cholinergic receptor, muscarinic 3, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, OR14I1  -  olfactory receptor, family 14, subfamily i, member 1, GPR6  -  g protein-coupled receptor 6, GABBR1  -  gamma-aminobutyric acid (gaba) b receptor, 1, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, GNG2  -  guanine nucleotide binding protein (g protein), gamma 2, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, LPHN3  -  latrophilin 3, VAV1  -  vav 1 guanine nucleotide exchange factor, RGS4  -  regulator of g-protein signaling 4, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, RGS14  -  regulator of g-protein signaling 14, CCL28  -  chemokine (c-c motif) ligand 28, NMU  -  neuromedin u, MCHR2  -  melanin-concentrating hormone receptor 2, GLRA2  -  glycine receptor, alpha 2, ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, GPR160  -  g protein-coupled receptor 160, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, SSTR1  -  somatostatin receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, TYRO3  -  tyro3 protein tyrosine kinase, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, GPR88  -  g protein-coupled receptor 88, ADCY7  -  adenylate cyclase 7, PDYN  -  prodynorphin, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, BDKRB2  -  bradykinin receptor b2, FGD3  -  fyve, rhogef and ph domain containing 3, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, DGKA  -  diacylglycerol kinase, alpha 80kda, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, DGKB  -  diacylglycerol kinase, beta 90kda, NPPA  -  natriuretic peptide a, GRM8  -  glutamate receptor, metabotropic 8, NPY5R  -  neuropeptide y receptor y5, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, NPY1R  -  neuropeptide y receptor y1, AKAP5  -  a kinase (prka) anchor protein 5]
GO:0048858	cell projection morphogenesis	1.03E-5	2.73E-3	2.17	14984	199	1385	40	[CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), PAX2  -  paired box 2, DRD2  -  dopamine receptor d2, SLITRK1  -  slit and ntrk-like family, member 1, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CDC42  -  cell division cycle 42, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, NFIB  -  nuclear factor i/b, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, MYO16  -  myosin xvi, NLGN1  -  neuroligin 1, DCC  -  deleted in colorectal carcinoma, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, GPM6A  -  glycoprotein m6a, NUMBL  -  numb homolog (drosophila)-like, KIRREL3  -  kin of irre like 3 (drosophila), STMN1  -  stathmin 1, TRIO  -  trio rho guanine nucleotide exchange factor, SLITRK2  -  slit and ntrk-like family, member 2, BDNF  -  brain-derived neurotrophic factor, NTNG2  -  netrin g2, DCDC2  -  doublecortin domain containing 2, TNN  -  tenascin n, EPHB1  -  eph receptor b1, SLC9A6  -  solute carrier family 9, subfamily a (nhe6, cation proton antiporter 6), member 6, EPHA4  -  eph receptor a4, VLDLR  -  very low density lipoprotein receptor, KLK8  -  kallikrein-related peptidase 8, BCL2  -  b-cell cll/lymphoma 2, NPTX1  -  neuronal pentraxin i, LPPR4  -  lipid phosphate phosphatase-related protein type 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CREB1  -  camp responsive element binding protein 1, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, DRAXIN  -  dorsal inhibitory axon guidance protein, NRCAM  -  neuronal cell adhesion molecule, WASF1  -  was protein family, member 1, CCK  -  cholecystokinin]
GO:0007155	cell adhesion	1.03E-5	2.69E-3	1.66	14984	758	1084	91	[TMEM8B  -  transmembrane protein 8b, RELN  -  reelin, VEZT  -  vezatin, adherens junctions transmembrane protein, RGMB  -  rgm domain family, member b, NCAM2  -  neural cell adhesion molecule 2, PCDH15  -  protocadherin-related 15, LRRC7  -  leucine rich repeat containing 7, CDH3  -  cadherin 3, type 1, p-cadherin (placental), ICAM5  -  intercellular adhesion molecule 5, telencephalin, PLXNC1  -  plexin c1, NOV  -  nephroblastoma overexpressed, GCNT1  -  glucosaminyl (n-acetyl) transferase 1, core 2, WNT7B  -  wingless-type mmtv integration site family, member 7b, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, PCDH1  -  protocadherin 1, CHL1  -  cell adhesion molecule l1-like, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CTNND2  -  catenin (cadherin-associated protein), delta 2, ASTN1  -  astrotactin 1, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), PCDHGA9  -  protocadherin gamma subfamily a, 9, PCDH10  -  protocadherin 10, CCL4  -  chemokine (c-c motif) ligand 4, FAM65B  -  family with sequence similarity 65, member b, FREM3  -  fras1 related extracellular matrix 3, IL1B  -  interleukin 1, beta, EXT1  -  exostosin glycosyltransferase 1, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, UNC5D  -  unc-5 homolog d (c. elegans), LPHN3  -  latrophilin 3, VSTM2L  -  v-set and transmembrane domain containing 2 like, DSP  -  desmoplakin, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), CXADR  -  coxsackie virus and adenovirus receptor, CD200  -  cd200 molecule, NLGN3  -  neuroligin 3, KIAA1462  -  kiaa1462, PARVB  -  parvin, beta, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CNTN3  -  contactin 3 (plasmacytoma associated), TEK  -  tek tyrosine kinase, endothelial, PCDH20  -  protocadherin 20, SLITRK1  -  slit and ntrk-like family, member 1, DLG2  -  discs, large homolog 2 (drosophila), CLDN20  -  claudin 20, PDZD2  -  pdz domain containing 2, PCDHGA12  -  protocadherin gamma subfamily a, 12, MYBPC1  -  myosin binding protein c, slow type, CGREF1  -  cell growth regulator with ef-hand domain 1, NRXN2  -  neurexin 2, PCDH11Y  -  protocadherin 11 y-linked, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), KIRREL2  -  kin of irre like 2 (drosophila), TYRO3  -  tyro3 protein tyrosine kinase, GPC4  -  glypican 4, EFNB2  -  ephrin-b2, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, TLN2  -  talin 2, RAP2B  -  rap2b, member of ras oncogene family, TNR  -  tenascin r, CNTN1  -  contactin 1, AMIGO2  -  adhesion molecule with ig-like domain 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, KIRREL3  -  kin of irre like 3 (drosophila), ATP2C1  -  atpase, ca++ transporting, type 2c, member 1, CORO1A  -  coronin, actin binding protein, 1a, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, SLITRK2  -  slit and ntrk-like family, member 2, NPHP1  -  nephronophthisis 1 (juvenile), NTNG2  -  netrin g2, CBLN1  -  cerebellin 1 precursor, TNN  -  tenascin n, TENM3  -  teneurin transmembrane protein 3, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, COL5A1  -  collagen, type v, alpha 1, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), PRPH2  -  peripherin 2 (retinal degeneration, slow), BCL2  -  b-cell cll/lymphoma 2, CDH8  -  cadherin 8, type 2, CDH9  -  cadherin 9, type 2 (t1-cadherin), COL12A1  -  collagen, type xii, alpha 1, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PCDH18  -  protocadherin 18, TMEFF2  -  transmembrane protein with egf-like and two follistatin-like domains 2, PCDH19  -  protocadherin 19, PTPRF  -  protein tyrosine phosphatase, receptor type, f, LAMB1  -  laminin, beta 1, EGFL6  -  egf-like-domain, multiple 6]
GO:0065008	regulation of biological quality	1.04E-5	2.67E-3	1.41	14984	3108	570	167	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, PRTN3  -  proteinase 3, PLXNC1  -  plexin c1, BTC  -  betacellulin, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, MYRIP  -  myosin viia and rab interacting protein, FAM49A  -  family with sequence similarity 49, member a, CELF4  -  cugbp, elav-like family member 4, SCARA5  -  scavenger receptor class a, member 5 (putative), PFN3  -  profilin 3, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, PALMD  -  palmdelphin, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, SOX4  -  sry (sex determining region y)-box 4, COCH  -  cochlin, BHMT  -  betaine--homocysteine s-methyltransferase, IL1B  -  interleukin 1, beta, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, FKBP1A  -  fk506 binding protein 1a, 12kda, GHR  -  growth hormone receptor, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, RGS4  -  regulator of g-protein signaling 4, LMO1  -  lim domain only 1 (rhombotin 1), RGS14  -  regulator of g-protein signaling 14, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, PARVB  -  parvin, beta, TPO  -  thyroid peroxidase, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, SESN3  -  sestrin 3, NMU  -  neuromedin u, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, NUS1  -  nuclear undecaprenyl pyrophosphate synthase 1 homolog (s. cerevisiae), SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, ACVR2A  -  activin a receptor, type iia, GLRA2  -  glycine receptor, alpha 2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), RIMS1  -  regulating synaptic membrane exocytosis 1, CDC42SE2  -  cdc42 small effector 2, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, CD52  -  cd52 molecule, SLC22A9  -  solute carrier family 22 (organic anion transporter), member 9, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, GPR88  -  g protein-coupled receptor 88, GPC4  -  glypican 4, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, ADCY7  -  adenylate cyclase 7, PTGES  -  prostaglandin e synthase, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, TMEM108  -  transmembrane protein 108, SRD5A3  -  steroid 5 alpha-reductase 3, MEST  -  mesoderm specific transcript, TMSB10  -  thymosin beta 10, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, MET  -  met proto-oncogene, DDRGK1  -  ddrgk domain containing 1, ASS1  -  argininosuccinate synthase 1, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NPPA  -  natriuretic peptide a, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, AKAP5  -  a kinase (prka) anchor protein 5, NPY1R  -  neuropeptide y receptor y1, HDC  -  histidine decarboxylase, CPLX3  -  complexin 3, GMFB  -  glia maturation factor, beta, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, SYN2  -  synapsin ii, DRD2  -  dopamine receptor d2, F12  -  coagulation factor xii (hageman factor), FABP3  -  fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor), ECE2  -  endothelin converting enzyme 2, TAC3  -  tachykinin 3, CHRM3  -  cholinergic receptor, muscarinic 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, ARHGAP28  -  rho gtpase activating protein 28, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, WNT10B  -  wingless-type mmtv integration site family, member 10b, NOV  -  nephroblastoma overexpressed, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, ACSL4  -  acyl-coa synthetase long-chain family member 4, TRIM71  -  tripartite motif containing 71, e3 ubiquitin protein ligase, ZCCHC17  -  zinc finger, cchc domain containing 17, PID1  -  phosphotyrosine interaction domain containing 1, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, CALB1  -  calbindin 1, 28kda, CALB2  -  calbindin 2, GPR6  -  g protein-coupled receptor 6, CCDC109B  -  coiled-coil domain containing 109b, GABBR1  -  gamma-aminobutyric acid (gaba) b receptor, 1, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, STX1A  -  syntaxin 1a (brain), GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, EXT1  -  exostosin glycosyltransferase 1, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, ATP6V1C1  -  atpase, h+ transporting, lysosomal 42kda, v1 subunit c1, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ERC2  -  elks/rab6-interacting/cast family member 2, VAV1  -  vav 1 guanine nucleotide exchange factor, CXADR  -  coxsackie virus and adenovirus receptor, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, TPH2  -  tryptophan hydroxylase 2, TNNI3  -  troponin i type 3 (cardiac), CCL28  -  chemokine (c-c motif) ligand 28, GSG1L  -  gsg1-like, TSHZ3  -  teashirt zinc finger homeobox 3, PLB1  -  phospholipase b1, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, NEK2  -  nima-related kinase 2, KL  -  klotho, NELL2  -  nel-like 2 (chicken), XKR4  -  xk, kell blood group complex subunit-related family, member 4, PRNP  -  prion protein, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, ISG15  -  isg15 ubiquitin-like modifier, ADTRP  -  androgen-dependent tfpi-regulating protein, TNFSF13B  -  tumor necrosis factor (ligand) superfamily, member 13b, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, TYRO3  -  tyro3 protein tyrosine kinase, ITPKA  -  inositol-trisphosphate 3-kinase a, GRIA1  -  glutamate receptor, ionotropic, ampa 1, BDKRB2  -  bradykinin receptor b2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, FGD3  -  fyve, rhogef and ph domain containing 3, GRIK2  -  glutamate receptor, ionotropic, kainate 2, CBLN1  -  cerebellin 1 precursor, MAPK1  -  mitogen-activated protein kinase 1, ANO3  -  anoctamin 3, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, TMSB15A  -  thymosin beta 15a, NANOS1  -  nanos homolog 1 (drosophila), PRKCG  -  protein kinase c, gamma, PRKCD  -  protein kinase c, delta, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, THRB  -  thyroid hormone receptor, beta, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta]
GO:1903530	regulation of secretion by cell	1.14E-5	2.88E-3	1.70	14984	486	1470	81	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, IL13RA2  -  interleukin 13 receptor, alpha 2, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, DRD2  -  dopamine receptor d2, EXPH5  -  exophilin 5, NNAT  -  neuronatin, TACR2  -  tachykinin receptor 2, RAB8B  -  rab8b, member ras oncogene family, SYT1  -  synaptotagmin i, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, NOV  -  nephroblastoma overexpressed, INHA  -  inhibin, alpha, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CARTPT  -  cart prepropeptide, ACSL4  -  acyl-coa synthetase long-chain family member 4, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, C2CD2L  -  c2cd2-like, MYRIP  -  myosin viia and rab interacting protein, KCNMB4  -  potassium large conductance calcium-activated channel, subfamily m, beta member 4, OXCT1  -  3-oxoacid coa transferase 1, NLGN1  -  neuroligin 1, RAB15  -  rab15, member ras oncogene family, CLASP2  -  cytoplasmic linker associated protein 2, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, STX1A  -  syntaxin 1a (brain), PCLO  -  piccolo presynaptic cytomatrix protein, SOX4  -  sry (sex determining region y)-box 4, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, VIP  -  vasoactive intestinal peptide, IL1B  -  interleukin 1, beta, CACNA1E  -  calcium channel, voltage-dependent, r type, alpha 1e subunit, CD84  -  cd84 molecule, CRH  -  corticotropin releasing hormone, UNC13B  -  unc-13 homolog b (c. elegans), FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, CREB1  -  camp responsive element binding protein 1, CD200  -  cd200 molecule, RAB27B  -  rab27b, member ras oncogene family, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, NEUROD1  -  neuronal differentiation 1, NMU  -  neuromedin u, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), RIMS1  -  regulating synaptic membrane exocytosis 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, ADTRP  -  androgen-dependent tfpi-regulating protein, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CNR1  -  cannabinoid receptor 1 (brain), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, SFRP1  -  secreted frizzled-related protein 1, PCK2  -  phosphoenolpyruvate carboxykinase 2 (mitochondrial), P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, IGF1  -  insulin-like growth factor 1 (somatomedin c), PHPT1  -  phosphohistidine phosphatase 1, KALRN  -  kalirin, rhogef kinase, EPHA5  -  eph receptor a5, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, RAB11FIP1  -  rab11 family interacting protein 1 (class i), IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, BAIAP3  -  bai1-associated protein 3, CCK  -  cholecystokinin]
GO:0034765	regulation of ion transmembrane transport	1.16E-5	2.88E-3	1.95	14984	408	1038	55	[RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, CHRM3  -  cholinergic receptor, muscarinic 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, DPP6  -  dipeptidyl-peptidase 6, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, KCNH5  -  potassium voltage-gated channel, subfamily h (eag-related), member 5, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, FKBP1A  -  fk506 binding protein 1a, 12kda, STIM1  -  stromal interaction molecule 1, JPH4  -  junctophilin 4, RGS4  -  regulator of g-protein signaling 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, NLGN3  -  neuroligin 3, FHL1  -  four and a half lim domains 1, KCNG3  -  potassium voltage-gated channel, subfamily g, member 3, GSG1L  -  gsg1-like, HPCA  -  hippocalcin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, FXYD6  -  fxyd domain containing ion transport regulator 6, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, DLG2  -  discs, large homolog 2 (drosophila), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PRNP  -  prion protein, DPP10  -  dipeptidyl-peptidase 10 (non-functional), HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, TWIST1  -  twist basic helix-loop-helix transcription factor 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, KCNV1  -  potassium channel, subfamily v, member 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, CORO1A  -  coronin, actin binding protein, 1a, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, NPPA  -  natriuretic peptide a, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, GRM5  -  glutamate receptor, metabotropic 5, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, FXYD7  -  fxyd domain containing ion transport regulator 7, PDE4B  -  phosphodiesterase 4b, camp-specific]
GO:0032102	negative regulation of response to external stimulus	1.28E-5	3.12E-3	2.49	14984	273	705	32	[TEK  -  tek tyrosine kinase, endothelial, DRD2  -  dopamine receptor d2, F12  -  coagulation factor xii (hageman factor), PTPRO  -  protein tyrosine phosphatase, receptor type, o, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, NOV  -  nephroblastoma overexpressed, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), ADTRP  -  androgen-dependent tfpi-regulating protein, CARTPT  -  cart prepropeptide, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), TYRO3  -  tyro3 protein tyrosine kinase, C5orf30  -  chromosome 5 open reading frame 30, ADCY7  -  adenylate cyclase 7, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, TNR  -  tenascin r, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, IGF1  -  insulin-like growth factor 1 (somatomedin c), RTN4RL1  -  reticulon 4 receptor-like 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, PYDC2  -  pyrin domain containing 2, EPHA4  -  eph receptor a4, SNAI2  -  snail family zinc finger 2, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, WNT4  -  wingless-type mmtv integration site family, member 4, NPY5R  -  neuropeptide y receptor y5, RTN4R  -  reticulon 4 receptor, PRKCD  -  protein kinase c, delta, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, CD200  -  cd200 molecule]
GO:0007612	learning	1.31E-5	3.14E-3	2.53	14984	124	1481	31	[FAM19A2  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a2, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), BAI3  -  brain-specific angiogenesis inhibitor 3, DRD5  -  dopamine receptor d5, DRD2  -  dopamine receptor d2, C1QL1  -  complement component 1, q subcomponent-like 1, TACR2  -  tachykinin receptor 2, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NRXN1  -  neurexin 1, NRXN2  -  neurexin 2, ATP8A1  -  atpase, aminophospholipid transporter (aplt), class i, type 8a, member 1, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, HRH1  -  histamine receptor h1, GPR88  -  g protein-coupled receptor 88, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, TNR  -  tenascin r, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), KALRN  -  kalirin, rhogef kinase, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, CRH  -  corticotropin releasing hormone, B4GALT2  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 2, GRM5  -  glutamate receptor, metabotropic 5, NPTX2  -  neuronal pentraxin ii, CREB1  -  camp responsive element binding protein 1, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, CCK  -  cholecystokinin]
GO:0007187	G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	1.39E-5	3.27E-3	4.07	14984	193	305	16	[GPR6  -  g protein-coupled receptor 6, DRD2  -  dopamine receptor d2, GNG2  -  guanine nucleotide binding protein (g protein), gamma 2, CHRM3  -  cholinergic receptor, muscarinic 3, GRM8  -  glutamate receptor, metabotropic 8, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, AKAP5  -  a kinase (prka) anchor protein 5, NPY1R  -  neuropeptide y receptor y1, SSTR1  -  somatostatin receptor 1, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, ADCY7  -  adenylate cyclase 7, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0022610	biological adhesion	1.41E-5	3.27E-3	1.65	14984	763	1084	91	[TMEM8B  -  transmembrane protein 8b, RELN  -  reelin, VEZT  -  vezatin, adherens junctions transmembrane protein, RGMB  -  rgm domain family, member b, NCAM2  -  neural cell adhesion molecule 2, PCDH15  -  protocadherin-related 15, LRRC7  -  leucine rich repeat containing 7, CDH3  -  cadherin 3, type 1, p-cadherin (placental), ICAM5  -  intercellular adhesion molecule 5, telencephalin, PLXNC1  -  plexin c1, NOV  -  nephroblastoma overexpressed, GCNT1  -  glucosaminyl (n-acetyl) transferase 1, core 2, WNT7B  -  wingless-type mmtv integration site family, member 7b, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, PCDH1  -  protocadherin 1, CHL1  -  cell adhesion molecule l1-like, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CTNND2  -  catenin (cadherin-associated protein), delta 2, ASTN1  -  astrotactin 1, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), PCDHGA9  -  protocadherin gamma subfamily a, 9, PCDH10  -  protocadherin 10, CCL4  -  chemokine (c-c motif) ligand 4, FAM65B  -  family with sequence similarity 65, member b, FREM3  -  fras1 related extracellular matrix 3, IL1B  -  interleukin 1, beta, EXT1  -  exostosin glycosyltransferase 1, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, UNC5D  -  unc-5 homolog d (c. elegans), LPHN3  -  latrophilin 3, VSTM2L  -  v-set and transmembrane domain containing 2 like, DSP  -  desmoplakin, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), CXADR  -  coxsackie virus and adenovirus receptor, CD200  -  cd200 molecule, NLGN3  -  neuroligin 3, KIAA1462  -  kiaa1462, PARVB  -  parvin, beta, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CNTN3  -  contactin 3 (plasmacytoma associated), TEK  -  tek tyrosine kinase, endothelial, PCDH20  -  protocadherin 20, SLITRK1  -  slit and ntrk-like family, member 1, DLG2  -  discs, large homolog 2 (drosophila), CLDN20  -  claudin 20, PDZD2  -  pdz domain containing 2, PCDHGA12  -  protocadherin gamma subfamily a, 12, MYBPC1  -  myosin binding protein c, slow type, CGREF1  -  cell growth regulator with ef-hand domain 1, NRXN2  -  neurexin 2, PCDH11Y  -  protocadherin 11 y-linked, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), KIRREL2  -  kin of irre like 2 (drosophila), TYRO3  -  tyro3 protein tyrosine kinase, GPC4  -  glypican 4, EFNB2  -  ephrin-b2, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, TLN2  -  talin 2, RAP2B  -  rap2b, member of ras oncogene family, TNR  -  tenascin r, CNTN1  -  contactin 1, AMIGO2  -  adhesion molecule with ig-like domain 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, KIRREL3  -  kin of irre like 3 (drosophila), ATP2C1  -  atpase, ca++ transporting, type 2c, member 1, CORO1A  -  coronin, actin binding protein, 1a, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, SLITRK2  -  slit and ntrk-like family, member 2, NPHP1  -  nephronophthisis 1 (juvenile), NTNG2  -  netrin g2, CBLN1  -  cerebellin 1 precursor, TNN  -  tenascin n, TENM3  -  teneurin transmembrane protein 3, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, COL5A1  -  collagen, type v, alpha 1, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), PRPH2  -  peripherin 2 (retinal degeneration, slow), BCL2  -  b-cell cll/lymphoma 2, CDH8  -  cadherin 8, type 2, CDH9  -  cadherin 9, type 2 (t1-cadherin), COL12A1  -  collagen, type xii, alpha 1, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PCDH18  -  protocadherin 18, TMEFF2  -  transmembrane protein with egf-like and two follistatin-like domains 2, PCDH19  -  protocadherin 19, PTPRF  -  protein tyrosine phosphatase, receptor type, f, LAMB1  -  laminin, beta 1, EGFL6  -  egf-like-domain, multiple 6]
GO:2000463	positive regulation of excitatory postsynaptic potential	1.42E-5	3.25E-3	4.78	14984	27	1392	12	[NRXN1  -  neurexin 1, RELN  -  reelin, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), STX1A  -  syntaxin 1a (brain), RGS4  -  regulator of g-protein signaling 4, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, NLGN3  -  neuroligin 3, RIMS1  -  regulating synaptic membrane exocytosis 1, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1]
GO:0007614	short-term memory	1.46E-5	3.28E-3	86.11	14984	6	87	3	[CALB1  -  calbindin 1, 28kda, PTCHD1  -  patched domain containing 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1]
GO:0051962	positive regulation of nervous system development	1.59E-5	3.53E-3	1.67	14984	466	1575	82	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, TIMP2  -  timp metallopeptidase inhibitor 2, OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, DRD2  -  dopamine receptor d2, LIG4  -  ligase iv, dna, atp-dependent, LRRC7  -  leucine rich repeat containing 7, ADRA2C  -  adrenoceptor alpha 2c, ENC1  -  ectodermal-neural cortex 1 (with btb domain), SYT1  -  synaptotagmin i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, SYT4  -  synaptotagmin iv, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, AGRN  -  agrin, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, NUMBL  -  numb homolog (drosophila)-like, TOX  -  thymocyte selection-associated high mobility group box, BDNF  -  brain-derived neurotrophic factor, VWC2L  -  von willebrand factor c domain containing protein 2-like, FLRT3  -  fibronectin leucine rich transmembrane protein 3, PLXNA1  -  plexin a1, IL1B  -  interleukin 1, beta, VLDLR  -  very low density lipoprotein receptor, CAMK1  -  calcium/calmodulin-dependent protein kinase i, IMPACT  -  impact rwd domain protein, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, RGS14  -  regulator of g-protein signaling 14, NLGN3  -  neuroligin 3, CRABP2  -  cellular retinoic acid binding protein 2, CPNE6  -  copine vi (neuronal), NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), SH3GL3  -  sh3-domain grb2-like 3, FAM150B  -  family with sequence similarity 150, member b, BAI3  -  brain-specific angiogenesis inhibitor 3, IL34  -  interleukin 34, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), RIMS1  -  regulating synaptic membrane exocytosis 1, RARB  -  retinoic acid receptor, beta, NRXN1  -  neurexin 1, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, CNR1  -  cannabinoid receptor 1 (brain), UNC13A  -  unc-13 homolog a (c. elegans), FZD1  -  frizzled family receptor 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, MAP2K1  -  mitogen-activated protein kinase kinase 1, LTK  -  leukocyte receptor tyrosine kinase, CNTN1  -  contactin 1, LINGO2  -  leucine rich repeat and ig domain containing 2, AMIGO2  -  adhesion molecule with ig-like domain 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), EPHA3  -  eph receptor a3, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, SLITRK2  -  slit and ntrk-like family, member 2, CBLN1  -  cerebellin 1 precursor, EPHB1  -  eph receptor b1, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, ELL3  -  elongation factor rna polymerase ii-like 3, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, PRKCI  -  protein kinase c, iota, BCL2  -  b-cell cll/lymphoma 2, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, MMD  -  monocyte to macrophage differentiation-associated, NRCAM  -  neuronal cell adhesion molecule, CPNE5  -  copine v]
GO:0120039	plasma membrane bounded cell projection morphogenesis	1.75E-5	3.82E-3	2.16	14984	195	1385	39	[CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), PAX2  -  paired box 2, DRD2  -  dopamine receptor d2, SLITRK1  -  slit and ntrk-like family, member 1, CDC42  -  cell division cycle 42, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, NFIB  -  nuclear factor i/b, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, MYO16  -  myosin xvi, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, GPM6A  -  glycoprotein m6a, NUMBL  -  numb homolog (drosophila)-like, KIRREL3  -  kin of irre like 3 (drosophila), STMN1  -  stathmin 1, TRIO  -  trio rho guanine nucleotide exchange factor, SLITRK2  -  slit and ntrk-like family, member 2, BDNF  -  brain-derived neurotrophic factor, NTNG2  -  netrin g2, DCDC2  -  doublecortin domain containing 2, TNN  -  tenascin n, EPHB1  -  eph receptor b1, SLC9A6  -  solute carrier family 9, subfamily a (nhe6, cation proton antiporter 6), member 6, EPHA4  -  eph receptor a4, VLDLR  -  very low density lipoprotein receptor, KLK8  -  kallikrein-related peptidase 8, BCL2  -  b-cell cll/lymphoma 2, NPTX1  -  neuronal pentraxin i, LPPR4  -  lipid phosphate phosphatase-related protein type 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CREB1  -  camp responsive element binding protein 1, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, DRAXIN  -  dorsal inhibitory axon guidance protein, NRCAM  -  neuronal cell adhesion molecule, WASF1  -  was protein family, member 1, CCK  -  cholecystokinin]
GO:0035249	synaptic transmission, glutamatergic	1.87E-5	4.03E-3	4.57	14984	25	1575	12	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, UNC13B  -  unc-13 homolog b (c. elegans), GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, CDH8  -  cadherin 8, type 2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, UNC13A  -  unc-13 homolog a (c. elegans), SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, EXT1  -  exostosin glycosyltransferase 1, SLC1A4  -  solute carrier family 1 (glutamate/neutral amino acid transporter), member 4]
GO:0001956	positive regulation of neurotransmitter secretion	2.1E-5	4.45E-3	6.30	14984	18	1189	9	[UNC13B  -  unc-13 homolog b (c. elegans), STX1A  -  syntaxin 1a (brain), CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, BAIAP3  -  bai1-associated protein 3, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)]
GO:0048812	neuron projection morphogenesis	2.24E-5	4.69E-3	2.16	14984	190	1385	38	[PAX2  -  paired box 2, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, SLITRK1  -  slit and ntrk-like family, member 1, CDC42  -  cell division cycle 42, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, NFIB  -  nuclear factor i/b, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, MYO16  -  myosin xvi, NLGN1  -  neuroligin 1, DCC  -  deleted in colorectal carcinoma, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, GPM6A  -  glycoprotein m6a, NUMBL  -  numb homolog (drosophila)-like, KIRREL3  -  kin of irre like 3 (drosophila), STMN1  -  stathmin 1, BDNF  -  brain-derived neurotrophic factor, TRIO  -  trio rho guanine nucleotide exchange factor, SLITRK2  -  slit and ntrk-like family, member 2, NTNG2  -  netrin g2, DCDC2  -  doublecortin domain containing 2, TNN  -  tenascin n, EPHB1  -  eph receptor b1, SLC9A6  -  solute carrier family 9, subfamily a (nhe6, cation proton antiporter 6), member 6, EPHA4  -  eph receptor a4, VLDLR  -  very low density lipoprotein receptor, KLK8  -  kallikrein-related peptidase 8, BCL2  -  b-cell cll/lymphoma 2, NPTX1  -  neuronal pentraxin i, LPPR4  -  lipid phosphate phosphatase-related protein type 4, CREB1  -  camp responsive element binding protein 1, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, DRAXIN  -  dorsal inhibitory axon guidance protein, CCK  -  cholecystokinin, NRCAM  -  neuronal cell adhesion molecule]
GO:0018958	phenol-containing compound metabolic process	2.27E-5	4.68E-3	5.28	14984	61	558	12	[TPO  -  thyroid peroxidase, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OCA2  -  oculocutaneous albinism ii, HDC  -  histidine decarboxylase, TYRP1  -  tyrosinase-related protein 1, DRD2  -  dopamine receptor d2, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), INSM1  -  insulinoma-associated 1, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), TPH2  -  tryptophan hydroxylase 2, PNMT  -  phenylethanolamine n-methyltransferase]
GO:0051046	regulation of secretion	2.29E-5	4.65E-3	1.68	14984	528	1331	79	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, IL13RA2  -  interleukin 13 receptor, alpha 2, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, DRD2  -  dopamine receptor d2, EXPH5  -  exophilin 5, NNAT  -  neuronatin, TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, NOV  -  nephroblastoma overexpressed, INHA  -  inhibin, alpha, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CARTPT  -  cart prepropeptide, ACSL4  -  acyl-coa synthetase long-chain family member 4, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, C2CD2L  -  c2cd2-like, MYRIP  -  myosin viia and rab interacting protein, OXCT1  -  3-oxoacid coa transferase 1, NLGN1  -  neuroligin 1, RAB15  -  rab15, member ras oncogene family, CLASP2  -  cytoplasmic linker associated protein 2, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, STX1A  -  syntaxin 1a (brain), P2RY2  -  purinergic receptor p2y, g-protein coupled, 2, PCLO  -  piccolo presynaptic cytomatrix protein, SOX4  -  sry (sex determining region y)-box 4, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, IL1B  -  interleukin 1, beta, CD84  -  cd84 molecule, CRH  -  corticotropin releasing hormone, UNC13B  -  unc-13 homolog b (c. elegans), FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, CREB1  -  camp responsive element binding protein 1, CD200  -  cd200 molecule, RAB27B  -  rab27b, member ras oncogene family, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, NEUROD1  -  neuronal differentiation 1, NMU  -  neuromedin u, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), RIMS1  -  regulating synaptic membrane exocytosis 1, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, ADTRP  -  androgen-dependent tfpi-regulating protein, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CNR1  -  cannabinoid receptor 1 (brain), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, PTGES  -  prostaglandin e synthase, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, PCK2  -  phosphoenolpyruvate carboxykinase 2 (mitochondrial), P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, IGF1  -  insulin-like growth factor 1 (somatomedin c), KALRN  -  kalirin, rhogef kinase, EPHA5  -  eph receptor a5, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, GRM7  -  glutamate receptor, metabotropic 7, DOC2A  -  double c2-like domains, alpha, NPY5R  -  neuropeptide y receptor y5, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, RAB11FIP1  -  rab11 family interacting protein 1 (class i), TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, BAIAP3  -  bai1-associated protein 3, CCK  -  cholecystokinin]
GO:0017156	calcium ion regulated exocytosis	2.56E-5	5.14E-3	4.23	14984	47	1055	14	[SYN2  -  synapsin ii, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, STX1A  -  syntaxin 1a (brain), PCLO  -  piccolo presynaptic cytomatrix protein, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, DOC2A  -  double c2-like domains, alpha, UNC13B  -  unc-13 homolog b (c. elegans), CPLX3  -  complexin 3, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4]
GO:0017157	regulation of exocytosis	2.65E-5	5.25E-3	2.20	14984	184	1331	36	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), IL13RA2  -  interleukin 13 receptor, alpha 2, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, DRD2  -  dopamine receptor d2, EXPH5  -  exophilin 5, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, RAB15  -  rab15, member ras oncogene family, CLASP2  -  cytoplasmic linker associated protein 2, STX1A  -  syntaxin 1a (brain), PCLO  -  piccolo presynaptic cytomatrix protein, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, CD84  -  cd84 molecule, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, DOC2A  -  double c2-like domains, alpha, UNC13B  -  unc-13 homolog b (c. elegans), PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, RAB27B  -  rab27b, member ras oncogene family, BAIAP3  -  bai1-associated protein 3]
GO:0045664	regulation of neuron differentiation	2.92E-5	5.7E-3	1.71	14984	579	1135	75	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, ENC1  -  ectodermal-neural cortex 1 (with btb domain), OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, LINGO1  -  leucine rich repeat and ig domain containing 1, SYT4  -  synaptotagmin iv, ABI2  -  abl-interactor 2, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, ARHGAP33  -  rho gtpase activating protein 33, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, BDNF  -  brain-derived neurotrophic factor, PLXNA1  -  plexin a1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, IMPACT  -  impact rwd domain protein, RTN4R  -  reticulon 4 receptor, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CPNE6  -  copine vi (neuronal), NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), FAM150B  -  family with sequence similarity 150, member b, BAI3  -  brain-specific angiogenesis inhibitor 3, CRMP1  -  collapsin response mediator protein 1, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), RIMS1  -  regulating synaptic membrane exocytosis 1, CSMD3  -  cub and sushi multiple domains 3, RARB  -  retinoic acid receptor, beta, UST  -  uronyl-2-sulfotransferase, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, EFNB3  -  ephrin-b3, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, TNR  -  tenascin r, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, SFRP2  -  secreted frizzled-related protein 2, NTNG2  -  netrin g2, RTN4RL1  -  reticulon 4 receptor-like 1, TENM3  -  teneurin transmembrane protein 3, TTL  -  tubulin tyrosine ligase, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, THRB  -  thyroid hormone receptor, beta, DRAXIN  -  dorsal inhibitory axon guidance protein, MMD  -  monocyte to macrophage differentiation-associated, PTPRF  -  protein tyrosine phosphatase, receptor type, f, CPNE5  -  copine v]
GO:0030030	cell projection organization	3.02E-5	5.83E-3	1.55	14984	732	1385	105	[NCAM2  -  neural cell adhesion molecule 2, PAX2  -  paired box 2, CCDC64  -  coiled-coil domain containing 64, NDN  -  necdin, melanoma antigen (mage) family member, CEP89  -  centrosomal protein 89kda, CDC42  -  cell division cycle 42, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, DCC  -  deleted in colorectal carcinoma, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DNAAF1  -  dynein, axonemal, assembly factor 1, MTSS1L  -  metastasis suppressor 1-like, NUMBL  -  numb homolog (drosophila)-like, ABLIM2  -  actin binding lim protein family, member 2, BDNF  -  brain-derived neurotrophic factor, TMEM17  -  transmembrane protein 17, FNBP1L  -  formin binding protein 1-like, KLK8  -  kallikrein-related peptidase 8, POC1A  -  poc1 centriolar protein a, LPPR4  -  lipid phosphate phosphatase-related protein type 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CREB1  -  camp responsive element binding protein 1, PARVB  -  parvin, beta, MYO7A  -  myosin viia, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), AK7  -  adenylate kinase 7, TPM1  -  tropomyosin 1 (alpha), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, FSCN1  -  fascin homolog 1, actin-bundling protein (strongylocentrotus purpuratus), VAPA  -  vamp (vesicle-associated membrane protein)-associated protein a, 33kda, GPR98  -  g protein-coupled receptor 98, C5orf30  -  chromosome 5 open reading frame 30, CNR1  -  cannabinoid receptor 1 (brain), MYO16  -  myosin xvi, CNTN1  -  contactin 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, TMEM108  -  transmembrane protein 108, TEKT2  -  tektin 2 (testicular), KIRREL3  -  kin of irre like 3 (drosophila), CORO1A  -  coronin, actin binding protein, 1a, STMN1  -  stathmin 1, SLITRK2  -  slit and ntrk-like family, member 2, TRIO  -  trio rho guanine nucleotide exchange factor, NTNG2  -  netrin g2, NPHP1  -  nephronophthisis 1 (juvenile), E2F5  -  e2f transcription factor 5, p130-binding, NPTX1  -  neuronal pentraxin i, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, LAMB1  -  laminin, beta 1, WASF1  -  was protein family, member 1, PTPRF  -  protein tyrosine phosphatase, receptor type, f, NRCAM  -  neuronal cell adhesion molecule, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, GPRIN2  -  g protein regulated inducer of neurite outgrowth 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CHL1  -  cell adhesion molecule l1-like, NLGN1  -  neuroligin 1, LRRC56  -  leucine rich repeat containing 56, CCDC41  -  coiled-coil domain containing 41, GPM6B  -  glycoprotein m6b, GPM6A  -  glycoprotein m6a, RILPL2  -  rab interacting lysosomal protein-like 2, DCDC2  -  doublecortin domain containing 2, SLC9A6  -  solute carrier family 9, subfamily a (nhe6, cation proton antiporter 6), member 6, FAM65B  -  family with sequence similarity 65, member b, VLDLR  -  very low density lipoprotein receptor, WDR52  -  wd repeat domain 52, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), RSPH9  -  radial spoke head 9 homolog (chlamydomonas), SLITRK1  -  slit and ntrk-like family, member 1, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), KLHL1  -  kelch-like family member 1, BLOC1S6  -  biogenesis of lysosomal organelles complex-1, subunit 6, pallidin, PRNP  -  prion protein, GPRIN1  -  g protein regulated inducer of neurite outgrowth 1, NFIB  -  nuclear factor i/b, CAMSAP1  -  calmodulin regulated spectrin-associated protein 1, CEP41  -  centrosomal protein 41kda, ITPKA  -  inositol-trisphosphate 3-kinase a, CSF1R  -  colony stimulating factor 1 receptor, EPHA3  -  eph receptor a3, ONECUT1  -  one cut homeobox 1, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, FGD3  -  fyve, rhogef and ph domain containing 3, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, TNN  -  tenascin n, RTN4RL1  -  reticulon 4 receptor-like 1, EPHB1  -  eph receptor b1, PRKG1  -  protein kinase, cgmp-dependent, type i, EPHA4  -  eph receptor a4, WDR16  -  wd repeat domain 16, EPHA8  -  eph receptor a8, ATXN10  -  ataxin 10, B9D1  -  b9 protein domain 1, BCL2  -  b-cell cll/lymphoma 2, GAP43  -  growth associated protein 43, DNAH5  -  dynein, axonemal, heavy chain 5, TMEM107  -  transmembrane protein 107, DRAXIN  -  dorsal inhibitory axon guidance protein, CCK  -  cholecystokinin]
GO:0071300	cellular response to retinoic acid	3.17E-5	6.04E-3	14.69	14984	51	120	6	[EPHA3  -  eph receptor a3, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, PAX2  -  paired box 2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, LTK  -  leukocyte receptor tyrosine kinase, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1]
GO:0007193	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	3.26E-5	6.13E-3	4.74	14984	74	555	13	[OPRM1  -  opioid receptor, mu 1, GABBR1  -  gamma-aminobutyric acid (gaba) b receptor, 1, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, DRD2  -  dopamine receptor d2, CHRM3  -  cholinergic receptor, muscarinic 3, HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, GRM8  -  glutamate receptor, metabotropic 8, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, AKAP5  -  a kinase (prka) anchor protein 5, NPY1R  -  neuropeptide y receptor y1, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, ADCY7  -  adenylate cyclase 7, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0071229	cellular response to acid chemical	3.59E-5	6.67E-3	6.85	14984	164	120	9	[EPHA3  -  eph receptor a3, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, PAX2  -  paired box 2, PDGFD  -  platelet derived growth factor d, GLRA2  -  glycine receptor, alpha 2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, LTK  -  leukocyte receptor tyrosine kinase, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, PID1  -  phosphotyrosine interaction domain containing 1]
GO:0007399	nervous system development	3.76E-5	6.9E-3	1.85	14984	286	1530	54	[MYLIP  -  myosin regulatory light chain interacting protein, OLFM1  -  olfactomedin 1, ENC1  -  ectodermal-neural cortex 1 (with btb domain), CHRM3  -  cholinergic receptor, muscarinic 3, FABP7  -  fatty acid binding protein 7, brain, ABI2  -  abl-interactor 2, GSS  -  glutathione synthetase, GDA  -  guanine deaminase, KCNQ2  -  potassium voltage-gated channel, kqt-like subfamily, member 2, DPF1  -  d4, zinc and double phd fingers family 1, BEX1  -  brain expressed, x-linked 1, PCDH1  -  protocadherin 1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, APAF1  -  apoptotic peptidase activating factor 1, MERTK  -  c-mer proto-oncogene tyrosine kinase, NLGN1  -  neuroligin 1, GPM6B  -  glycoprotein m6b, NUMBL  -  numb homolog (drosophila)-like, BDNF  -  brain-derived neurotrophic factor, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, DPF3  -  d4, zinc and double phd fingers, family 3, VLDLR  -  very low density lipoprotein receptor, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, CAMK1  -  calcium/calmodulin-dependent protein kinase i, ST8SIA4  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 4, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), CNTN3  -  contactin 3 (plasmacytoma associated), CPNE6  -  copine vi (neuronal), TRAPPC6B  -  trafficking protein particle complex 6b, CRMP1  -  collapsin response mediator protein 1, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, NELL1  -  nel-like 1 (chicken), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), C3orf70  -  chromosome 3 open reading frame 70, KIAA2022  -  kiaa2022, LY6H  -  lymphocyte antigen 6 complex, locus h, GPR98  -  g protein-coupled receptor 98, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, TYRO3  -  tyro3 protein tyrosine kinase, EFNB3  -  ephrin-b3, BZW2  -  basic leucine zipper and w2 domains 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), GRIK1  -  glutamate receptor, ionotropic, kainate 1, CBLN1  -  cerebellin 1 precursor, DPYSL4  -  dihydropyrimidinase-like 4, MET  -  met proto-oncogene, KALRN  -  kalirin, rhogef kinase, ATXN10  -  ataxin 10, DOC2A  -  double c2-like domains, alpha, GMFB  -  glia maturation factor, beta, NAV3  -  neuron navigator 3, CYP46A1  -  cytochrome p450, family 46, subfamily a, polypeptide 1, VPS13A  -  vacuolar protein sorting 13 homolog a (s. cerevisiae)]
GO:0098660	inorganic ion transmembrane transport	3.87E-5	7.01E-3	2.09	14984	544	568	43	[CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, OPRM1  -  opioid receptor, mu 1, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, DRD2  -  dopamine receptor d2, GLRA2  -  glycine receptor, alpha 2, ADAMTS8  -  adam metallopeptidase with thrombospondin type 1 motif, 8, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PKD2L1  -  polycystic kidney disease 2-like 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, KCNV1  -  potassium channel, subfamily v, member 1, GPM6A  -  glycoprotein m6a, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, CCDC109B  -  coiled-coil domain containing 109b, SCARA5  -  scavenger receptor class a, member 5 (putative), P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, ANO3  -  anoctamin 3, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, GLRA3  -  glycine receptor, alpha 3, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, ATP6V1C1  -  atpase, h+ transporting, lysosomal 42kda, v1 subunit c1, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, FKBP1A  -  fk506 binding protein 1a, 12kda, KCNT2  -  potassium channel, subfamily t, member 2, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, ASIC4  -  acid-sensing (proton-gated) ion channel family member 4, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7]
GO:0060284	regulation of cell development	4.01E-5	7.17E-3	1.52	14984	813	1357	112	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, LIG4  -  ligase iv, dna, atp-dependent, CDC42  -  cell division cycle 42, ENC1  -  ectodermal-neural cortex 1 (with btb domain), RFX3  -  regulatory factor x, 3 (influences hla class ii expression), ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, LINGO1  -  leucine rich repeat and ig domain containing 1, ABI2  -  abl-interactor 2, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, KIAA1024  -  kiaa1024, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, NUMBL  -  numb homolog (drosophila)-like, BDNF  -  brain-derived neurotrophic factor, PLXNA1  -  plexin a1, IL1B  -  interleukin 1, beta, HAMP  -  hepcidin antimicrobial peptide, KLK8  -  kallikrein-related peptidase 8, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RGS4  -  regulator of g-protein signaling 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CREB1  -  camp responsive element binding protein 1, RGS14  -  regulator of g-protein signaling 14, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), FAM150B  -  family with sequence similarity 150, member b, ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, RIMS1  -  regulating synaptic membrane exocytosis 1, UST  -  uronyl-2-sulfotransferase, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, EFNB3  -  ephrin-b3, PTHLH  -  parathyroid hormone-like hormone, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, FZD1  -  frizzled family receptor 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, TNR  -  tenascin r, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), NTNG2  -  netrin g2, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), ACAP3  -  arfgap with coiled-coil, ankyrin repeat and ph domains 3, PTPRG  -  protein tyrosine phosphatase, receptor type, g, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, NRCAM  -  neuronal cell adhesion molecule, PTPRF  -  protein tyrosine phosphatase, receptor type, f, ASCL2  -  achaete-scute complex homolog 2 (drosophila), TIMP2  -  timp metallopeptidase inhibitor 2, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, PTPRO  -  protein tyrosine phosphatase, receptor type, o, OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, SYT4  -  synaptotagmin iv, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, ARHGAP33  -  rho gtpase activating protein 33, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, TOX  -  thymocyte selection-associated high mobility group box, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, VLDLR  -  very low density lipoprotein receptor, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, FAM19A1  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a1, IMPACT  -  impact rwd domain protein, RTN4R  -  reticulon 4 receptor, HDAC9  -  histone deacetylase 9, CPNE6  -  copine vi (neuronal), NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), BAI3  -  brain-specific angiogenesis inhibitor 3, CRMP1  -  collapsin response mediator protein 1, IL34  -  interleukin 34, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CSMD3  -  cub and sushi multiple domains 3, DLL3  -  delta-like 3 (drosophila), KIAA2022  -  kiaa2022, RARB  -  retinoic acid receptor, beta, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, EPHA3  -  eph receptor a3, SFRP2  -  secreted frizzled-related protein 2, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, IGF1  -  insulin-like growth factor 1 (somatomedin c), TNN  -  tenascin n, RTN4RL1  -  reticulon 4 receptor-like 1, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, TTL  -  tubulin tyrosine ligase, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, ELL3  -  elongation factor rna polymerase ii-like 3, FBXO31  -  f-box protein 31, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, NRG3  -  neuregulin 3, THRB  -  thyroid hormone receptor, beta, MPL  -  myeloproliferative leukemia virus oncogene, DRAXIN  -  dorsal inhibitory axon guidance protein, MMD  -  monocyte to macrophage differentiation-associated, CPNE5  -  copine v]
GO:1900449	regulation of glutamate receptor signaling pathway	4.12E-5	7.29E-3	3.12	14984	59	1547	19	[GSG1L  -  gsg1-like, RELN  -  reelin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, OPRM1  -  opioid receptor, mu 1, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, PRNP  -  prion protein, ACTN2  -  actinin, alpha 2, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, CRH  -  corticotropin releasing hormone, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, NECAB2  -  n-terminal ef-hand calcium binding protein 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, FRRS1L  -  ferric-chelate reductase 1-like, NLGN3  -  neuroligin 3, GRIA1  -  glutamate receptor, ionotropic, ampa 1]
GO:0010035	response to inorganic substance	4.33E-5	7.57E-3	3.08	14984	441	232	21	[CPNE6  -  copine vi (neuronal), PAX2  -  paired box 2, DRD2  -  dopamine receptor d2, RASAL1  -  ras protein activator like 1 (gap1 like), GLRA2  -  glycine receptor, alpha 2, MAPK1  -  mitogen-activated protein kinase 1, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, PDCD6  -  programmed cell death 6, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, PKD2L1  -  polycystic kidney disease 2-like 1, PDGFD  -  platelet derived growth factor d, PRKCD  -  protein kinase c, delta, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TPH2  -  tryptophan hydroxylase 2, ADCY7  -  adenylate cyclase 7, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, CPNE8  -  copine viii, CPNE7  -  copine vii, CPNE5  -  copine v]
GO:0010976	positive regulation of neuron projection development	4.37E-5	7.56E-3	2.09	14984	253	1135	40	[CPNE6  -  copine vi (neuronal), PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), RELN  -  reelin, FAM150B  -  family with sequence similarity 150, member b, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), LRRC7  -  leucine rich repeat containing 7, SYT1  -  synaptotagmin i, RIMS1  -  regulating synaptic membrane exocytosis 1, ENC1  -  ectodermal-neural cortex 1 (with btb domain), PLXNC1  -  plexin c1, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, SYT17  -  synaptotagmin xvii, SYT4  -  synaptotagmin iv, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, TOX  -  thymocyte selection-associated high mobility group box, BDNF  -  brain-derived neurotrophic factor, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, PLXNA1  -  plexin a1, EPHA4  -  eph receptor a4, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, CPNE5  -  copine v]
GO:0032990	cell part morphogenesis	4.54E-5	7.75E-3	2.03	14984	218	1385	41	[CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), PAX2  -  paired box 2, DRD2  -  dopamine receptor d2, SLITRK1  -  slit and ntrk-like family, member 1, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CDC42  -  cell division cycle 42, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, NFIB  -  nuclear factor i/b, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, MYO16  -  myosin xvi, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, PID1  -  phosphotyrosine interaction domain containing 1, GPM6A  -  glycoprotein m6a, NUMBL  -  numb homolog (drosophila)-like, KIRREL3  -  kin of irre like 3 (drosophila), STMN1  -  stathmin 1, TRIO  -  trio rho guanine nucleotide exchange factor, SLITRK2  -  slit and ntrk-like family, member 2, BDNF  -  brain-derived neurotrophic factor, NTNG2  -  netrin g2, DCDC2  -  doublecortin domain containing 2, TNN  -  tenascin n, EPHB1  -  eph receptor b1, SLC9A6  -  solute carrier family 9, subfamily a (nhe6, cation proton antiporter 6), member 6, EPHA4  -  eph receptor a4, VLDLR  -  very low density lipoprotein receptor, KLK8  -  kallikrein-related peptidase 8, BCL2  -  b-cell cll/lymphoma 2, NPTX1  -  neuronal pentraxin i, LPPR4  -  lipid phosphate phosphatase-related protein type 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CREB1  -  camp responsive element binding protein 1, PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, DRAXIN  -  dorsal inhibitory axon guidance protein, NRCAM  -  neuronal cell adhesion molecule, WASF1  -  was protein family, member 1, CCK  -  cholecystokinin]
GO:0017158	regulation of calcium ion-dependent exocytosis	4.68E-5	7.89E-3	2.81	14984	93	1317	23	[STX1A  -  syntaxin 1a (brain), DRD2  -  dopamine receptor d2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, DOC2A  -  double c2-like domains, alpha, UNC13B  -  unc-13 homolog b (c. elegans), PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, BAIAP3  -  bai1-associated protein 3, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a]
GO:0042596	fear response	4.68E-5	7.81E-3	6.33	14984	27	789	9	[HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, BCL2  -  b-cell cll/lymphoma 2, GRIK2  -  glutamate receptor, ionotropic, kainate 2, USP46  -  ubiquitin specific peptidase 46, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, ASIC4  -  acid-sensing (proton-gated) ion channel family member 4, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1]
GO:1904424	regulation of GTP binding	4.8E-5	7.93E-3	10.03	14984	11	815	6	[STMN1  -  stathmin 1, MET  -  met proto-oncogene, ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, FAM65B  -  family with sequence similarity 65, member b, EPHA4  -  eph receptor a4, ARHGAP28  -  rho gtpase activating protein 28]
GO:1904062	regulation of cation transmembrane transport	5.04E-5	8.22E-3	2.07	14984	286	1038	41	[GSG1L  -  gsg1-like, HPCA  -  hippocalcin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, FXYD6  -  fxyd domain containing ion transport regulator 6, DRD2  -  dopamine receptor d2, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PRNP  -  prion protein, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, DPP10  -  dipeptidyl-peptidase 10 (non-functional), DPP6  -  dipeptidyl-peptidase 6, TWIST1  -  twist basic helix-loop-helix transcription factor 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, CORO1A  -  coronin, actin binding protein, 1a, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, NPPA  -  natriuretic peptide a, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, FKBP1A  -  fk506 binding protein 1a, 12kda, STIM1  -  stromal interaction molecule 1, JPH4  -  junctophilin 4, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, RGS4  -  regulator of g-protein signaling 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, NLGN3  -  neuroligin 3, PDE4B  -  phosphodiesterase 4b, camp-specific, FXYD7  -  fxyd domain containing ion transport regulator 7, FHL1  -  four and a half lim domains 1]
GO:0031646	positive regulation of neurological system process	5.77E-5	9.32E-3	3.33	14984	55	1392	17	[RELN  -  reelin, NMU  -  neuromedin u, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), STX1A  -  syntaxin 1a (brain), CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, RIMS1  -  regulating synaptic membrane exocytosis 1, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, NRXN1  -  neurexin 1, UNC13B  -  unc-13 homolog b (c. elegans), RGS4  -  regulator of g-protein signaling 4, CARTPT  -  cart prepropeptide, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, NLGN3  -  neuroligin 3, TNR  -  tenascin r, CCK  -  cholecystokinin]
GO:0051932	synaptic transmission, GABAergic	5.95E-5	9.51E-3	10.49	14984	14	612	6	[GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA4  -  gamma-aminobutyric acid (gaba) a receptor, alpha 4, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3]
GO:0071241	cellular response to inorganic substance	6.07E-5	9.6E-3	2.26	14984	194	1096	32	[CPNE6  -  copine vi (neuronal), PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), HPCA  -  hippocalcin, DLG2  -  discs, large homolog 2 (drosophila), RASAL1  -  ras protein activator like 1 (gap1 like), GLRA2  -  glycine receptor, alpha 2, LIG4  -  ligase iv, dna, atp-dependent, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SYT1  -  synaptotagmin i, PRNP  -  prion protein, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SYT5  -  synaptotagmin v, SYT17  -  synaptotagmin xvii, SYT4  -  synaptotagmin iv, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, NQO1  -  nad(p)h dehydrogenase, quinone 1, NLGN1  -  neuroligin 1, ADCY7  -  adenylate cyclase 7, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, CPNE8  -  copine viii, CPNE7  -  copine vii, DDI2  -  dna-damage inducible 1 homolog 2 (s. cerevisiae), GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, BLM  -  bloom syndrome, recq helicase-like, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, OGG1  -  8-oxoguanine dna glycosylase, TPH2  -  tryptophan hydroxylase 2, CPNE5  -  copine v]
GO:1903861	positive regulation of dendrite extension	6.29E-5	9.84E-3	5.81	14984	22	1055	9	[CPNE6  -  copine vi (neuronal), PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, RASAL1  -  ras protein activator like 1 (gap1 like), RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, SYT17  -  synaptotagmin xvii, CPNE5  -  copine v, SYT4  -  synaptotagmin iv]
GO:0033555	multicellular organismal response to stress	6.69E-5	1.04E-2	4.97	14984	42	789	11	[HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, RELN  -  reelin, BCL2  -  b-cell cll/lymphoma 2, PRKCG  -  protein kinase c, gamma, GRIK2  -  glutamate receptor, ionotropic, kainate 2, USP46  -  ubiquitin specific peptidase 46, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, ASIC4  -  acid-sensing (proton-gated) ion channel family member 4, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1]
GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	6.94E-5	1.06E-2	3.93	14984	175	305	14	[GPR6  -  g protein-coupled receptor 6, DRD2  -  dopamine receptor d2, GNG2  -  guanine nucleotide binding protein (g protein), gamma 2, CHRM3  -  cholinergic receptor, muscarinic 3, GRM8  -  glutamate receptor, metabotropic 8, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, AKAP5  -  a kinase (prka) anchor protein 5, NPY1R  -  neuropeptide y receptor y1, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, ADCY7  -  adenylate cyclase 7, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0007210	serotonin receptor signaling pathway	7.08E-5	1.07E-2	17.15	14984	26	168	5	[HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CHRM3  -  cholinergic receptor, muscarinic 3, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:2001257	regulation of cation channel activity	7.19E-5	1.08E-2	2.36	14984	149	1193	28	[GSG1L  -  gsg1-like, RELN  -  reelin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, HPCA  -  hippocalcin, OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, NPPA  -  natriuretic peptide a, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, FKBP1A  -  fk506 binding protein 1a, 12kda, CRH  -  corticotropin releasing hormone, STIM1  -  stromal interaction molecule 1, JPH4  -  junctophilin 4, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, NLGN3  -  neuroligin 3, PDE4B  -  phosphodiesterase 4b, camp-specific]
GO:0051480	regulation of cytosolic calcium ion concentration	7.24E-5	1.08E-2	3.98	14984	246	214	14	[CALB1  -  calbindin 1, 28kda, CCL28  -  chemokine (c-c motif) ligand 28, CALB2  -  calbindin 2, GPR6  -  g protein-coupled receptor 6, BDKRB2  -  bradykinin receptor b2, DRD2  -  dopamine receptor d2, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, GRM1  -  glutamate receptor, metabotropic 1, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4]
GO:0001101	response to acid chemical	7.55E-5	1.11E-2	5.05	14984	272	120	11	[EPHA3  -  eph receptor a3, PKD2L1  -  polycystic kidney disease 2-like 1, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, PAX2  -  paired box 2, PDGFD  -  platelet derived growth factor d, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, GLRA2  -  glycine receptor, alpha 2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, LTK  -  leukocyte receptor tyrosine kinase, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, PID1  -  phosphotyrosine interaction domain containing 1]
GO:0071248	cellular response to metal ion	7.96E-5	1.16E-2	2.33	14984	170	1096	29	[CPNE6  -  copine vi (neuronal), PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), HPCA  -  hippocalcin, DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, LIG4  -  ligase iv, dna, atp-dependent, RASAL1  -  ras protein activator like 1 (gap1 like), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SYT1  -  synaptotagmin i, PRNP  -  prion protein, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, NQO1  -  nad(p)h dehydrogenase, quinone 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, ADCY7  -  adenylate cyclase 7, NLGN1  -  neuroligin 1, CPNE8  -  copine viii, CPNE7  -  copine vii, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, OGG1  -  8-oxoguanine dna glycosylase, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, TPH2  -  tryptophan hydroxylase 2, CPNE5  -  copine v]
GO:0019932	second-messenger-mediated signaling	7.99E-5	1.15E-2	2.16	14984	259	936	35	[NEUROD1  -  neuronal differentiation 1, HPCA  -  hippocalcin, DRD2  -  dopamine receptor d2, PDE7B  -  phosphodiesterase 7b, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, CHRM3  -  cholinergic receptor, muscarinic 3, PRNP  -  prion protein, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HRH1  -  histamine receptor h1, PPP3R1  -  protein phosphatase 3, regulatory subunit b, alpha, CNR1  -  cannabinoid receptor 1 (brain), PTHLH  -  parathyroid hormone-like hormone, ADCY7  -  adenylate cyclase 7, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GPR6  -  g protein-coupled receptor 6, CAP2  -  cap, adenylate cyclase-associated protein, 2 (yeast), PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, PCLO  -  piccolo presynaptic cytomatrix protein, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, GNG2  -  guanine nucleotide binding protein (g protein), gamma 2, EPHA5  -  eph receptor a5, NPPA  -  natriuretic peptide a, AHR  -  aryl hydrocarbon receptor, LPHN3  -  latrophilin 3, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, GRM5  -  glutamate receptor, metabotropic 5, CALCRL  -  calcitonin receptor-like, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, TNNI3  -  troponin i type 3 (cardiac)]
GO:0098742	cell-cell adhesion via plasma-membrane adhesion molecules	8.09E-5	1.16E-2	2.23	14984	199	1082	32	[PCDH20  -  protocadherin 20, PCDH15  -  protocadherin-related 15, SLITRK1  -  slit and ntrk-like family, member 1, CLDN20  -  claudin 20, CDH3  -  cadherin 3, type 1, p-cadherin (placental), PCDHGA12  -  protocadherin gamma subfamily a, 12, PCDH11Y  -  protocadherin 11 y-linked, PCDH1  -  protocadherin 1, GPC4  -  glypican 4, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), AMIGO2  -  adhesion molecule with ig-like domain 2, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), KIRREL3  -  kin of irre like 3 (drosophila), ATP2C1  -  atpase, ca++ transporting, type 2c, member 1, PCDHGA9  -  protocadherin gamma subfamily a, 9, PCDH10  -  protocadherin 10, SLITRK2  -  slit and ntrk-like family, member 2, NTNG2  -  netrin g2, CBLN1  -  cerebellin 1 precursor, TENM3  -  teneurin transmembrane protein 3, UNC5D  -  unc-5 homolog d (c. elegans), LPHN3  -  latrophilin 3, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), VSTM2L  -  v-set and transmembrane domain containing 2 like, CDH8  -  cadherin 8, type 2, CXADR  -  coxsackie virus and adenovirus receptor, CDH9  -  cadherin 9, type 2 (t1-cadherin), IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PCDH18  -  protocadherin 18, PCDH19  -  protocadherin 19, PTPRF  -  protein tyrosine phosphatase, receptor type, f]
GO:0019935	cyclic-nucleotide-mediated signaling	8.27E-5	1.17E-2	4.40	14984	134	305	12	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, GPR6  -  g protein-coupled receptor 6, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, DRD2  -  dopamine receptor d2, GNG2  -  guanine nucleotide binding protein (g protein), gamma 2, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, PTHLH  -  parathyroid hormone-like hormone, ADCY7  -  adenylate cyclase 7, EPHA5  -  eph receptor a5, NPPA  -  natriuretic peptide a]
GO:0042325	regulation of phosphorylation	8.7E-5	1.22E-2	2.23	14984	1353	169	34	[CDC6  -  cell division cycle 6, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, DRD2  -  dopamine receptor d2, ACVR2A  -  activin a receptor, type iia, PTPRR  -  protein tyrosine phosphatase, receptor type, r, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PDGFD  -  platelet derived growth factor d, KIRREL2  -  kin of irre like 2 (drosophila), NECAB2  -  n-terminal ef-hand calcium binding protein 2, ADCY7  -  adenylate cyclase 7, BANK1  -  b-cell scaffold protein with ankyrin repeats 1, LTK  -  leukocyte receptor tyrosine kinase, PID1  -  phosphotyrosine interaction domain containing 1, CLSPN  -  claspin, EPHA3  -  eph receptor a3, BDKRB2  -  bradykinin receptor b2, NHLRC1  -  nhl repeat containing 1, MECOM  -  mds1 and evi1 complex locus, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, MAPK1  -  mitogen-activated protein kinase 1, MET  -  met proto-oncogene, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, NPPA  -  natriuretic peptide a, PYDC1  -  pyd (pyrin domain) containing 1, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, GHR  -  growth hormone receptor, DIRAS3  -  diras family, gtp-binding ras-like 3, PRKCD  -  protein kinase c, delta, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RGS14  -  regulator of g-protein signaling 14, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta]
GO:0120040	regulation of macrophage proliferation	8.83E-5	1.23E-2	9.87	14984	6	1265	5	[CSF1R  -  colony stimulating factor 1 receptor, IL34  -  interleukin 34, MAPK3  -  mitogen-activated protein kinase 3, IL33  -  interleukin 33, MAPK1  -  mitogen-activated protein kinase 1]
GO:0014827	intestine smooth muscle contraction	8.96E-5	1.23E-2	169.31	14984	3	59	2	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0010469	regulation of signaling receptor activity	1.01E-4	1.38E-2	2.31	14984	144	1262	28	[GSG1L  -  gsg1-like, RELN  -  reelin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, OPRM1  -  opioid receptor, mu 1, DLG2  -  discs, large homolog 2 (drosophila), LRRC7  -  leucine rich repeat containing 7, BTC  -  betacellulin, LY6H  -  lymphocyte antigen 6 complex, locus h, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CNRIP1  -  cannabinoid receptor interacting protein 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, NPTXR  -  neuronal pentraxin receptor, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, ANKRD13C  -  ankyrin repeat domain 13c, CRH  -  corticotropin releasing hormone, FAM19A1  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a1, PHLDA2  -  pleckstrin homology-like domain, family a, member 2, NPTX1  -  neuronal pentraxin i, BEGAIN  -  brain-enriched guanylate kinase-associated, PRKCD  -  protein kinase c, delta, DLGAP3  -  discs, large (drosophila) homolog-associated protein 3, NPTX2  -  neuronal pentraxin ii, LYPD6B  -  ly6/plaur domain containing 6b, NLGN3  -  neuroligin 3, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4]
GO:0050433	regulation of catecholamine secretion	1.05E-4	1.42E-2	3.74	14984	47	1193	14	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, STX1A  -  syntaxin 1a (brain), DRD2  -  dopamine receptor d2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), SYT1  -  synaptotagmin i, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, CRH  -  corticotropin releasing hormone, CARTPT  -  cart prepropeptide, CNR1  -  cannabinoid receptor 1 (brain), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled]
GO:0051048	negative regulation of secretion	1.08E-4	1.44E-2	3.03	14984	133	669	18	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, NMU  -  neuromedin u, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, IL13RA2  -  interleukin 13 receptor, alpha 2, DRD2  -  dopamine receptor d2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), TACR2  -  tachykinin receptor 2, IL1B  -  interleukin 1, beta, NOV  -  nephroblastoma overexpressed, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, NPY5R  -  neuropeptide y receptor y5, ADTRP  -  androgen-dependent tfpi-regulating protein, CARTPT  -  cart prepropeptide, RAB11FIP1  -  rab11 family interacting protein 1 (class i), CD200  -  cd200 molecule, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1]
GO:0051953	negative regulation of amine transport	1.13E-4	1.5E-2	4.25	14984	25	1552	11	[GRM7  -  glutamate receptor, metabotropic 7, CRH  -  corticotropin releasing hormone, NPY5R  -  neuropeptide y receptor y5, OSR1  -  odd-skipped related 1 (drosophila), P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, RGS4  -  regulator of g-protein signaling 4, DRD2  -  dopamine receptor d2, ADRA2C  -  adrenoceptor alpha 2c, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CNR1  -  cannabinoid receptor 1 (brain), SYT4  -  synaptotagmin iv]
GO:0031650	regulation of heat generation	1.14E-4	1.49E-2	8.88	14984	12	844	6	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), NMU  -  neuromedin u, CNR1  -  cannabinoid receptor 1 (brain), TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, IL1B  -  interleukin 1, beta, PTGES  -  prostaglandin e synthase]
GO:0007218	neuropeptide signaling pathway	1.15E-4	1.5E-2	4.24	14984	84	547	13	[OPRM1  -  opioid receptor, mu 1, NMU  -  neuromedin u, MCHR2  -  melanin-concentrating hormone receptor 2, GLRA2  -  glycine receptor, alpha 2, TAC3  -  tachykinin 3, GLRA3  -  glycine receptor, alpha 3, NPPA  -  natriuretic peptide a, NPY5R  -  neuropeptide y receptor y5, NPY1R  -  neuropeptide y receptor y1, SSTR1  -  somatostatin receptor 1, CARTPT  -  cart prepropeptide, TYRO3  -  tyro3 protein tyrosine kinase, PDYN  -  prodynorphin]
GO:0051590	positive regulation of neurotransmitter transport	1.16E-4	1.5E-2	4.47	14984	31	1189	11	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), UNC13B  -  unc-13 homolog b (c. elegans), STX1A  -  syntaxin 1a (brain), DRD2  -  dopamine receptor d2, CNR1  -  cannabinoid receptor 1 (brain), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, NLGN1  -  neuroligin 1, TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, BAIAP3  -  bai1-associated protein 3, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)]
GO:0034220	ion transmembrane transport	1.16E-4	1.49E-2	1.85	14984	757	568	53	[OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, SLC7A4  -  solute carrier family 7, member 4, ADAMTS8  -  adam metallopeptidase with thrombospondin type 1 motif, 8, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, GPM6A  -  glycoprotein m6a, SCARA5  -  scavenger receptor class a, member 5 (putative), CCDC109B  -  coiled-coil domain containing 109b, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, FAM26F  -  family with sequence similarity 26, member f, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ATP6V1C1  -  atpase, h+ transporting, lysosomal 42kda, v1 subunit c1, FKBP1A  -  fk506 binding protein 1a, 12kda, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, KCNH7  -  potassium voltage-gated channel, subfamily h (eag-related), member 7, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, KCNA4  -  potassium voltage-gated channel, shaker-related subfamily, member 4, KCNA3  -  potassium voltage-gated channel, shaker-related subfamily, member 3, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, GLRA2  -  glycine receptor, alpha 2, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, GABRG1  -  gamma-aminobutyric acid (gaba) a receptor, gamma 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PKD2L1  -  polycystic kidney disease 2-like 1, SLC22A9  -  solute carrier family 22 (organic anion transporter), member 9, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, KCNV1  -  potassium channel, subfamily v, member 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, ANO3  -  anoctamin 3, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, KCNT2  -  potassium channel, subfamily t, member 2, SLC16A8  -  solute carrier family 16 (monocarboxylate transporter), member 8, ASIC4  -  acid-sensing (proton-gated) ion channel family member 4]
GO:1903305	regulation of regulated secretory pathway	1.17E-4	1.49E-2	2.42	14984	130	1331	28	[IL13RA2  -  interleukin 13 receptor, alpha 2, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, DRD2  -  dopamine receptor d2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, RAB15  -  rab15, member ras oncogene family, STX1A  -  syntaxin 1a (brain), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, CD84  -  cd84 molecule, DOC2A  -  double c2-like domains, alpha, UNC13B  -  unc-13 homolog b (c. elegans), PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), BAIAP3  -  bai1-associated protein 3]
GO:0070050	neuron cellular homeostasis	1.19E-4	1.5E-2	10.80	14984	29	287	6	[CALB1  -  calbindin 1, 28kda, CALB2  -  calbindin 2, NELL2  -  nel-like 2 (chicken), TYRO3  -  tyro3 protein tyrosine kinase, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1]
GO:0007165	signal transduction	1.19E-4	1.49E-2	1.38	14984	3637	439	147	[OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, IL13RA2  -  interleukin 13 receptor, alpha 2, BIRC3  -  baculoviral iap repeat containing 3, CD244  -  cd244 molecule, natural killer cell receptor 2b4, PRTN3  -  proteinase 3, PLXNC1  -  plexin c1, BTC  -  betacellulin, WSB2  -  wd repeat and socs box containing 2, CARTPT  -  cart prepropeptide, HRH1  -  histamine receptor h1, DCC  -  deleted in colorectal carcinoma, MOB1B  -  mob kinase activator 1b, OR14I1  -  olfactory receptor, family 14, subfamily i, member 1, NUMBL  -  numb homolog (drosophila)-like, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, GNG2  -  guanine nucleotide binding protein (g protein), gamma 2, SOX4  -  sry (sex determining region y)-box 4, FNBP1L  -  formin binding protein 1-like, IL1B  -  interleukin 1, beta, PYDC1  -  pyd (pyrin domain) containing 1, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, CFD  -  complement factor d (adipsin), UNC5D  -  unc-5 homolog d (c. elegans), GHR  -  growth hormone receptor, LPPR4  -  lipid phosphate phosphatase-related protein type 4, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, RGS14  -  regulator of g-protein signaling 14, SESN3  -  sestrin 3, NUS1  -  nuclear undecaprenyl pyrophosphate synthase 1 homolog (s. cerevisiae), SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, BATF  -  basic leucine zipper transcription factor, atf-like, GLRA2  -  glycine receptor, alpha 2, ACVR2A  -  activin a receptor, type iia, HPCAL4  -  hippocalcin like 4, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), RASGEF1B  -  rasgef domain family, member 1b, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, DDX54  -  dead (asp-glu-ala-asp) box polypeptide 54, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, GPR88  -  g protein-coupled receptor 88, GPC4  -  glypican 4, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, ARHGAP6  -  rho gtpase activating protein 6, ADCY7  -  adenylate cyclase 7, PDYN  -  prodynorphin, PTGES  -  prostaglandin e synthase, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled, BSN  -  bassoon presynaptic cytomatrix protein, DGKA  -  diacylglycerol kinase, alpha 80kda, MET  -  met proto-oncogene, MESP1  -  mesoderm posterior 1 homolog (mouse), CMTM8  -  cklf-like marvel transmembrane domain containing 8, DGKB  -  diacylglycerol kinase, beta 90kda, HTR3B  -  5-hydroxytryptamine (serotonin) receptor 3b, ionotropic, RASL11B  -  ras-like, family 11, member b, NPPA  -  natriuretic peptide a, SNAI2  -  snail family zinc finger 2, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, NPY5R  -  neuropeptide y receptor y5, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, AKAP5  -  a kinase (prka) anchor protein 5, NPY1R  -  neuropeptide y receptor y1, PTCHD1  -  patched domain containing 1, GMFB  -  glia maturation factor, beta, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, GNG10  -  guanine nucleotide binding protein (g protein), gamma 10, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, TAC3  -  tachykinin 3, PTPRR  -  protein tyrosine phosphatase, receptor type, r, CHRM3  -  cholinergic receptor, muscarinic 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, ARHGAP28  -  rho gtpase activating protein 28, NOV  -  nephroblastoma overexpressed, PDCD6  -  programmed cell death 6, CHL1  -  cell adhesion molecule l1-like, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, SLA  -  src-like-adaptor, PEA15  -  phosphoprotein enriched in astrocytes 15, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, GPR6  -  g protein-coupled receptor 6, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, STX1A  -  syntaxin 1a (brain), DCDC2  -  doublecortin domain containing 2, GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, EXT1  -  exostosin glycosyltransferase 1, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, STYK1  -  serine/threonine/tyrosine kinase 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, CAMK4  -  calcium/calmodulin-dependent protein kinase iv, FAM19A1  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a1, RTN4R  -  reticulon 4 receptor, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), DIRAS3  -  diras family, gtp-binding ras-like 3, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, PITPNM2  -  phosphatidylinositol transfer protein, membrane-associated 2, TNNI3  -  troponin i type 3 (cardiac), PPP1R1A  -  protein phosphatase 1, regulatory (inhibitor) subunit 1a, CCL28  -  chemokine (c-c motif) ligand 28, KL  -  klotho, CCDC68  -  coiled-coil domain containing 68, RASAL1  -  ras protein activator like 1 (gap1 like), DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, DLL3  -  delta-like 3 (drosophila), GPR160  -  g protein-coupled receptor 160, GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, LY6H  -  lymphocyte antigen 6 complex, locus h, PKD2L1  -  polycystic kidney disease 2-like 1, ISG15  -  isg15 ubiquitin-like modifier, ADTRP  -  androgen-dependent tfpi-regulating protein, PDGFD  -  platelet derived growth factor d, SSTR1  -  somatostatin receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, TNFSF13B  -  tumor necrosis factor (ligand) superfamily, member 13b, RFTN1  -  raftlin, lipid raft linker 1, TYRO3  -  tyro3 protein tyrosine kinase, RAP2B  -  rap2b, member of ras oncogene family, CD5  -  cd5 molecule, LTK  -  leukocyte receptor tyrosine kinase, EPHA3  -  eph receptor a3, ONECUT1  -  one cut homeobox 1, BDKRB2  -  bradykinin receptor b2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, FGD3  -  fyve, rhogef and ph domain containing 3, GRIK2  -  glutamate receptor, ionotropic, kainate 2, MAPK1  -  mitogen-activated protein kinase 1, GLRA3  -  glycine receptor, alpha 3, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, RSPO3  -  r-spondin 3, GRM8  -  glutamate receptor, metabotropic 8, B9D1  -  b9 protein domain 1, PRKCG  -  protein kinase c, gamma, PRKCD  -  protein kinase c, delta, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator]
GO:0031620	regulation of fever generation	1.21E-4	1.5E-2	11.10	14984	8	844	5	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), CNR1  -  cannabinoid receptor 1 (brain), TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, IL1B  -  interleukin 1, beta, PTGES  -  prostaglandin e synthase]
GO:0045666	positive regulation of neuron differentiation	1.22E-4	1.5E-2	1.73	14984	324	1575	59	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, TIMP2  -  timp metallopeptidase inhibitor 2, LRRC7  -  leucine rich repeat containing 7, ADRA2C  -  adrenoceptor alpha 2c, SYT1  -  synaptotagmin i, ENC1  -  ectodermal-neural cortex 1 (with btb domain), PLXNC1  -  plexin c1, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, SYT17  -  synaptotagmin xvii, SYT4  -  synaptotagmin iv, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, TOX  -  thymocyte selection-associated high mobility group box, BDNF  -  brain-derived neurotrophic factor, VWC2L  -  von willebrand factor c domain containing protein 2-like, PLXNA1  -  plexin a1, VLDLR  -  very low density lipoprotein receptor, CAMK1  -  calcium/calmodulin-dependent protein kinase i, IMPACT  -  impact rwd domain protein, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CRABP2  -  cellular retinoic acid binding protein 2, CPNE6  -  copine vi (neuronal), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), NEUROD1  -  neuronal differentiation 1, SH3GL3  -  sh3-domain grb2-like 3, FAM150B  -  family with sequence similarity 150, member b, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), RIMS1  -  regulating synaptic membrane exocytosis 1, RARB  -  retinoic acid receptor, beta, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, CNR1  -  cannabinoid receptor 1 (brain), UNC13A  -  unc-13 homolog a (c. elegans), FZD1  -  frizzled family receptor 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, MAP2K1  -  mitogen-activated protein kinase kinase 1, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), EPHA3  -  eph receptor a3, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, FBXO31  -  f-box protein 31, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), PRKCI  -  protein kinase c, iota, BCL2  -  b-cell cll/lymphoma 2, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, CPNE5  -  copine v, MMD  -  monocyte to macrophage differentiation-associated, NRCAM  -  neuronal cell adhesion molecule]
GO:0007600	sensory perception	1.26E-4	1.53E-2	2.36	14984	337	547	29	[NCAM2  -  neural cell adhesion molecule 2, OPRM1  -  opioid receptor, mu 1, NMU  -  neuromedin u, PAX2  -  paired box 2, PCDH15  -  protocadherin-related 15, DRD2  -  dopamine receptor d2, RIMS1  -  regulating synaptic membrane exocytosis 1, WNT10B  -  wingless-type mmtv integration site family, member 10b, PKD2L1  -  polycystic kidney disease 2-like 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, PDYN  -  prodynorphin, OTOGL  -  otogelin-like, PTGES  -  prostaglandin e synthase, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit, SLC26A4  -  solute carrier family 26 (anion exchanger), member 4, DCDC2  -  doublecortin domain containing 2, MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, COCH  -  cochlin, FAM65B  -  family with sequence similarity 65, member b, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5, SNAI2  -  snail family zinc finger 2, GRM8  -  glutamate receptor, metabotropic 8, PRPH2  -  peripherin 2 (retinal degeneration, slow), NPY1R  -  neuropeptide y receptor y1, CPLX3  -  complexin 3, THRB  -  thyroid hormone receptor, beta, MYO7A  -  myosin viia]
GO:0098693	regulation of synaptic vesicle cycle	1.28E-4	1.54E-2	2.72	14984	92	1317	22	[PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, STX1A  -  syntaxin 1a (brain), BSN  -  bassoon presynaptic cytomatrix protein, DRD2  -  dopamine receptor d2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, UNC13B  -  unc-13 homolog b (c. elegans), PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35)]
GO:0086010	membrane depolarization during action potential	1.28E-4	1.54E-2	4.36	14984	29	1304	11	[SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit]
GO:0031175	neuron projection development	1.29E-4	1.53E-2	1.89	14984	229	1520	44	[NCAM2  -  neural cell adhesion molecule 2, GALR2  -  galanin receptor 2, CCDC64  -  coiled-coil domain containing 64, NDN  -  necdin, melanoma antigen (mage) family member, KLHL1  -  kelch-like family member 1, BLOC1S6  -  biogenesis of lysosomal organelles complex-1, subunit 6, pallidin, CDC42  -  cell division cycle 42, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, GPRIN2  -  g protein regulated inducer of neurite outgrowth 2, VAPA  -  vamp (vesicle-associated membrane protein)-associated protein a, 33kda, GPRIN1  -  g protein regulated inducer of neurite outgrowth 1, GPR98  -  g protein-coupled receptor 98, CAMSAP1  -  calmodulin regulated spectrin-associated protein 1, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CHL1  -  cell adhesion molecule l1-like, CTNND2  -  catenin (cadherin-associated protein), delta 2, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, GPM6B  -  glycoprotein m6b, CNTN1  -  contactin 1, GPM6A  -  glycoprotein m6a, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, TMEM108  -  transmembrane protein 108, EPHA3  -  eph receptor a3, STMN1  -  stathmin 1, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, RTN4RL1  -  reticulon 4 receptor-like 1, TOR1A  -  torsin family 1, member a (torsin a), EPHB1  -  eph receptor b1, FAM65B  -  family with sequence similarity 65, member b, FLRT3  -  fibronectin leucine rich transmembrane protein 3, PRKG1  -  protein kinase, cgmp-dependent, type i, EPHA4  -  eph receptor a4, EPHA8  -  eph receptor a8, ATXN10  -  ataxin 10, BCL2  -  b-cell cll/lymphoma 2, GAP43  -  growth associated protein 43, WASL  -  wiskott-aldrich syndrome-like, NRCAM  -  neuronal cell adhesion molecule, PTPRF  -  protein tyrosine phosphatase, receptor type, f, LAMB1  -  laminin, beta 1, MYO7A  -  myosin viia, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35)]
GO:0051241	negative regulation of multicellular organismal process	1.35E-4	1.59E-2	1.62	14984	988	739	79	[KREMEN2  -  kringle containing transmembrane protein 2, PAX2  -  paired box 2, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, F12  -  coagulation factor xii (hageman factor), PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTPRR  -  protein tyrosine phosphatase, receptor type, r, TACR2  -  tachykinin receptor 2, APOC1  -  apolipoprotein c-i, LINGO1  -  leucine rich repeat and ig domain containing 1, NOV  -  nephroblastoma overexpressed, WNT10B  -  wingless-type mmtv integration site family, member 10b, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, CARTPT  -  cart prepropeptide, DPYSL3  -  dihydropyrimidinase-like 3, DCC  -  deleted in colorectal carcinoma, BANK1  -  b-cell scaffold protein with ankyrin repeats 1, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, CELF4  -  cugbp, elav-like family member 4, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, ZNF706  -  zinc finger protein 706, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, TWIST2  -  twist basic helix-loop-helix transcription factor 2, AHSG  -  alpha-2-hs-glycoprotein, IL1B  -  interleukin 1, beta, FKBP1A  -  fk506 binding protein 1a, 12kda, CREB3L1  -  camp responsive element binding protein 3-like 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, WNT4  -  wingless-type mmtv integration site family, member 4, RTN4R  -  reticulon 4 receptor, RGS4  -  regulator of g-protein signaling 4, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CD200  -  cd200 molecule, TNNT1  -  troponin t type 1 (skeletal, slow), MLIP  -  muscular lmna-interacting protein, TEK  -  tek tyrosine kinase, endothelial, NMU  -  neuromedin u, PTCH1  -  patched 1, PRNP  -  prion protein, DLL3  -  delta-like 3 (drosophila), KIAA2022  -  kiaa2022, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), NR2F2  -  nuclear receptor subfamily 2, group f, member 2, SPRED1  -  sprouty-related, evh1 domain containing 1, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), TWIST1  -  twist basic helix-loop-helix transcription factor 1, ISG15  -  isg15 ubiquitin-like modifier, ADTRP  -  androgen-dependent tfpi-regulating protein, C5orf30  -  chromosome 5 open reading frame 30, EFNB3  -  ephrin-b3, EFNB2  -  ephrin-b2, PTHLH  -  parathyroid hormone-like hormone, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ADCY7  -  adenylate cyclase 7, TNR  -  tenascin r, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), SFRP2  -  secreted frizzled-related protein 2, CBLN1  -  cerebellin 1 precursor, IGF1  -  insulin-like growth factor 1 (somatomedin c), RTN4RL1  -  reticulon 4 receptor-like 1, TNN  -  tenascin n, MESP1  -  mesoderm posterior 1 homolog (mouse), SLIT1  -  slit homolog 1 (drosophila), PYDC2  -  pyrin domain containing 2, EPHA4  -  eph receptor a4, SNAI2  -  snail family zinc finger 2, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PRKCD  -  protein kinase c, delta, RAB11FIP1  -  rab11 family interacting protein 1 (class i), YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, NAV3  -  neuron navigator 3, PTPRG  -  protein tyrosine phosphatase, receptor type, g, NRG3  -  neuregulin 3, THRB  -  thyroid hormone receptor, beta, DRAXIN  -  dorsal inhibitory axon guidance protein, ASCL2  -  achaete-scute complex homolog 2 (drosophila)]
GO:0043549	regulation of kinase activity	1.35E-4	1.58E-2	2.77	14984	783	152	22	[CLSPN  -  claspin, EPHA3  -  eph receptor a3, NHLRC1  -  nhl repeat containing 1, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, DRD2  -  dopamine receptor d2, MAPK1  -  mitogen-activated protein kinase 1, MET  -  met proto-oncogene, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, NPPA  -  natriuretic peptide a, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, PYDC1  -  pyd (pyrin domain) containing 1, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, GHR  -  growth hormone receptor, PDGFD  -  platelet derived growth factor d, DIRAS3  -  diras family, gtp-binding ras-like 3, PRKCD  -  protein kinase c, delta, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, ADCY7  -  adenylate cyclase 7, RGS14  -  regulator of g-protein signaling 14, LTK  -  leukocyte receptor tyrosine kinase, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta]
GO:1903859	regulation of dendrite extension	1.37E-4	1.59E-2	4.19	14984	25	1575	11	[CPNE6  -  copine vi (neuronal), PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, RASAL1  -  ras protein activator like 1 (gap1 like), BCL11A  -  b-cell cll/lymphoma 11a (zinc finger protein), UNC13A  -  unc-13 homolog a (c. elegans), SYT1  -  synaptotagmin i, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT17  -  synaptotagmin xvii, CPNE5  -  copine v, SYT4  -  synaptotagmin iv]
GO:0032989	cellular component morphogenesis	1.4E-4	1.62E-2	1.73	14984	368	1385	59	[RELN  -  reelin, PAX2  -  paired box 2, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD2  -  dopamine receptor d2, PTPRO  -  protein tyrosine phosphatase, receptor type, o, CDC42  -  cell division cycle 42, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, ABI2  -  abl-interactor 2, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, NLGN1  -  neuroligin 1, MERTK  -  c-mer proto-oncogene tyrosine kinase, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DCC  -  deleted in colorectal carcinoma, PID1  -  phosphotyrosine interaction domain containing 1, GPM6A  -  glycoprotein m6a, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, NUMBL  -  numb homolog (drosophila)-like, CAP2  -  cap, adenylate cyclase-associated protein, 2 (yeast), BDNF  -  brain-derived neurotrophic factor, RILPL2  -  rab interacting lysosomal protein-like 2, DCDC2  -  doublecortin domain containing 2, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, SLC9A6  -  solute carrier family 9, subfamily a (nhe6, cation proton antiporter 6), member 6, VLDLR  -  very low density lipoprotein receptor, KLK8  -  kallikrein-related peptidase 8, FAM84A  -  family with sequence similarity 84, member a, LPPR4  -  lipid phosphate phosphatase-related protein type 4, CREB1  -  camp responsive element binding protein 1, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, PARVB  -  parvin, beta, TEK  -  tek tyrosine kinase, endothelial, SLITRK1  -  slit and ntrk-like family, member 1, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), NFIB  -  nuclear factor i/b, TYRO3  -  tyro3 protein tyrosine kinase, MYO16  -  myosin xvi, KIRREL3  -  kin of irre like 3 (drosophila), STMN1  -  stathmin 1, TRIO  -  trio rho guanine nucleotide exchange factor, SLITRK2  -  slit and ntrk-like family, member 2, NTNG2  -  netrin g2, TNN  -  tenascin n, EPHB1  -  eph receptor b1, MET  -  met proto-oncogene, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, BCL2  -  b-cell cll/lymphoma 2, NPTX1  -  neuronal pentraxin i, CDH8  -  cadherin 8, type 2, CDH9  -  cadherin 9, type 2 (t1-cadherin), PAK6  -  p21 protein (cdc42/rac)-activated kinase 6, TMEFF2  -  transmembrane protein with egf-like and two follistatin-like domains 2, DRAXIN  -  dorsal inhibitory axon guidance protein, LAMB1  -  laminin, beta 1, WASF1  -  was protein family, member 1, CCK  -  cholecystokinin, NRCAM  -  neuronal cell adhesion molecule]
GO:0060359	response to ammonium ion	1.5E-4	1.71E-2	2.68	14984	88	1398	22	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, PEA15  -  phosphoprotein enriched in astrocytes 15, ATG7  -  autophagy related 7, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), HNMT  -  histamine n-methyltransferase, DRD5  -  dopamine receptor d5, DRD2  -  dopamine receptor d2, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, ASS1  -  argininosuccinate synthase 1, HTR3A  -  5-hydroxytryptamine (serotonin) receptor 3a, ionotropic, CRH  -  corticotropin releasing hormone, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, PRKCG  -  protein kinase c, gamma, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, RGS4  -  regulator of g-protein signaling 4, HRH1  -  histamine receptor h1, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, CNR1  -  cannabinoid receptor 1 (brain), GRIA1  -  glutamate receptor, ionotropic, ampa 1]
GO:0030278	regulation of ossification	1.54E-4	1.74E-2	2.44	14984	174	881	25	[KREMEN2  -  kringle containing transmembrane protein 2, KL  -  klotho, ACVR2A  -  activin a receptor, type iia, NELL1  -  nel-like 1 (chicken), ACVR2B  -  activin a receptor, type iib, PTCH1  -  patched 1, WNT10B  -  wingless-type mmtv integration site family, member 10b, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), TWIST1  -  twist basic helix-loop-helix transcription factor 1, WNT7B  -  wingless-type mmtv integration site family, member 7b, ISG15  -  isg15 ubiquitin-like modifier, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, SFRP2  -  secreted frizzled-related protein 2, SMAD1  -  smad family member 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), MAPK1  -  mitogen-activated protein kinase 1, TNN  -  tenascin n, TWIST2  -  twist basic helix-loop-helix transcription factor 2, FERMT2  -  fermitin family member 2, AHSG  -  alpha-2-hs-glycoprotein, SNAI2  -  snail family zinc finger 2, WNT4  -  wingless-type mmtv integration site family, member 4, BCL2  -  b-cell cll/lymphoma 2, SMAD3  -  smad family member 3, MGP  -  matrix gla protein]
GO:0008038	neuron recognition	1.56E-4	1.76E-2	3.55	14984	44	1344	14	[ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), NCAM2  -  neural cell adhesion molecule 2, EPHA3  -  eph receptor a3, NDN  -  necdin, melanoma antigen (mage) family member, TNN  -  tenascin n, EXT1  -  exostosin glycosyltransferase 1, EPHA4  -  eph receptor a4, VSTM2L  -  v-set and transmembrane domain containing 2 like, GAP43  -  growth associated protein 43, EFNB3  -  ephrin-b3, CNR1  -  cannabinoid receptor 1 (brain), NRCAM  -  neuronal cell adhesion molecule, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35)]
GO:1902803	regulation of synaptic vesicle transport	1.59E-4	1.78E-2	3.01	14984	68	1317	18	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), STX1A  -  syntaxin 1a (brain), DRD2  -  dopamine receptor d2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, SYT1  -  synaptotagmin i, RIMS1  -  regulating synaptic membrane exocytosis 1, LOH12CR1  -  loss of heterozygosity, 12, chromosomal region 1, UNC13B  -  unc-13 homolog b (c. elegans), PRKCG  -  protein kinase c, gamma, CPLX3  -  complexin 3, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a]
GO:0031346	positive regulation of cell projection organization	1.6E-4	1.78E-2	1.71	14984	343	1532	60	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, LRRC7  -  leucine rich repeat containing 7, CDC42  -  cell division cycle 42, SYT1  -  synaptotagmin i, RAB8B  -  rab8b, member ras oncogene family, ENC1  -  ectodermal-neural cortex 1 (with btb domain), PLXNC1  -  plexin c1, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, SYT17  -  synaptotagmin xvii, SYT4  -  synaptotagmin iv, ABI2  -  abl-interactor 2, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, AGRN  -  agrin, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, GPM6A  -  glycoprotein m6a, TOX  -  thymocyte selection-associated high mobility group box, BDNF  -  brain-derived neurotrophic factor, FAM65B  -  family with sequence similarity 65, member b, FNBP1L  -  formin binding protein 1-like, PLXNA1  -  plexin a1, VLDLR  -  very low density lipoprotein receptor, CAMK1  -  calcium/calmodulin-dependent protein kinase i, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, CRABP2  -  cellular retinoic acid binding protein 2, CPNE6  -  copine vi (neuronal), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), FAM150B  -  family with sequence similarity 150, member b, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, FSCN1  -  fascin homolog 1, actin-bundling protein (strongylocentrotus purpuratus), RIMS1  -  regulating synaptic membrane exocytosis 1, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, CNR1  -  cannabinoid receptor 1 (brain), FZD1  -  frizzled family receptor 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, MAP2K1  -  mitogen-activated protein kinase kinase 1, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), EPHA3  -  eph receptor a3, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, FBXO31  -  f-box protein 31, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), PRKCI  -  protein kinase c, iota, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, WASL  -  wiskott-aldrich syndrome-like, CPNE5  -  copine v]
GO:0010720	positive regulation of cell development	1.74E-4	1.92E-2	1.64	14984	471	1357	70	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, TIMP2  -  timp metallopeptidase inhibitor 2, OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, LIG4  -  ligase iv, dna, atp-dependent, CDC42  -  cell division cycle 42, ENC1  -  ectodermal-neural cortex 1 (with btb domain), SYT1  -  synaptotagmin i, ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, SYT4  -  synaptotagmin iv, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, NUMBL  -  numb homolog (drosophila)-like, TOX  -  thymocyte selection-associated high mobility group box, BDNF  -  brain-derived neurotrophic factor, PLXNA1  -  plexin a1, IL1B  -  interleukin 1, beta, VLDLR  -  very low density lipoprotein receptor, HAMP  -  hepcidin antimicrobial peptide, IMPACT  -  impact rwd domain protein, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, RGS14  -  regulator of g-protein signaling 14, CPNE6  -  copine vi (neuronal), NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), FAM150B  -  family with sequence similarity 150, member b, IL34  -  interleukin 34, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, RIMS1  -  regulating synaptic membrane exocytosis 1, RARB  -  retinoic acid receptor, beta, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, FZD1  -  frizzled family receptor 1, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), EPHA3  -  eph receptor a3, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, IGF1  -  insulin-like growth factor 1 (somatomedin c), TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, ELL3  -  elongation factor rna polymerase ii-like 3, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, BCL2  -  b-cell cll/lymphoma 2, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, MPL  -  myeloproliferative leukemia virus oncogene, MMD  -  monocyte to macrophage differentiation-associated, NRCAM  -  neuronal cell adhesion molecule, CPNE5  -  copine v]
GO:0071242	cellular response to ammonium ion	1.78E-4	1.95E-2	3.71	14984	39	1345	13	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), ATG7  -  autophagy related 7, OPRM1  -  opioid receptor, mu 1, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, ASS1  -  argininosuccinate synthase 1, CRH  -  corticotropin releasing hormone, GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, HRH1  -  histamine receptor h1, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, GRIA1  -  glutamate receptor, ionotropic, ampa 1]
GO:0050769	positive regulation of neurogenesis	1.84E-4	1.99E-2	1.77	14984	410	1135	55	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, LIG4  -  ligase iv, dna, atp-dependent, SYT1  -  synaptotagmin i, ENC1  -  ectodermal-neural cortex 1 (with btb domain), ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, SYT4  -  synaptotagmin iv, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, DPYSL3  -  dihydropyrimidinase-like 3, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NUMBL  -  numb homolog (drosophila)-like, TOX  -  thymocyte selection-associated high mobility group box, BDNF  -  brain-derived neurotrophic factor, PLXNA1  -  plexin a1, IL1B  -  interleukin 1, beta, IMPACT  -  impact rwd domain protein, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, RGS14  -  regulator of g-protein signaling 14, CPNE6  -  copine vi (neuronal), FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), NEUROD1  -  neuronal differentiation 1, FAM150B  -  family with sequence similarity 150, member b, IL34  -  interleukin 34, SLITRK1  -  slit and ntrk-like family, member 1, RASAL1  -  ras protein activator like 1 (gap1 like), RIMS1  -  regulating synaptic membrane exocytosis 1, RARB  -  retinoic acid receptor, beta, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), EPHA3  -  eph receptor a3, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, EPHA4  -  eph receptor a4, ELL3  -  elongation factor rna polymerase ii-like 3, FBXO31  -  f-box protein 31, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), BCL2  -  b-cell cll/lymphoma 2, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, MMD  -  monocyte to macrophage differentiation-associated, CPNE5  -  copine v]
GO:0051963	regulation of synapse assembly	1.86E-4	2.01E-2	2.64	14984	90	1385	22	[ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), BAI3  -  brain-specific angiogenesis inhibitor 3, SLITRK2  -  slit and ntrk-like family, member 2, BDNF  -  brain-derived neurotrophic factor, NTNG2  -  netrin g2, CBLN1  -  cerebellin 1 precursor, SLITRK1  -  slit and ntrk-like family, member 1, EPHB1  -  eph receptor b1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SLIT1  -  slit homolog 1 (drosophila), LRRTM1  -  leucine rich repeat transmembrane neuronal 1, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, NRXN1  -  neurexin 1, GAP43  -  growth associated protein 43, AGRN  -  agrin, GPC4  -  glypican 4, NLGN1  -  neuroligin 1, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), NLGN3  -  neuroligin 3, LINGO2  -  leucine rich repeat and ig domain containing 2, AMIGO2  -  adhesion molecule with ig-like domain 2]
GO:0019220	regulation of phosphate metabolic process	1.87E-4	2E-2	2.09	14984	1527	169	36	[CDC6  -  cell division cycle 6, DRD2  -  dopamine receptor d2, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, ACVR2A  -  activin a receptor, type iia, PTPRR  -  protein tyrosine phosphatase, receptor type, r, APOC1  -  apolipoprotein c-i, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PDGFD  -  platelet derived growth factor d, KIRREL2  -  kin of irre like 2 (drosophila), NECAB2  -  n-terminal ef-hand calcium binding protein 2, ADCY7  -  adenylate cyclase 7, BANK1  -  b-cell scaffold protein with ankyrin repeats 1, LTK  -  leukocyte receptor tyrosine kinase, PID1  -  phosphotyrosine interaction domain containing 1, CLSPN  -  claspin, EPHA3  -  eph receptor a3, BDKRB2  -  bradykinin receptor b2, NHLRC1  -  nhl repeat containing 1, MECOM  -  mds1 and evi1 complex locus, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, MAPK1  -  mitogen-activated protein kinase 1, MET  -  met proto-oncogene, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, NPPA  -  natriuretic peptide a, PYDC1  -  pyd (pyrin domain) containing 1, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, GHR  -  growth hormone receptor, DIRAS3  -  diras family, gtp-binding ras-like 3, SYTL2  -  synaptotagmin-like 2, PRKCD  -  protein kinase c, delta, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RGS14  -  regulator of g-protein signaling 14, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta]
GO:0051174	regulation of phosphorus metabolic process	1.87E-4	1.98E-2	2.09	14984	1527	169	36	[CDC6  -  cell division cycle 6, DRD2  -  dopamine receptor d2, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, ACVR2A  -  activin a receptor, type iia, PTPRR  -  protein tyrosine phosphatase, receptor type, r, APOC1  -  apolipoprotein c-i, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PDGFD  -  platelet derived growth factor d, KIRREL2  -  kin of irre like 2 (drosophila), NECAB2  -  n-terminal ef-hand calcium binding protein 2, ADCY7  -  adenylate cyclase 7, BANK1  -  b-cell scaffold protein with ankyrin repeats 1, LTK  -  leukocyte receptor tyrosine kinase, PID1  -  phosphotyrosine interaction domain containing 1, CLSPN  -  claspin, EPHA3  -  eph receptor a3, BDKRB2  -  bradykinin receptor b2, NHLRC1  -  nhl repeat containing 1, MECOM  -  mds1 and evi1 complex locus, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, MAPK1  -  mitogen-activated protein kinase 1, MET  -  met proto-oncogene, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, NPPA  -  natriuretic peptide a, PYDC1  -  pyd (pyrin domain) containing 1, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, GHR  -  growth hormone receptor, DIRAS3  -  diras family, gtp-binding ras-like 3, SYTL2  -  synaptotagmin-like 2, PRKCD  -  protein kinase c, delta, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RGS14  -  regulator of g-protein signaling 14, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta]
GO:0045762	positive regulation of adenylate cyclase activity	1.87E-4	1.97E-2	7.15	14984	9	1398	6	[HPCA  -  hippocalcin, STIM1  -  stromal interaction molecule 1, TIMP2  -  timp metallopeptidase inhibitor 2, AKAP5  -  a kinase (prka) anchor protein 5, DRD5  -  dopamine receptor d5, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit]
GO:0015913	short-chain fatty acid import	2E-4	2.09E-2	4,994.67	14984	1	3	1	[SLC22A9  -  solute carrier family 22 (organic anion transporter), member 9]
GO:0051338	regulation of transferase activity	2.08E-4	2.16E-2	2.85	14984	876	120	20	[CLSPN  -  claspin, EPHA3  -  eph receptor a3, NEK2  -  nima-related kinase 2, NHLRC1  -  nhl repeat containing 1, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, DRD2  -  dopamine receptor d2, MET  -  met proto-oncogene, GRM1  -  glutamate receptor, metabotropic 1, EPHA5  -  eph receptor a5, NPPA  -  natriuretic peptide a, PYDC1  -  pyd (pyrin domain) containing 1, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, GHR  -  growth hormone receptor, PDGFD  -  platelet derived growth factor d, PRKCD  -  protein kinase c, delta, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, ADCY7  -  adenylate cyclase 7, RGS14  -  regulator of g-protein signaling 14, LTK  -  leukocyte receptor tyrosine kinase, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta]
GO:0045761	regulation of adenylate cyclase activity	2.2E-4	2.27E-2	4.05	14984	28	1452	11	[P2RY13  -  purinergic receptor p2y, g-protein coupled, 13, HPCA  -  hippocalcin, STIM1  -  stromal interaction molecule 1, CAP2  -  cap, adenylate cyclase-associated protein, 2 (yeast), GPR98  -  g protein-coupled receptor 98, TIMP2  -  timp metallopeptidase inhibitor 2, GALR2  -  galanin receptor 2, AKAP5  -  a kinase (prka) anchor protein 5, DRD5  -  dopamine receptor d5, DRD2  -  dopamine receptor d2, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit]
GO:0050805	negative regulation of synaptic transmission	2.21E-4	2.27E-2	3.53	14984	53	1120	14	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), CELF4  -  cugbp, elav-like family member 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, DRD2  -  dopamine receptor d2, GRIK3  -  glutamate receptor, ionotropic, kainate 3, CBLN1  -  cerebellin 1 precursor, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), IL1B  -  interleukin 1, beta, SYT4  -  synaptotagmin iv, NPY5R  -  neuropeptide y receptor y5, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, TNR  -  tenascin r, GRIA1  -  glutamate receptor, ionotropic, ampa 1]
GO:0001933	negative regulation of protein phosphorylation	2.31E-4	2.35E-2	4.13	14984	372	117	12	[DACT1  -  dishevelled-binding antagonist of beta-catenin 1, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, DRD2  -  dopamine receptor d2, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, KIRREL2  -  kin of irre like 2 (drosophila), PRKCD  -  protein kinase c, delta, PTPRR  -  protein tyrosine phosphatase, receptor type, r, RGS14  -  regulator of g-protein signaling 14, NPPA  -  natriuretic peptide a, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta, PID1  -  phosphotyrosine interaction domain containing 1, PYDC1  -  pyd (pyrin domain) containing 1]
GO:0019228	neuronal action potential	2.4E-4	2.42E-2	9.20	14984	25	391	6	[SCN3A  -  sodium channel, voltage-gated, type iii, alpha subunit, GRIK2  -  glutamate receptor, ionotropic, kainate 2, SCN2A  -  sodium channel, voltage-gated, type ii, alpha subunit, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, GPR88  -  g protein-coupled receptor 88, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit]
GO:0007626	locomotory behavior	2.54E-4	2.55E-2	8.75	14984	137	75	6	[CALB1  -  calbindin 1, 28kda, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NPY1R  -  neuropeptide y receptor y1, DRD2  -  dopamine receptor d2, GRM1  -  glutamate receptor, metabotropic 1, GPR88  -  g protein-coupled receptor 88]
GO:0019934	cGMP-mediated signaling	2.54E-4	2.53E-2	195.87	14984	17	9	2	[HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NPPA  -  natriuretic peptide a]
GO:0031652	positive regulation of heat generation	2.54E-4	2.52E-2	9.86	14984	9	844	5	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), NMU  -  neuromedin u, CNR1  -  cannabinoid receptor 1 (brain), TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, IL1B  -  interleukin 1, beta]
GO:0032101	regulation of response to external stimulus	2.67E-4	2.63E-2	2.00	14984	669	436	39	[OPRM1  -  opioid receptor, mu 1, BIRC3  -  baculoviral iap repeat containing 3, DRD2  -  dopamine receptor d2, F12  -  coagulation factor xii (hageman factor), PTPRO  -  protein tyrosine phosphatase, receptor type, o, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), NOV  -  nephroblastoma overexpressed, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), ADTRP  -  androgen-dependent tfpi-regulating protein, PDGFD  -  platelet derived growth factor d, CARTPT  -  cart prepropeptide, TYRO3  -  tyro3 protein tyrosine kinase, C5orf30  -  chromosome 5 open reading frame 30, ADCY7  -  adenylate cyclase 7, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, PTGES  -  prostaglandin e synthase, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, MAPK1  -  mitogen-activated protein kinase 1, MET  -  met proto-oncogene, FAM65B  -  family with sequence similarity 65, member b, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, PYDC2  -  pyrin domain containing 2, IL1B  -  interleukin 1, beta, EPHA4  -  eph receptor a4, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, SNAI2  -  snail family zinc finger 2, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, NPY5R  -  neuropeptide y receptor y5, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, KLK5  -  kallikrein-related peptidase 5, RTN4R  -  reticulon 4 receptor, PRKCG  -  protein kinase c, gamma, PRKCD  -  protein kinase c, delta, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, CD200  -  cd200 molecule]
GO:0099550	trans-synaptic signaling, modulating synaptic transmission	2.88E-4	2.82E-2	6.90	14984	10	1303	6	[GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, GRM5  -  glutamate receptor, metabotropic 5, EFNB3  -  ephrin-b3, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CNR1  -  cannabinoid receptor 1 (brain)]
GO:0003012	muscle system process	2.89E-4	2.81E-2	4.69	14984	202	158	10	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), BDKRB2  -  bradykinin receptor b2, DRD2  -  dopamine receptor d2, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RCSD1  -  rcsd domain containing 1, TCAP  -  titin-cap, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, TNNT1  -  troponin t type 1 (skeletal, slow), HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0006936	muscle contraction	2.92E-4	2.82E-2	5.11	14984	167	158	9	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), BDKRB2  -  bradykinin receptor b2, DRD2  -  dopamine receptor d2, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RCSD1  -  rcsd domain containing 1, TCAP  -  titin-cap, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, TNNT1  -  troponin t type 1 (skeletal, slow), HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0014821	phasic smooth muscle contraction	2.96E-4	2.83E-2	39.96	14984	15	75	3	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), DRD2  -  dopamine receptor d2, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0099643	signal release from synapse	2.98E-4	2.84E-2	3.31	14984	64	1061	15	[SYN2  -  synapsin ii, STX1A  -  syntaxin 1a (brain), PCLO  -  piccolo presynaptic cytomatrix protein, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), SYT1  -  synaptotagmin i, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT5  -  synaptotagmin v, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, DOC2A  -  double c2-like domains, alpha, NRXN2  -  neurexin 2, UNC13B  -  unc-13 homolog b (c. elegans), CPLX3  -  complexin 3, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1]
GO:0007158	neuron cell-cell adhesion	3E-4	2.84E-2	5.16	14984	17	1366	8	[NRXN1  -  neurexin 1, NRXN2  -  neurexin 2, NCAM2  -  neural cell adhesion molecule 2, ASTN1  -  astrotactin 1, NLGN1  -  neuroligin 1, NLGN3  -  neuroligin 3, TNR  -  tenascin r, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35)]
GO:0001932	regulation of protein phosphorylation	3.06E-4	2.88E-2	2.22	14984	1196	169	30	[CDC6  -  cell division cycle 6, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, DRD2  -  dopamine receptor d2, ACVR2A  -  activin a receptor, type iia, PTPRR  -  protein tyrosine phosphatase, receptor type, r, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PDGFD  -  platelet derived growth factor d, KIRREL2  -  kin of irre like 2 (drosophila), NECAB2  -  n-terminal ef-hand calcium binding protein 2, ADCY7  -  adenylate cyclase 7, BANK1  -  b-cell scaffold protein with ankyrin repeats 1, PID1  -  phosphotyrosine interaction domain containing 1, CLSPN  -  claspin, BDKRB2  -  bradykinin receptor b2, NHLRC1  -  nhl repeat containing 1, MECOM  -  mds1 and evi1 complex locus, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, NPPA  -  natriuretic peptide a, PYDC1  -  pyd (pyrin domain) containing 1, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, GHR  -  growth hormone receptor, DIRAS3  -  diras family, gtp-binding ras-like 3, PRKCD  -  protein kinase c, delta, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RGS14  -  regulator of g-protein signaling 14, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta]
GO:0070494	regulation of thrombin-activated receptor signaling pathway	3.12E-4	2.91E-2	18.39	14984	3	815	3	[STMN1  -  stathmin 1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), MET  -  met proto-oncogene]
GO:0070495	negative regulation of thrombin-activated receptor signaling pathway	3.12E-4	2.9E-2	18.39	14984	3	815	3	[STMN1  -  stathmin 1, MET  -  met proto-oncogene, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor)]
GO:0048585	negative regulation of response to stimulus	3.18E-4	2.93E-2	1.59	14984	1388	523	77	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), KREMEN2  -  kringle containing transmembrane protein 2, OPRM1  -  opioid receptor, mu 1, IL13RA2  -  interleukin 13 receptor, alpha 2, DRD2  -  dopamine receptor d2, F12  -  coagulation factor xii (hageman factor), PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTPRR  -  protein tyrosine phosphatase, receptor type, r, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), NOV  -  nephroblastoma overexpressed, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, BTC  -  betacellulin, ANKRD6  -  ankyrin repeat domain 6, PDCD6  -  programmed cell death 6, CARTPT  -  cart prepropeptide, DLK2  -  delta-like 2 homolog (drosophila), DCC  -  deleted in colorectal carcinoma, BANK1  -  b-cell scaffold protein with ankyrin repeats 1, PID1  -  phosphotyrosine interaction domain containing 1, TNFAIP8L1  -  tumor necrosis factor, alpha-induced protein 8-like 1, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, PEA15  -  phosphoprotein enriched in astrocytes 15, CELF4  -  cugbp, elav-like family member 4, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, BDNF  -  brain-derived neurotrophic factor, MECOM  -  mds1 and evi1 complex locus, FAM65B  -  family with sequence similarity 65, member b, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, IL1B  -  interleukin 1, beta, PYDC1  -  pyd (pyrin domain) containing 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, KLK8  -  kallikrein-related peptidase 8, RTN4R  -  reticulon 4 receptor, OGG1  -  8-oxoguanine dna glycosylase, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, RMI2  -  recq mediated genome instability 2, CD200  -  cd200 molecule, RGS14  -  regulator of g-protein signaling 14, MLIP  -  muscular lmna-interacting protein, CLEC4G  -  c-type lectin domain family 4, member g, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, SESN3  -  sestrin 3, RASAL1  -  ras protein activator like 1 (gap1 like), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PRNP  -  prion protein, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, SH3RF1  -  sh3 domain containing ring finger 1, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), TWIST1  -  twist basic helix-loop-helix transcription factor 1, ADTRP  -  androgen-dependent tfpi-regulating protein, CXorf57  -  chromosome x open reading frame 57, TYRO3  -  tyro3 protein tyrosine kinase, C5orf30  -  chromosome 5 open reading frame 30, ADCY7  -  adenylate cyclase 7, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a, ONECUT1  -  one cut homeobox 1, BDKRB2  -  bradykinin receptor b2, CBLN1  -  cerebellin 1 precursor, TNN  -  tenascin n, MET  -  met proto-oncogene, MESP1  -  mesoderm posterior 1 homolog (mouse), DDRGK1  -  ddrgk domain containing 1, PYDC2  -  pyrin domain containing 2, NPPA  -  natriuretic peptide a, EPHA4  -  eph receptor a4, RASL11B  -  ras-like, family 11, member b, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, SNAI2  -  snail family zinc finger 2, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, NPY5R  -  neuropeptide y receptor y5, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, AUNIP  -  aurora kinase a and ninein interacting protein, PRKCD  -  protein kinase c, delta, OTUB2  -  otu domain, ubiquitin aldehyde binding 2, TNFRSF10B  -  tumor necrosis factor receptor superfamily, member 10b]
GO:0030656	regulation of vitamin metabolic process	3.28E-4	3E-2	15.49	14984	9	430	4	[VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, CLYBL  -  citrate lyase beta like, IL1B  -  interleukin 1, beta, SNAI2  -  snail family zinc finger 2]
GO:0045936	negative regulation of phosphate metabolic process	3.29E-4	3E-2	1.96	14984	508	603	40	[TMEM132D  -  transmembrane protein 132d, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), ELFN2  -  extracellular leucine-rich repeat and fibronectin type iii domain containing 2, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, DRD2  -  dopamine receptor d2, ARPP19  -  camp-regulated phosphoprotein, 19kda, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PTPRR  -  protein tyrosine phosphatase, receptor type, r, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, PRNP  -  prion protein, APOC1  -  apolipoprotein c-i, KIAA1244  -  kiaa1244, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, SPRED1  -  sprouty-related, evh1 domain containing 1, TWIST1  -  twist basic helix-loop-helix transcription factor 1, PPP4R4  -  protein phosphatase 4, regulatory subunit 4, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), KIRREL2  -  kin of irre like 2 (drosophila), RIMBP2  -  rims binding protein 2, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, PPP1R14C  -  protein phosphatase 1, regulatory (inhibitor) subunit 14c, PID1  -  phosphotyrosine interaction domain containing 1, MYCNOS  -  mycn opposite strand/antisense rna, BDKRB2  -  bradykinin receptor b2, INSM1  -  insulinoma-associated 1, MECOM  -  mds1 and evi1 complex locus, NPPA  -  natriuretic peptide a, IL1B  -  interleukin 1, beta, PYDC1  -  pyd (pyrin domain) containing 1, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, FKBP1A  -  fk506 binding protein 1a, 12kda, SYTL2  -  synaptotagmin-like 2, RGS4  -  regulator of g-protein signaling 4, PRKCD  -  protein kinase c, delta, GMFB  -  glia maturation factor, beta, FAM212B  -  family with sequence similarity 212, member b, RGS14  -  regulator of g-protein signaling 14, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta, PPP1R1A  -  protein phosphatase 1, regulatory (inhibitor) subunit 1a]
GO:0060732	positive regulation of inositol phosphate biosynthetic process	3.37E-4	3.06E-2	15.34	14984	9	434	4	[CD244  -  cd244 molecule, natural killer cell receptor 2b4, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, HRH1  -  histamine receptor h1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor)]
GO:0010563	negative regulation of phosphorus metabolic process	3.46E-4	3.11E-2	1.95	14984	509	603	40	[TMEM132D  -  transmembrane protein 132d, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), ELFN2  -  extracellular leucine-rich repeat and fibronectin type iii domain containing 2, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, DRD2  -  dopamine receptor d2, ARPP19  -  camp-regulated phosphoprotein, 19kda, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PTPRR  -  protein tyrosine phosphatase, receptor type, r, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, PRNP  -  prion protein, APOC1  -  apolipoprotein c-i, KIAA1244  -  kiaa1244, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, SPRED1  -  sprouty-related, evh1 domain containing 1, TWIST1  -  twist basic helix-loop-helix transcription factor 1, PPP4R4  -  protein phosphatase 4, regulatory subunit 4, FARP1  -  ferm, rhogef (arhgef) and pleckstrin domain protein 1 (chondrocyte-derived), KIRREL2  -  kin of irre like 2 (drosophila), RIMBP2  -  rims binding protein 2, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, PPP1R14C  -  protein phosphatase 1, regulatory (inhibitor) subunit 14c, PID1  -  phosphotyrosine interaction domain containing 1, MYCNOS  -  mycn opposite strand/antisense rna, BDKRB2  -  bradykinin receptor b2, INSM1  -  insulinoma-associated 1, MECOM  -  mds1 and evi1 complex locus, NPPA  -  natriuretic peptide a, IL1B  -  interleukin 1, beta, PYDC1  -  pyd (pyrin domain) containing 1, DACT1  -  dishevelled-binding antagonist of beta-catenin 1, FKBP1A  -  fk506 binding protein 1a, 12kda, SYTL2  -  synaptotagmin-like 2, RGS4  -  regulator of g-protein signaling 4, PRKCD  -  protein kinase c, delta, GMFB  -  glia maturation factor, beta, FAM212B  -  family with sequence similarity 212, member b, RGS14  -  regulator of g-protein signaling 14, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta, PPP1R1A  -  protein phosphatase 1, regulatory (inhibitor) subunit 1a]
GO:0042423	catecholamine biosynthetic process	3.48E-4	3.12E-2	10.33	14984	13	558	5	[HDC  -  histidine decarboxylase, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), INSM1  -  insulinoma-associated 1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PNMT  -  phenylethanolamine n-methyltransferase]
GO:0009713	catechol-containing compound biosynthetic process	3.48E-4	3.1E-2	10.33	14984	13	558	5	[HDC  -  histidine decarboxylase, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), INSM1  -  insulinoma-associated 1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PNMT  -  phenylethanolamine n-methyltransferase]
GO:0051968	positive regulation of synaptic transmission, glutamatergic	3.53E-4	3.12E-2	4.22	14984	26	1366	10	[NRXN1  -  neurexin 1, TSHZ3  -  teashirt zinc finger homeobox 3, RELN  -  reelin, CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, SHANK2  -  sh3 and multiple ankyrin repeat domains 2, NLGN1  -  neuroligin 1, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NLGN3  -  neuroligin 3, TNR  -  tenascin r, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)]
GO:1902805	positive regulation of synaptic vesicle transport	3.59E-4	3.16E-2	6.87	14984	11	1189	6	[LOH12CR1  -  loss of heterozygosity, 12, chromosomal region 1, UNC13B  -  unc-13 homolog b (c. elegans), CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, SYT1  -  synaptotagmin i]
GO:0051271	negative regulation of cellular component movement	3.69E-4	3.23E-2	3.44	14984	270	226	14	[CCL28  -  chemokine (c-c motif) ligand 28, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, DRD2  -  dopamine receptor d2, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTPRR  -  protein tyrosine phosphatase, receptor type, r, FAM65B  -  family with sequence similarity 65, member b, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), NR2F2  -  nuclear receptor subfamily 2, group f, member 2, C5orf30  -  chromosome 5 open reading frame 30, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, RAP2B  -  rap2b, member of ras oncogene family]
GO:1902932	positive regulation of alcohol biosynthetic process	3.7E-4	3.21E-2	7.95	14984	18	628	6	[WNT4  -  wingless-type mmtv integration site family, member 4, CD244  -  cd244 molecule, natural killer cell receptor 2b4, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, HRH1  -  histamine receptor h1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), IL1B  -  interleukin 1, beta]
GO:0007215	glutamate receptor signaling pathway	3.7E-4	3.19E-2	3.78	14984	44	1081	12	[GRM8  -  glutamate receptor, metabotropic 8, GRM7  -  glutamate receptor, metabotropic 7, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, SSTR1  -  somatostatin receptor 1, GRIK3  -  glutamate receptor, ionotropic, kainate 3, GRM5  -  glutamate receptor, metabotropic 5, GRM1  -  glutamate receptor, metabotropic 1, GRIA1  -  glutamate receptor, ionotropic, ampa 1, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a]
GO:0031279	regulation of cyclase activity	3.73E-4	3.2E-2	3.44	14984	39	1452	13	[P2RY13  -  purinergic receptor p2y, g-protein coupled, 13, HPCA  -  hippocalcin, TIMP2  -  timp metallopeptidase inhibitor 2, GALR2  -  galanin receptor 2, CAP2  -  cap, adenylate cyclase-associated protein, 2 (yeast), DRD5  -  dopamine receptor d5, DRD2  -  dopamine receptor d2, MAPK3  -  mitogen-activated protein kinase 3, GRM7  -  glutamate receptor, metabotropic 7, GPR98  -  g protein-coupled receptor 98, STIM1  -  stromal interaction molecule 1, AKAP5  -  a kinase (prka) anchor protein 5, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit]
GO:0045744	negative regulation of G protein-coupled receptor signaling pathway	3.75E-4	3.21E-2	19.51	14984	32	96	4	[DRD2  -  dopamine receptor d2, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, MET  -  met proto-oncogene, RGS14  -  regulator of g-protein signaling 14]
GO:0009187	cyclic nucleotide metabolic process	3.95E-4	3.35E-2	4.37	14984	33	1038	10	[PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, PDE2A  -  phosphodiesterase 2a, cgmp-stimulated, GUCY1B3  -  guanylate cyclase 1, soluble, beta 3, GUCY1A3  -  guanylate cyclase 1, soluble, alpha 3, PTHLH  -  parathyroid hormone-like hormone, PDE7B  -  phosphodiesterase 7b, ADCY7  -  adenylate cyclase 7, NPPA  -  natriuretic peptide a, PDE4B  -  phosphodiesterase 4b, camp-specific, ADCY2  -  adenylate cyclase 2 (brain)]
GO:0014059	regulation of dopamine secretion	4E-4	3.37E-2	4.34	14984	32	1079	10	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), DRD2  -  dopamine receptor d2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CNR1  -  cannabinoid receptor 1 (brain), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, SYT1  -  synaptotagmin i, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, SYT4  -  synaptotagmin iv]
GO:0048149	behavioral response to ethanol	4.01E-4	3.37E-2	13.17	14984	7	650	4	[OPRM1  -  opioid receptor, mu 1, DRD2  -  dopamine receptor d2, USP46  -  ubiquitin specific peptidase 46, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase)]
GO:0006874	cellular calcium ion homeostasis	4.17E-4	3.48E-2	3.24	14984	324	214	15	[CALB1  -  calbindin 1, 28kda, CCL28  -  chemokine (c-c motif) ligand 28, BDKRB2  -  bradykinin receptor b2, CALB2  -  calbindin 2, GPR6  -  g protein-coupled receptor 6, DRD2  -  dopamine receptor d2, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, GRM1  -  glutamate receptor, metabotropic 1, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4]
GO:0072221	metanephric distal convoluted tubule development	4.24E-4	3.52E-2	94.84	14984	4	79	2	[CALB1  -  calbindin 1, 28kda, PAX2  -  paired box 2]
GO:0072025	distal convoluted tubule development	4.24E-4	3.5E-2	94.84	14984	4	79	2	[CALB1  -  calbindin 1, 28kda, PAX2  -  paired box 2]
GO:0014831	gastro-intestinal system smooth muscle contraction	4.31E-4	3.54E-2	101.59	14984	5	59	2	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0031622	positive regulation of fever generation	4.32E-4	3.53E-2	11.84	14984	6	844	4	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), CNR1  -  cannabinoid receptor 1 (brain), TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, IL1B  -  interleukin 1, beta]
GO:0019233	sensory perception of pain	4.36E-4	3.54E-2	4.44	14984	40	844	10	[OPRM1  -  opioid receptor, mu 1, NMU  -  neuromedin u, NPY1R  -  neuropeptide y receptor y1, NDN  -  necdin, melanoma antigen (mage) family member, MAPK1  -  mitogen-activated protein kinase 1, GRM1  -  glutamate receptor, metabotropic 1, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CNR1  -  cannabinoid receptor 1 (brain), PTGES  -  prostaglandin e synthase, SCN9A  -  sodium channel, voltage-gated, type ix, alpha subunit]
GO:0055074	calcium ion homeostasis	4.53E-4	3.66E-2	2.22	14984	333	568	28	[CCL28  -  chemokine (c-c motif) ligand 28, CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, NMU  -  neuromedin u, KL  -  klotho, DRD2  -  dopamine receptor d2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, CD52  -  cd52 molecule, GRIA1  -  glutamate receptor, ionotropic, ampa 1, CALB1  -  calbindin 1, 28kda, BDKRB2  -  bradykinin receptor b2, CALB2  -  calbindin 2, GPR6  -  g protein-coupled receptor 6, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, CCDC109B  -  coiled-coil domain containing 109b, GRIK2  -  glutamate receptor, ionotropic, kainate 2, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, GRM1  -  glutamate receptor, metabotropic 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNI3  -  troponin i type 3 (cardiac)]
GO:0010038	response to metal ion	4.57E-4	3.67E-2	1.75	14984	313	1340	49	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), DRD2  -  dopamine receptor d2, LIG4  -  ligase iv, dna, atp-dependent, SYT1  -  synaptotagmin i, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SYT17  -  synaptotagmin xvii, SYT5  -  synaptotagmin v, GSS  -  glutathione synthetase, SYT4  -  synaptotagmin iv, ANXA11  -  annexin a11, PDCD6  -  programmed cell death 6, NLGN1  -  neuroligin 1, CPNE7  -  copine vii, ENTPD6  -  ectonucleoside triphosphate diphosphohydrolase 6 (putative), AQP9  -  aquaporin 9, HAMP  -  hepcidin antimicrobial peptide, STIM1  -  stromal interaction molecule 1, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, OGG1  -  8-oxoguanine dna glycosylase, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CREB1  -  camp responsive element binding protein 1, TNNC1  -  troponin c type 1 (slow), TPH2  -  tryptophan hydroxylase 2, CPNE6  -  copine vi (neuronal), HPCA  -  hippocalcin, DLG2  -  discs, large homolog 2 (drosophila), GLRA2  -  glycine receptor, alpha 2, RASAL1  -  ras protein activator like 1 (gap1 like), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), PRNP  -  prion protein, GPR98  -  g protein-coupled receptor 98, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARG1  -  arginase 1, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, NQO1  -  nad(p)h dehydrogenase, quinone 1, ADCY7  -  adenylate cyclase 7, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, PTGES  -  prostaglandin e synthase, CPNE8  -  copine viii, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, SLC30A4  -  solute carrier family 30 (zinc transporter), member 4, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, ASS1  -  argininosuccinate synthase 1, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, BCL2  -  b-cell cll/lymphoma 2, CPNE5  -  copine v]
GO:0098664	G protein-coupled serotonin receptor signaling pathway	4.78E-4	3.82E-2	7.94	14984	23	492	6	[HTR4  -  5-hydroxytryptamine (serotonin) receptor 4, g protein-coupled, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HRH1  -  histamine receptor h1, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, CHRM3  -  cholinergic receptor, muscarinic 3, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0006939	smooth muscle contraction	5.04E-4	4E-2	18.53	14984	42	77	4	[PTGER3  -  prostaglandin e receptor 3 (subtype ep3), DRD2  -  dopamine receptor d2, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, HTR1D  -  5-hydroxytryptamine (serotonin) receptor 1d, g protein-coupled]
GO:0061436	establishment of skin barrier	5.05E-4	3.99E-2	133.19	14984	15	15	2	[MET  -  met proto-oncogene, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1]
GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	5.08E-4	3.99E-2	124.87	14984	12	20	2	[NPPA  -  natriuretic peptide a, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta]
GO:0002028	regulation of sodium ion transport	5.09E-4	3.98E-2	12.47	14984	78	77	5	[DRD2  -  dopamine receptor d2, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta]
GO:0045956	positive regulation of calcium ion-dependent exocytosis	5.3E-4	4.12E-2	4.47	14984	24	1257	9	[UNC13B  -  unc-13 homolog b (c. elegans), STX1A  -  syntaxin 1a (brain), CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, SYT1  -  synaptotagmin i, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, SYT4  -  synaptotagmin iv]
GO:1903522	regulation of blood circulation	5.48E-4	4.24E-2	1.99	14984	230	1079	33	[CACNG3  -  calcium channel, voltage-dependent, gamma subunit 3, NMU  -  neuromedin u, FXYD6  -  fxyd domain containing ion transport regulator 6, DRD2  -  dopamine receptor d2, TPM1  -  tropomyosin 1 (alpha), DOCK4  -  dedicator of cytokinesis 4, CHRM3  -  cholinergic receptor, muscarinic 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, HRH1  -  histamine receptor h1, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, BDKRB2  -  bradykinin receptor b2, KCNK1  -  potassium channel, subfamily k, member 1, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, NPPA  -  natriuretic peptide a, STIM1  -  stromal interaction molecule 1, DSP  -  desmoplakin, RGS4  -  regulator of g-protein signaling 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, CXADR  -  coxsackie virus and adenovirus receptor, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, THRB  -  thyroid hormone receptor, beta, THRA  -  thyroid hormone receptor, alpha, TNNI3  -  troponin i type 3 (cardiac), FXYD7  -  fxyd domain containing ion transport regulator 7, PDE4B  -  phosphodiesterase 4b, camp-specific]
GO:0042326	negative regulation of phosphorylation	5.67E-4	4.37E-2	3.79	14984	406	117	12	[DACT1  -  dishevelled-binding antagonist of beta-catenin 1, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, DRD2  -  dopamine receptor d2, PKIA  -  protein kinase (camp-dependent, catalytic) inhibitor alpha, KIRREL2  -  kin of irre like 2 (drosophila), PRKCD  -  protein kinase c, delta, PTPRR  -  protein tyrosine phosphatase, receptor type, r, RGS14  -  regulator of g-protein signaling 14, NPPA  -  natriuretic peptide a, PID1  -  phosphotyrosine interaction domain containing 1, PKIB  -  protein kinase (camp-dependent, catalytic) inhibitor beta, PYDC1  -  pyd (pyrin domain) containing 1]
GO:0040013	negative regulation of locomotion	5.68E-4	4.35E-2	3.28	14984	283	226	14	[CCL28  -  chemokine (c-c motif) ligand 28, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, DRD2  -  dopamine receptor d2, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PTPRR  -  protein tyrosine phosphatase, receptor type, r, FAM65B  -  family with sequence similarity 65, member b, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), NR2F2  -  nuclear receptor subfamily 2, group f, member 2, C5orf30  -  chromosome 5 open reading frame 30, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, RAP2B  -  rap2b, member of ras oncogene family]
GO:0003254	regulation of membrane depolarization	5.97E-4	4.55E-2	35.73	14984	37	34	3	[SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta]
GO:2000300	regulation of synaptic vesicle exocytosis	6.06E-4	4.59E-2	2.94	14984	62	1317	16	[STX1A  -  syntaxin 1a (brain), DRD2  -  dopamine receptor d2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, SYT1  -  synaptotagmin i, RIMS1  -  regulating synaptic membrane exocytosis 1, UNC13B  -  unc-13 homolog b (c. elegans), CPLX3  -  complexin 3, PRKCG  -  protein kinase c, gamma, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, GRIN3A  -  glutamate receptor, ionotropic, n-methyl-d-aspartate 3a]
GO:0032526	response to retinoic acid	6.18E-4	4.66E-2	8.81	14984	85	120	6	[EPHA3  -  eph receptor a3, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, PAX2  -  paired box 2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, LTK  -  leukocyte receptor tyrosine kinase, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1]
GO:1903531	negative regulation of secretion by cell	6.3E-4	4.73E-2	2.31	14984	117	1388	25	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), OPRM1  -  opioid receptor, mu 1, IL13RA2  -  interleukin 13 receptor, alpha 2, DRD2  -  dopamine receptor d2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), TACR2  -  tachykinin receptor 2, SYT4  -  synaptotagmin iv, INHA  -  inhibin, alpha, NOV  -  nephroblastoma overexpressed, ADTRP  -  androgen-dependent tfpi-regulating protein, CARTPT  -  cart prepropeptide, CNR1  -  cannabinoid receptor 1 (brain), SFRP1  -  secreted frizzled-related protein 1, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, KALRN  -  kalirin, rhogef kinase, IL1B  -  interleukin 1, beta, CD84  -  cd84 molecule, GRM7  -  glutamate receptor, metabotropic 7, NPY5R  -  neuropeptide y receptor y5, CRH  -  corticotropin releasing hormone, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, RAB11FIP1  -  rab11 family interacting protein 1 (class i), CD200  -  cd200 molecule, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1]
GO:0060509	type I pneumocyte differentiation	6.34E-4	4.73E-2	9.58	14984	5	1251	4	[NFIB  -  nuclear factor i/b, CREB1  -  camp responsive element binding protein 1, THRB  -  thyroid hormone receptor, beta, THRA  -  thyroid hormone receptor, alpha]
GO:0051047	positive regulation of secretion	6.5E-4	4.83E-2	1.84	14984	258	1264	40	[CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, NMU  -  neuromedin u, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, DRD2  -  dopamine receptor d2, EXPH5  -  exophilin 5, NNAT  -  neuronatin, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), TACR2  -  tachykinin receptor 2, SYT1  -  synaptotagmin i, SYT4  -  synaptotagmin iv, INHA  -  inhibin, alpha, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, CARTPT  -  cart prepropeptide, ACSL4  -  acyl-coa synthetase long-chain family member 4, C2CD2L  -  c2cd2-like, MYRIP  -  myosin viia and rab interacting protein, CNR1  -  cannabinoid receptor 1 (brain), NLGN1  -  neuroligin 1, OXCT1  -  3-oxoacid coa transferase 1, PTGES  -  prostaglandin e synthase, KMO  -  kynurenine 3-monooxygenase (kynurenine 3-hydroxylase), RAB15  -  rab15, member ras oncogene family, CLASP2  -  cytoplasmic linker associated protein 2, PCK2  -  phosphoenolpyruvate carboxykinase 2 (mitochondrial), PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, P2RY2  -  purinergic receptor p2y, g-protein coupled, 2, STX1A  -  syntaxin 1a (brain), IGF1  -  insulin-like growth factor 1 (somatomedin c), SOX4  -  sry (sex determining region y)-box 4, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, IL1B  -  interleukin 1, beta, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit, CRH  -  corticotropin releasing hormone, UNC13B  -  unc-13 homolog b (c. elegans), CREB1  -  camp responsive element binding protein 1, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, RAB27B  -  rab27b, member ras oncogene family, BAIAP3  -  bai1-associated protein 3, CCK  -  cholecystokinin]
GO:0099566	regulation of postsynaptic cytosolic calcium ion concentration	6.52E-4	4.82E-2	27.24	14984	11	150	3	[CALB1  -  calbindin 1, 28kda, GRM1  -  glutamate receptor, metabotropic 1, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2]
GO:0045597	positive regulation of cell differentiation	6.55E-4	4.81E-2	1.43	14984	832	1357	108	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, OPRM1  -  opioid receptor, mu 1, PAX2  -  paired box 2, LIG4  -  ligase iv, dna, atp-dependent, CD83  -  cd83 molecule, CDC42  -  cell division cycle 42, ENC1  -  ectodermal-neural cortex 1 (with btb domain), RFX3  -  regulatory factor x, 3 (influences hla class ii expression), ATP8A2  -  atpase, aminophospholipid transporter, class i, type 8a, member 2, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, BTC  -  betacellulin, LMO3  -  lim domain only 3 (rhombotin-like 2), SHANK2  -  sh3 and multiple ankyrin repeat domains 2, SHANK1  -  sh3 and multiple ankyrin repeat domains 1, NUMBL  -  numb homolog (drosophila)-like, BDNF  -  brain-derived neurotrophic factor, CD53  -  cd53 molecule, EGR3  -  early growth response 3, MEDAG  -  mesenteric estrogen-dependent adipogenesis, SOX4  -  sry (sex determining region y)-box 4, PLXNA1  -  plexin a1, IL1B  -  interleukin 1, beta, LPL  -  lipoprotein lipase, HAMP  -  hepcidin antimicrobial peptide, WNT4  -  wingless-type mmtv integration site family, member 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, GDPD2  -  glycerophosphodiester phosphodiesterase domain containing 2, CREB1  -  camp responsive element binding protein 1, RGS14  -  regulator of g-protein signaling 14, FAM150B  -  family with sequence similarity 150, member b, ACVR2A  -  activin a receptor, type iia, ACVR2B  -  activin a receptor, type iib, ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, PTCH1  -  patched 1, RIMS1  -  regulating synaptic membrane exocytosis 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, CEBPA  -  ccaat/enhancer binding protein (c/ebp), alpha, FZD1  -  frizzled family receptor 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, CNTN1  -  contactin 1, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), INSM1  -  insulinoma-associated 1, MESP1  -  mesoderm posterior 1 homolog (mouse), CDH4  -  cadherin 4, type 1, r-cadherin (retinal), IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, NRCAM  -  neuronal cell adhesion molecule, TIMP2  -  timp metallopeptidase inhibitor 2, DRD2  -  dopamine receptor d2, LRRC7  -  leucine rich repeat containing 7, OLFM1  -  olfactomedin 1, SYT1  -  synaptotagmin i, SYT4  -  synaptotagmin iv, WNT10B  -  wingless-type mmtv integration site family, member 10b, WNT7B  -  wingless-type mmtv integration site family, member 7b, NLGN1  -  neuroligin 1, DPYSL3  -  dihydropyrimidinase-like 3, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, TOX  -  thymocyte selection-associated high mobility group box, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, FAM65B  -  family with sequence similarity 65, member b, VLDLR  -  very low density lipoprotein receptor, IMPACT  -  impact rwd domain protein, CPNE6  -  copine vi (neuronal), NEUROD1  -  neuronal differentiation 1, FUT9  -  fucosyltransferase 9 (alpha (1,3) fucosyltransferase), IL34  -  interleukin 34, SLITRK1  -  slit and ntrk-like family, member 1, NELL1  -  nel-like 1 (chicken), RASAL1  -  ras protein activator like 1 (gap1 like), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), BLOC1S6  -  biogenesis of lysosomal organelles complex-1, subunit 6, pallidin, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, RARB  -  retinoic acid receptor, beta, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ISG15  -  isg15 ubiquitin-like modifier, RBM24  -  rna binding motif protein 24, ITPKA  -  inositol-trisphosphate 3-kinase a, LTK  -  leukocyte receptor tyrosine kinase, MAPK11  -  mitogen-activated protein kinase 11, EPHA3  -  eph receptor a3, SFRP2  -  secreted frizzled-related protein 2, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, SMAD1  -  smad family member 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), RIPK2  -  receptor-interacting serine-threonine kinase 2, TENM3  -  teneurin transmembrane protein 3, KALRN  -  kalirin, rhogef kinase, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, ELL3  -  elongation factor rna polymerase ii-like 3, FBXO31  -  f-box protein 31, BCL2  -  b-cell cll/lymphoma 2, SMAD3  -  smad family member 3, MPL  -  myeloproliferative leukemia virus oncogene, MMD  -  monocyte to macrophage differentiation-associated, CPNE5  -  copine v]
GO:0120041	positive regulation of macrophage proliferation	6.58E-4	4.82E-2	9.48	14984	5	1265	4	[CSF1R  -  colony stimulating factor 1 receptor, IL34  -  interleukin 34, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1]
GO:0010817	regulation of hormone levels	6.59E-4	4.8E-2	3.72	14984	420	115	12	[TPO  -  thyroid peroxidase, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, MYB  -  v-myb avian myeloblastosis viral oncogene homolog, GHR  -  growth hormone receptor, STX1A  -  syntaxin 1a (brain), SLC22A9  -  solute carrier family 22 (organic anion transporter), member 9, DRD2  -  dopamine receptor d2, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, EPHA5  -  eph receptor a5, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1]
GO:0006836	neurotransmitter transport	6.71E-4	4.86E-2	2.17	14984	123	1575	28	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), SYN2  -  synapsin ii, SLC6A7  -  solute carrier family 6 (neurotransmitter transporter), member 7, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, NRXN1  -  neurexin 1, SLC17A6  -  solute carrier family 17 (vesicular glutamate transporter), member 6, NRXN2  -  neurexin 2, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), SLC17A8  -  solute carrier family 17 (vesicular glutamate transporter), member 8, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, UNC13A  -  unc-13 homolog a (c. elegans), SLC6A16  -  solute carrier family 6, member 16, SLC25A22  -  solute carrier family 25 (mitochondrial carrier: glutamate), member 22, SLC6A20  -  solute carrier family 6 (proline imino transporter), member 20, SV2B  -  synaptic vesicle glycoprotein 2b, PRAF2  -  pra1 domain family, member 2, STX1A  -  syntaxin 1a (brain), GABRA2  -  gamma-aminobutyric acid (gaba) a receptor, alpha 2, GRM1  -  glutamate receptor, metabotropic 1, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, SLC1A4  -  solute carrier family 1 (glutamate/neutral amino acid transporter), member 4, DOC2A  -  double c2-like domains, alpha, UNC13B  -  unc-13 homolog b (c. elegans), SLC22A3  -  solute carrier family 22 (organic cation transporter), member 3, SLC17A7  -  solute carrier family 17 (vesicular glutamate transporter), member 7]
GO:0033561	regulation of water loss via skin	6.77E-4	4.88E-2	117.52	14984	17	15	2	[MET  -  met proto-oncogene, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1]
GO:0086045	membrane depolarization during AV node cell action potential	7.41E-4	5.32E-2	9.19	14984	5	1304	4	[SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1G  -  calcium channel, voltage-dependent, t type, alpha 1g subunit]
GO:0001662	behavioral fear response	7.71E-4	5.51E-2	5.78	14984	23	789	7	[HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, BCL2  -  b-cell cll/lymphoma 2, GRIK2  -  glutamate receptor, ionotropic, kainate 2, USP46  -  ubiquitin specific peptidase 46, HTR1A  -  5-hydroxytryptamine (serotonin) receptor 1a, g protein-coupled, ASIC4  -  acid-sensing (proton-gated) ion channel family member 4, GABRA5  -  gamma-aminobutyric acid (gaba) a receptor, alpha 5]
GO:0030336	negative regulation of cell migration	7.87E-4	5.59E-2	2.22	14984	229	737	25	[CCL28  -  chemokine (c-c motif) ligand 28, DRD2  -  dopamine receptor d2, PTPRR  -  protein tyrosine phosphatase, receptor type, r, PTPRJ  -  protein tyrosine phosphatase, receptor type, j, KIAA2022  -  kiaa2022, NOV  -  nephroblastoma overexpressed, PTGER4  -  prostaglandin e receptor 4 (subtype ep4), SPRED1  -  sprouty-related, evh1 domain containing 1, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, ADTRP  -  androgen-dependent tfpi-regulating protein, C5orf30  -  chromosome 5 open reading frame 30, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, DPYSL3  -  dihydropyrimidinase-like 3, RAP2B  -  rap2b, member of ras oncogene family, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), SFRP2  -  secreted frizzled-related protein 2, TNN  -  tenascin n, FAM65B  -  family with sequence similarity 65, member b, WNT4  -  wingless-type mmtv integration site family, member 4, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, NAV3  -  neuron navigator 3, CD200  -  cd200 molecule, PTPRG  -  protein tyrosine phosphatase, receptor type, g, NRG3  -  neuregulin 3]
GO:0015912	short-chain fatty acid transport	7.92E-4	5.6E-2	2,497.33	14984	2	3	1	[SLC22A9  -  solute carrier family 22 (organic anion transporter), member 9]
GO:0010919	regulation of inositol phosphate biosynthetic process	8.16E-4	5.74E-2	12.55	14984	11	434	4	[CD244  -  cd244 molecule, natural killer cell receptor 2b4, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, HRH1  -  histamine receptor h1, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor)]
GO:0048878	chemical homeostasis	8.38E-4	5.87E-2	6.01	14984	873	20	7	[HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, MET  -  met proto-oncogene, GRM1  -  glutamate receptor, metabotropic 1, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, CYP26B1  -  cytochrome p450, family 26, subfamily b, polypeptide 1]
GO:0022604	regulation of cell morphogenesis	8.78E-4	6.13E-2	1.64	14984	449	1180	58	[PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), RELN  -  reelin, PTPRO  -  protein tyrosine phosphatase, receptor type, o, CDC42  -  cell division cycle 42, SYT1  -  synaptotagmin i, OLFM1  -  olfactomedin 1, PLXNC1  -  plexin c1, SYT17  -  synaptotagmin xvii, LINGO1  -  leucine rich repeat and ig domain containing 1, SYT4  -  synaptotagmin iv, ABI2  -  abl-interactor 2, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, ARHGAP33  -  rho gtpase activating protein 33, NLGN1  -  neuroligin 1, DCC  -  deleted in colorectal carcinoma, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, BDNF  -  brain-derived neurotrophic factor, PALMD  -  palmdelphin, COCH  -  cochlin, PLXNA1  -  plexin a1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, RTN4R  -  reticulon 4 receptor, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, PARVB  -  parvin, beta, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), CPNE6  -  copine vi (neuronal), BAI3  -  brain-specific angiogenesis inhibitor 3, SLITRK1  -  slit and ntrk-like family, member 1, TPM1  -  tropomyosin 1 (alpha), RASAL1  -  ras protein activator like 1 (gap1 like), ARHGEF7  -  rho guanine nucleotide exchange factor (gef) 7, RIMS1  -  regulating synaptic membrane exocytosis 1, CDC42SE2  -  cdc42 small effector 2, UST  -  uronyl-2-sulfotransferase, NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, CAMSAP1  -  calmodulin regulated spectrin-associated protein 1, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, BRWD1  -  bromodomain and wd repeat domain containing 1, EFNB3  -  ephrin-b3, ITPKA  -  inositol-trisphosphate 3-kinase a, TNR  -  tenascin r, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), CORO1A  -  coronin, actin binding protein, 1a, FGD3  -  fyve, rhogef and ph domain containing 3, NTNG2  -  netrin g2, KALRN  -  kalirin, rhogef kinase, TTL  -  tubulin tyrosine ligase, FERMT2  -  fermitin family member 2, EPHA4  -  eph receptor a4, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), FBXO31  -  f-box protein 31, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, IL1RAPL1  -  interleukin 1 receptor accessory protein-like 1, DRAXIN  -  dorsal inhibitory axon guidance protein, MPL  -  myeloproliferative leukemia virus oncogene, CPNE5  -  copine v]
GO:0023061	signal release	8.81E-4	6.12E-2	2.51	14984	118	1061	21	[LTBP4  -  latent transforming growth factor beta binding protein 4, NEUROD1  -  neuronal differentiation 1, SYN2  -  synapsin ii, STX1A  -  syntaxin 1a (brain), PCLO  -  piccolo presynaptic cytomatrix protein, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), TACR2  -  tachykinin receptor 2, RIMS1  -  regulating synaptic membrane exocytosis 1, SYT1  -  synaptotagmin i, SYT5  -  synaptotagmin v, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, DOC2A  -  double c2-like domains, alpha, NRXN2  -  neurexin 2, UNC13B  -  unc-13 homolog b (c. elegans), PPFIA2  -  protein tyrosine phosphatase, receptor type, f polypeptide (ptprf), interacting protein (liprin), alpha 2, CPLX3  -  complexin 3, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, CARTPT  -  cart prepropeptide, CASK  -  calcium/calmodulin-dependent serine protein kinase (maguk family), APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4]
GO:0006928	movement of cell or subcellular component	8.99E-4	6.21E-2	1.33	14984	1166	1550	160	[PRSS3  -  protease, serine, 3, SIRPA  -  signal-regulatory protein alpha, RELN  -  reelin, CCDC64  -  coiled-coil domain containing 64, NDN  -  necdin, melanoma antigen (mage) family member, RABL5  -  rab, member ras oncogene family-like 5, CD244  -  cd244 molecule, natural killer cell receptor 2b4, AP3M2  -  adaptor-related protein complex 3, mu 2 subunit, CDC42  -  cell division cycle 42, SPDL1  -  spindle apparatus coiled-coil protein 1, PRTN3  -  proteinase 3, RFX3  -  regulatory factor x, 3 (influences hla class ii expression), ABI2  -  abl-interactor 2, ING2  -  inhibitor of growth family, member 2, HRH1  -  histamine receptor h1, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, KIF12  -  kinesin family member 12, DCC  -  deleted in colorectal carcinoma, DNAAF1  -  dynein, axonemal, assembly factor 1, TUBB2A  -  tubulin, beta 2a class iia, BDNF  -  brain-derived neurotrophic factor, EGR3  -  early growth response 3, CCL4  -  chemokine (c-c motif) ligand 4, CCNYL1  -  cyclin y-like 1, FNBP1L  -  formin binding protein 1-like, CD84  -  cd84 molecule, LOH12CR1  -  loss of heterozygosity, 12, chromosomal region 1, DOK6  -  docking protein 6, UNC5D  -  unc-5 homolog d (c. elegans), LPHN3  -  latrophilin 3, VSTM2L  -  v-set and transmembrane domain containing 2 like, FAM84A  -  family with sequence similarity 84, member a, KIF16B  -  kinesin family member 16b, PAK1  -  p21 protein (cdc42/rac)-activated kinase 1, MYO7A  -  myosin viia, CDK5R1  -  cyclin-dependent kinase 5, regulatory subunit 1 (p35), TPM3  -  tropomyosin 3, DNAH14  -  dynein, axonemal, heavy chain 14, CENPE  -  centromere protein e, 312kda, TPM1  -  tropomyosin 1 (alpha), PTCH1  -  patched 1, FSCN1  -  fascin homolog 1, actin-bundling protein (strongylocentrotus purpuratus), ACTN2  -  actinin, alpha 2, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, MYH7  -  myosin, heavy chain 7, cardiac muscle, beta, MYBPC1  -  myosin binding protein c, slow type, EFNB3  -  ephrin-b3, TCAP  -  titin-cap, GPC4  -  glypican 4, EFNB2  -  ephrin-b2, CYP1B1  -  cytochrome p450, family 1, subfamily b, polypeptide 1, WDR66  -  wd repeat domain 66, TNR  -  tenascin r, RND3  -  rho family gtpase 3, TMEM108  -  transmembrane protein 108, ROBO1  -  roundabout, axon guidance receptor, homolog 1 (drosophila), TEKT2  -  tektin 2 (testicular), ROBO2  -  roundabout, axon guidance receptor, homolog 2 (drosophila), KIRREL3  -  kin of irre like 3 (drosophila), CORO1A  -  coronin, actin binding protein, 1a, TRIO  -  trio rho guanine nucleotide exchange factor, NTNG2  -  netrin g2, DBH  -  dopamine beta-hydroxylase (dopamine beta-monooxygenase), DPYSL4  -  dihydropyrimidinase-like 4, SLIT3  -  slit homolog 3 (drosophila), MET  -  met proto-oncogene, MESP1  -  mesoderm posterior 1 homolog (mouse), KIF21B  -  kinesin family member 21b, SLIT1  -  slit homolog 1 (drosophila), SPEF2  -  sperm flagellar 2, COL5A1  -  collagen, type v, alpha 1, SNAI2  -  snail family zinc finger 2, DNAL4  -  dynein, axonemal, light chain 4, CDH4  -  cadherin 4, type 1, r-cadherin (retinal), PTPRA  -  protein tyrosine phosphatase, receptor type, a, ARMC4  -  armadillo repeat containing 4, ACAP3  -  arfgap with coiled-coil, ankyrin repeat and ph domains 3, TMEFF2  -  transmembrane protein with egf-like and two follistatin-like domains 2, NRCAM  -  neuronal cell adhesion molecule, WASF1  -  was protein family, member 1, PDE4B  -  phosphodiesterase 4b, camp-specific, PTPRF  -  protein tyrosine phosphatase, receptor type, f, LAMB1  -  laminin, beta 1, DRD2  -  dopamine receptor d2, DOCK4  -  dedicator of cytokinesis 4, PTPRO  -  protein tyrosine phosphatase, receptor type, o, PPP1R9B  -  protein phosphatase 1, regulatory subunit 9b, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, NOV  -  nephroblastoma overexpressed, SEMA4A  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4a, PARVA  -  parvin, alpha, ASTN1  -  astrotactin 1, CHL1  -  cell adhesion molecule l1-like, MERTK  -  c-mer proto-oncogene tyrosine kinase, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), GPM6A  -  glycoprotein m6a, PPIL2  -  peptidylprolyl isomerase (cyclophilin)-like 2, SEMA3D  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3d, DCDC2  -  doublecortin domain containing 2, TOR1A  -  torsin family 1, member a (torsin a), MKL1  -  megakaryoblastic leukemia (translocation) 1, FLRT3  -  fibronectin leucine rich transmembrane protein 3, EXT1  -  exostosin glycosyltransferase 1, VLDLR  -  very low density lipoprotein receptor, TEX101  -  testis expressed 101, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), VAV1  -  vav 1 guanine nucleotide exchange factor, WDR52  -  wd repeat domain 52, RAC2  -  ras-related c3 botulinum toxin substrate 2 (rho family, small gtp binding protein rac2), CXADR  -  coxsackie virus and adenovirus receptor, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNC1  -  troponin c type 1 (slow), RAB27B  -  rab27b, member ras oncogene family, TNNT1  -  troponin t type 1 (skeletal, slow), TNNI3  -  troponin i type 3 (cardiac), CCL28  -  chemokine (c-c motif) ligand 28, TEK  -  tek tyrosine kinase, endothelial, RNF165  -  ring finger protein 165, CRMP1  -  collapsin response mediator protein 1, RSPH9  -  radial spoke head 9 homolog (chlamydomonas), DLG2  -  discs, large homolog 2 (drosophila), BLOC1S6  -  biogenesis of lysosomal organelles complex-1, subunit 6, pallidin, SH3RF1  -  sh3 domain containing ring finger 1, NFIB  -  nuclear factor i/b, NR2F2  -  nuclear receptor subfamily 2, group f, member 2, NRXN1  -  neurexin 1, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ADTRP  -  androgen-dependent tfpi-regulating protein, HSPB11  -  heat shock protein family b (small), member 11, TYRO3  -  tyro3 protein tyrosine kinase, TMEM18  -  transmembrane protein 18, MAP2K1  -  mitogen-activated protein kinase kinase 1, CSF1R  -  colony stimulating factor 1 receptor, EPHA3  -  eph receptor a3, RAPGEF2  -  rap guanine nucleotide exchange factor (gef) 2, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, MAPK3  -  mitogen-activated protein kinase 3, MAPK1  -  mitogen-activated protein kinase 1, EPHB1  -  eph receptor b1, PRKG1  -  protein kinase, cgmp-dependent, type i, KALRN  -  kalirin, rhogef kinase, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, EPHA8  -  eph receptor a8, PRKCQ  -  protein kinase c, theta, PIK3CD  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta, NANOS1  -  nanos homolog 1 (drosophila), PRKCI  -  protein kinase c, iota, AGBL4  -  atp/gtp binding protein-like 4, PRKCD  -  protein kinase c, delta, DNAH5  -  dynein, axonemal, heavy chain 5, SLC16A8  -  solute carrier family 16 (monocarboxylate transporter), member 8, DNAH6  -  dynein, axonemal, heavy chain 6, TNFRSF11A  -  tumor necrosis factor receptor superfamily, member 11a, nfkb activator, WASL  -  wiskott-aldrich syndrome-like, TNFRSF10B  -  tumor necrosis factor receptor superfamily, member 10b, DRAXIN  -  dorsal inhibitory axon guidance protein, VPS13A  -  vacuolar protein sorting 13 homolog a (s. cerevisiae), CCK  -  cholecystokinin]
GO:1905097	regulation of guanyl-nucleotide exchange factor activity	9.08E-4	6.25E-2	10.51	14984	7	815	4	[STMN1  -  stathmin 1, MET  -  met proto-oncogene, FAM65B  -  family with sequence similarity 65, member b, EPHA4  -  eph receptor a4]
GO:0072503	cellular divalent inorganic cation homeostasis	9.26E-4	6.34E-2	3.01	14984	349	214	15	[CALB1  -  calbindin 1, 28kda, CCL28  -  chemokine (c-c motif) ligand 28, BDKRB2  -  bradykinin receptor b2, CALB2  -  calbindin 2, GPR6  -  g protein-coupled receptor 6, DRD2  -  dopamine receptor d2, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, GRM1  -  glutamate receptor, metabotropic 1, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4]
GO:0001581	detection of chemical stimulus involved in sensory perception of sour taste	9.34E-4	6.37E-2	1,070.29	14984	1	14	1	[PKD2L1  -  polycystic kidney disease 2-like 1]
GO:0006579	amino-acid betaine catabolic process	9.35E-4	6.34E-2	13.75	14984	3	1090	3	[DMGDH  -  dimethylglycine dehydrogenase, ACADL  -  acyl-coa dehydrogenase, long chain, BHMT  -  betaine--homocysteine s-methyltransferase]
GO:0010959	regulation of metal ion transport	9.37E-4	6.33E-2	1.64	14984	313	1574	54	[TRIM27  -  tripartite motif containing 27, GALR2  -  galanin receptor 2, DRD2  -  dopamine receptor d2, CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, NKAIN2  -  na+/k+ transporting atpase interacting 2, CAMK2A  -  calcium/calmodulin-dependent protein kinase ii alpha, KCNE2  -  potassium voltage-gated channel, isk-related family, member 2, DPP6  -  dipeptidyl-peptidase 6, PPAPDC1A  -  phosphatidic acid phosphatase type 2 domain containing 1a, CTNNB1  -  catenin (cadherin-associated protein), beta 1, 88kda, WFS1  -  wolfram syndrome 1 (wolframin), P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, CCL4  -  chemokine (c-c motif) ligand 4, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, SCN3B  -  sodium channel, voltage-gated, type iii, beta subunit, VIP  -  vasoactive intestinal peptide, CACNB2  -  calcium channel, voltage-dependent, beta 2 subunit, CD84  -  cd84 molecule, HAMP  -  hepcidin antimicrobial peptide, FKBP1A  -  fk506 binding protein 1a, 12kda, NKAIN4  -  na+/k+ transporting atpase interacting 4, STIM1  -  stromal interaction molecule 1, CRH  -  corticotropin releasing hormone, JPH4  -  junctophilin 4, RGS4  -  regulator of g-protein signaling 4, FKBP1B  -  fk506 binding protein 1b, 12.6 kda, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, FHL1  -  four and a half lim domains 1, HPCA  -  hippocalcin, FXYD6  -  fxyd domain containing ion transport regulator 6, OSR1  -  odd-skipped related 1 (drosophila), SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), ACTN2  -  actinin, alpha 2, PRNP  -  prion protein, DPP10  -  dipeptidyl-peptidase 10 (non-functional), NEDD4L  -  neural precursor cell expressed, developmentally down-regulated 4-like, e3 ubiquitin protein ligase, SCN5A  -  sodium channel, voltage-gated, type v, alpha subunit, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CNTN1  -  contactin 1, CORO1A  -  coronin, actin binding protein, 1a, P2RY12  -  purinergic receptor p2y, g-protein coupled, 12, GNAO1  -  guanine nucleotide binding protein (g protein), alpha activating activity polypeptide o, NETO2  -  neuropilin (nrp) and tolloid (tll)-like 2, PTPN3  -  protein tyrosine phosphatase, non-receptor type 3, NPPA  -  natriuretic peptide a, NETO1  -  neuropilin (nrp) and tolloid (tll)-like 1, BCL2  -  b-cell cll/lymphoma 2, KCNG1  -  potassium voltage-gated channel, subfamily g, member 1, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, FXYD7  -  fxyd domain containing ion transport regulator 7, PDE4B  -  phosphodiesterase 4b, camp-specific]
GO:0002526	acute inflammatory response	9.41E-4	6.32E-2	6.10	14984	40	430	7	[OPRM1  -  opioid receptor, mu 1, OGG1  -  8-oxoguanine dna glycosylase, F12  -  coagulation factor xii (hageman factor), ASS1  -  argininosuccinate synthase 1, IL1B  -  interleukin 1, beta, EXT1  -  exostosin glycosyltransferase 1, PTGES  -  prostaglandin e synthase]
GO:0003009	skeletal muscle contraction	9.45E-4	6.33E-2	9.31	14984	23	350	5	[RCSD1  -  rcsd domain containing 1, TCAP  -  titin-cap, TNNT1  -  troponin t type 1 (skeletal, slow), TNNI3  -  troponin i type 3 (cardiac), MYH7  -  myosin, heavy chain 7, cardiac muscle, beta]
GO:0055085	transmembrane transport	9.47E-4	6.31E-2	5.78	14984	1067	17	7	[GABRE  -  gamma-aminobutyric acid (gaba) a receptor, epsilon, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PKD2L1  -  polycystic kidney disease 2-like 1, SLC22A9  -  solute carrier family 22 (organic anion transporter), member 9, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, GRM1  -  glutamate receptor, metabotropic 1, SLC22A10  -  solute carrier family 22, member 10]
GO:0007275	multicellular organism development	9.64E-4	6.4E-2	2.02	14984	545	435	32	[TSHZ3  -  teashirt zinc finger homeobox 3, ADAMTS3  -  adam metallopeptidase with thrombospondin type 1 motif, 3, RNF165  -  ring finger protein 165, NXF5  -  nuclear rna export factor 5, TSHZ2  -  teashirt zinc finger homeobox 2, LRRC7  -  leucine rich repeat containing 7, CREG1  -  cellular repressor of e1a-stimulated genes 1, PTPRR  -  protein tyrosine phosphatase, receptor type, r, SLCO4C1  -  solute carrier organic anion transporter family, member 4c1, TAF7L  -  taf7-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 50kda, ENC1  -  ectodermal-neural cortex 1 (with btb domain), TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), HILS1  -  histone linker h1 domain, spermatid-specific 1, pseudogene, MYBPHL  -  myosin binding protein h-like, PDGFD  -  platelet derived growth factor d, DIAPH2  -  diaphanous-related formin 2, TYRO3  -  tyro3 protein tyrosine kinase, APBA1  -  amyloid beta (a4) precursor protein-binding, family a, member 1, LTK  -  leukocyte receptor tyrosine kinase, VDR  -  vitamin d (1,25- dihydroxyvitamin d3) receptor, EPHA3  -  eph receptor a3, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, CELF4  -  cugbp, elav-like family member 4, AKIRIN2  -  akirin 2, MET  -  met proto-oncogene, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, OBSCN  -  obscurin, cytoskeletal calmodulin and titin-interacting rhogef, RCN1  -  reticulocalbin 1, ef-hand calcium binding domain, MST1R  -  macrophage stimulating 1 receptor (c-met-related tyrosine kinase), CDH8  -  cadherin 8, type 2, CDH9  -  cadherin 9, type 2 (t1-cadherin)]
GO:0072507	divalent inorganic cation homeostasis	9.74E-4	6.43E-2	2.09	14984	366	568	29	[CCL28  -  chemokine (c-c motif) ligand 28, PARK2  -  parkinson protein 2, e3 ubiquitin protein ligase (parkin), CAMK2N1  -  calcium/calmodulin-dependent protein kinase ii inhibitor 1, NMU  -  neuromedin u, KL  -  klotho, DRD2  -  dopamine receptor d2, SNCA  -  synuclein, alpha (non a4 component of amyloid precursor), CAMK2D  -  calcium/calmodulin-dependent protein kinase ii delta, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, PTGER3  -  prostaglandin e receptor 3 (subtype ep3), PTGER4  -  prostaglandin e receptor 4 (subtype ep4), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, CD52  -  cd52 molecule, GRIA1  -  glutamate receptor, ionotropic, ampa 1, CALB1  -  calbindin 1, 28kda, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, BDKRB2  -  bradykinin receptor b2, CALB2  -  calbindin 2, GPR6  -  g protein-coupled receptor 6, CCDC109B  -  coiled-coil domain containing 109b, GRIK2  -  glutamate receptor, ionotropic, kainate 2, P2RY6  -  pyrimidinergic receptor p2y, g-protein coupled, 6, CACNA2D1  -  calcium channel, voltage-dependent, alpha 2/delta subunit 1, GRM1  -  glutamate receptor, metabotropic 1, CACNB3  -  calcium channel, voltage-dependent, beta 3 subunit, BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, SLC25A23  -  solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNNI3  -  troponin i type 3 (cardiac)]
